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SUMM ART
SUMMARY
The history of knowledge on plasma proteins and the methods of
separation are reviewed with particular reference to the development of
the quantitative Immunoelectrophoresis technique used in the present work.
The discovery of plasma protein abnormalities in liver disease and
the evidence that the liver is the main site of synthesis is discussed.
The mechanisms of plasma protein synthesis and cataholisss and their
control are outlined.
A summary is given of the properties and functions of the 14 plasma
proteins studied in this work (prealbumin, ^-easily precipitable glyco¬
protein, «^-antitrypsin, group component, o^-macroglobulin, eaeruloplasmin,
haptoglobin, haemopexin, transferrin,-lipoprotein, A-C globulin (C3,
third component of complement) and protein numbers 10, 16 and 18).
A quantitative modification (Clarke and Freeman) of Laurell's crossed
Immunoelectrophoresis method using large plates is described.
Clarke and Freeman's method has been adapted for 5 x 5ess. plates
(miniplates) with great saving in cost. This tfciniplate method was shown
to give a reproducible and quantitative measure of plasma protein
concentration.
Aliquots of sera were stored at -20°C. The concentration of f-
lipoprotein fell by 30-50$ bwt the levels of other proteins were unchanged
over a period of 12 months.
Using the miniplate method a normal range for 13 proteins was
established in a control population of 70 healthy blood donors and
laboratory personnel. Prealbumin was found to be significantly higher in
males than females and o^macroglobulin and caeruloplasmin were higher in
females. Haemopexin and easily precipitahle glycoprotein increased
significantly with age. These findings are in agreement with other
published studies. Repeated samples from normal individuals over a period
of months showed there was little change in the concentration of any
protein.
As few pure protein standards are available, protein concentrations
in this study have been expressed as a percentage of a standard serum.
However, absolute values for 6 proteins were obtained ty reference to a
standard serum with known concentrations of these proteins. The normal
ranges for these proteins in the control population agree well with other
published Besuits.
Sera from seven diagnostic groups of patients were examined. Large
plates were used to study sera from patients with primary haemochromatosis
(29), alcoholic cirrhosis (12), cryptogenic cirrhosis (12) and active
chronic hepatitis (20). Miniplates were used for sera from patients with
acute viral hepatitis (12), extrahepatic biliary obstruction (12), primary
biliary cirrhosis (?0) and a further series of patients with haemochromatosis
(28).
Statistically significant changes in the concentration of at least one
piasma protein were found in all diagnostic groups studied and the most
striking and numerous changes occurred in the disease groups with the greatest
abnormality of liver function tests.
Prealbumin, lean levels were low in each of the 4 groups of patients studied
(viral hepatitis, extrahepatic obstructive jaundice, primary biliary cirrhosis
and haemochromatosis).
Easily precipitable glycoprotein. Mean levels were raised in acute viral
hepatitis, extrahepatic obstructive jaundice, primary biliary cirrhosis and
active chronic hepatitis but normal in the other diagnostic groups.
Alpha-l-antitrypsin levels. Alpha-l-antitrypsin levels were raised in acute
viral hepatitis, extrahepatic obstructive jaundice, andjsrimary biliary
cirrhosis but normal in primary haemochromatosis,
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Group component. Mean concentrations were normal in all the seven diagnostic
groups of patients with liver disease.
Alpha-2-macroglobulin. The mean concentration was raised inly in those
groups of patients with extensive hepatic fibrosis or cirrhosis.
Caefruloplaamin. The concentration was normal in haemochromatosis and
cryptogenic cirrhosis but raised in the other 5 groups.
Protein 10. The concentration was raised in acute viral hepatitis but
normal in all other diagnostic groups.
Haptoglobin. The concentration was low in acute viral hepatitis and
active chronic hepatitis and no visible precipitation arc was seen in some
cases. Levels were normal in the other groups.
Haemopexin. The concentration was low in acute viral hepatitis, extraheptic
obstructive jaundice, and primary biliary cirrhosis but normal in the other
diagnostic groups.
Transferrin. The concentration was low in extrahepatie obstructive jaundice,
haemochromatosis and alcoholic cirrhosis but raised in active chronic hepatitis.
Beta lipoprotein. The concentration was raised in acute viral hepatitis
and reduced in extrahepatic obstructive jaundice but normal in the other
groups.
Protein 16. The concentration was raised in extrahepatic obstructive
jaundice and primary biliary cirrhosis but normwl in acute viral hepatitis
and haemochromatosis.
Protein 18. The mean concentration was reduced in extrahepatic obstructive
jaundice and the protein was undetectable in several cases. Levels were
normal in acute viral hepatitis, primary biliary cirrhosis and haemochromatosis.
Beta 1--AC globulin (C3). was measured only in the large plate studies and
was raised in cryptogenic and alcoholic cirrhosis and active ohronic
hepatitis.
The pattern of changes seen was very similar to the non-specifio
"acute phase reaction". When there was severe parenchymal liver disease
the pattern appeared to he modified by the reduced hepatic capacity for
protein synthesis. ThiB was clearly seen in cases of active chronic
hepatitis where only after liver function had improved with treatment was
the synthetic capacity of the liver increased sufficiently to egress the
acute phase reaction fully. The major differences from the acute phase
reaction as normally seen were normal or low concentrations of haptoglobin
thought to he due at least in part to shortened red-cell life span and
raised levels of alpha-2-ciacroglohulin which were found only in liver
disease in which there was extensive fibrosis or established cirrhosis.
The previously reported finding of raised concentrations of haemopexin
and other proteins in primary haemochromatosis was not confirmed in further
studies using the rainiplate technique, and detailed examination of the
discrepancy suggested that a technical error accounted for the results of
the earlier study. Serial venesection in 6 patients with haemochromatosis
did not significantly effect the concentration of any protein with the
exception of transferrin which rose progressively in 3 cases.
Haemopexin concentrations were also normal in close relatives of patieSts
with haemochromatosis and in patients with secondary iron overload. The
serum transferrin concentration was significantly reduced in the relatives
of patients with haemochromatosis.
There was no evidence for in vivo conversion of the third component of
complement (C3) in a small number of patients with active chronic hepatitis
and primary biliary cirrhosis.
The changes in plasma protein concentration following orthotopic
transplantation of the liver were followed in 4 patients. TJie same pattern
of changes was seen post-operatively with rejection of the graft, biliary
obstruction and sarcinomatosis and the pattern was similar to the "acute
phase reaction". In one case a precipitous fall in C3 occurred at the
onset of an acute rejection episode suggesting consumption of complement.
11. In the sera from 7 patients with severe deficiency of alpha-1-antitrypsin
deficiency the concentration of the other proteins was normal apart from a
rise in ^-macroglobulin and protein 10,
12. No change occurred in the concentration of the 13 proteins studied over
a 7-day period in two normal subjects during hepatic microsomal enzyme
induction.
In 15 epileptic patients receiving long-term anti-convulsant therapy,
in whom raised urinary glucaric acid excretion indicated hepatic enzyme
induction, there were significant increases in the concentration of easily
precipitable glycoprotein, * ^-antitrypsin, group component, ^-macroglobulin,
caeruloplasiain and protein 16.
13. Th© acute phase reaction and the factors controlling its expression
are reviewed. The changes in the concentration of the individual proteins
in the different categories of liver disease are discussed in relation to
the factors known to control their synthesis and eatabolism.
14. The diagnostic value of the plasma proteins measured by immunoelectro-
phoresis was assessed using a linear stepwise discriminant function and a
sequential Bayesian. function to reclassify the cases inkseven diagnostic
groups. The overall error using both methods lay between 12 and 34^-• No
protein was of particular diagnostic value and the error in reclassification
was least when the values of all proteins measured were used. The error in
reclassification of 85 casss intseven diagnostic groups using data derived
only from the cellulose acetate electrophoresis strip was 51$« Diagnostic
accuracy was greatest when all the data from Immunoelectrophoresis and






1. History of plasr.a proteins and their identification
The history of plasma proteins starts with the discovery of nitrogen
by Daniel Rutherford who obtained his Doctorate in Medicine in 1772 frosa
the University of Edinburgh for his "Bissertatio inauguralis d© Aere Fixo
Dieto, aut Mephitico". liagendie (l8l6) was the first to recognise the
importance of nitrogen in food stuffs and from dietary experiments in
dogs he concluded that nitrogen containing nutrients were an essential
part of the diet. The Butch chemist Gerard Mulder (1839) examined a series
of nitrogen-rich organic compounds including fibrin and egg albumen and
concluded that they all contained the same basic elements in the same pro¬
portions and he proposed the name protein from the greek verb meaning "I
take the first rank" (Liebig l842j. The view that all proteins were
chemically identical was generally accepted for some years (Liebig 1842)
but Liebig later (1847) argued against this unitary hypothesis on the basis
of further analyses.
The earliest attempt to fractionate the serum proteins was by
Parnum (l851» 1852) who found that dilution of serum after weak acidifi¬
cation produced a precipitate. He claimed this separated 'Casein' from
serum ?/hile albumin, a different protein, remained in solution. This
technique of separation was later known as iso-electric fractionation.
Denis (1856) also described the use of salt precipitation and was the first
to use the word globulin in relation to serum proteins. This fraction
appears to have consisted of erythrocyte stroma contaminated by precipitated
globulin. He thought it contained dissolved 'globules' of blood and for
this reason called it globulin. The term albumin ("albumins") had first
been used by Fourcroy in 1789 (see Denis 1856) to describe egg white.
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Numerous other fractions were described by other authors and the
system was simplified by Hoppe—Seyler (l8?0) who called globulin that
fraction which precipitated on dilution following weak acidification and
albumin the protein which remained in solution.
■There ?<as little further advance in protein chemistry until the end
of the 19th Century when there were two further major discoveries. The
electro-chemistry of proteins was introduced in 1892 when Pieton and
Linden observed the displacement of the line of demarcation between a
haemoglobin solution and an aqueous solvent under the influence of an
electric current. The second major advance was in analytical chemistry
and Fischer was able to conclude after several years research (1906) that
acid hydrolysis of all proteins studied yielded amino ac.idsf and he deduced
that proteins are made up of a large number of J- amino acid residues
condensed by the formation of an amide link between the cL amino group of
one molecule and the carbosyl group of another.
The next real advance was due to the work of the Swedes Svedberg
and Tiselius in the 1930's. Svedberg (1928) developed the ultracentrifug
and showed that the weight of protein molecules could be deduced from the
equilibrium established in a suitable gravitational field between
sedimentation and diffusion, Tiselius (1937) developed an apparatus which
allowed the study of the movement of protein ions in an electric field.
All serum could be separated into 5 components designated Sp y , ,cJ.
and A (albumin) in increasing order of speed of migration towards the anode.
In the classical paper ultra-violet absorption was used for detection of
the concentration gradients and this was later superseded by measurement
of the gradient of the index of the re-fraction. Increasing resolution
was also achieved by increasing the time of electrophoresis and altering
the pH of the buffers. Both techniques showed the heterogenous nature of
saruzn proteins obtained by fractional precipitation using ammonium sulphate
and iso-electric fractionation but these techniques remain useful as
preliminary steps in the separation of proteins.
Cohn (1953) developed a new and highly selective method of protein
precipitation by varying the alcohol concentration, salt concentration,
and pH and by these measures not only was the separation better but more
nearly quantitative.
Tiselius* method of electrophoresis was technically difficult and
time consuming and turbid lipaemic serum could not be analysed due to
interference with the optical system of the appartus. Improvements in
electrophoretic separation followed changes in the supporting medium.
Paper electrophoresis was introduced in 1950 (Purrum 1950) and although
more convenient the protein bands were indistinct. Electrophoresis in
gels has the advantage that adsorption of the protein is less and with
starch (Smithies 1955) and polyaery],amide there is also a molecular
sieving effect. For most routine purposes cellulose acetate is now used
(Kohn 1957)* However with these techniques identification and quantitation
of individual proteins is difficult or impossible.
More recently techniques have been developed suitable for the
isolation of individual proteins. These include ion exchange chromato¬
graphy (Freeman 1970), exclusion chromatography (Hjerten, 1971) and
electrofocussing (A'rigley 1971) but none are applicable to the examination
of several different proteins in large numbers of individual sera.
Immunecheat!stry arid Immunoelectrophoresis
The first application of immunological techniques to the identifi¬
cation and measurement of serum proteins was in 194- by Oudin (Oudin 1953)
who used vertical diffusion of antigen and antibody in a test tube and
showed that human serum contained at least 10 components. In 1948
Quchtsrlony adapted the method and carried out precipitation reactions
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horizontally on a plats of agar# Because of the proximity of the different
precipitin lines these methods are not suitable for examining the large
numbers of antigens in serum simultaneously and one solution to the problem
was to first separate the proteins by electrophoresis. This was first
described in 1953 tjy Grabar and Williams. The serum was separated into
its components by electrophoresis in agar and after its completion anti¬
body was placed in a trough which bordered the length of the agar plate.
The antigen and antibody diffused towards each other and precipitated in
zones of equivalence. Between the arcs of albumin and gamma globulin
there were at least 18 distinct proteins. The density of the precipitation
lines was higher in certain regions corresponding to the and ,6'
globulin bands originally described by Tiselius. A micro-aodification of
the method was introduced by Scheidegger (1955)*
Immunoelectrophoresis represented a considerable advance as it
clearly showed that the 5 conventional electrophoretic fractions were
composed of a large number of individual proteins many of which were
identified for the first time. However, accurate quantitation of the
proteins was not possible and resolution of the arcs was poor because of
the diffusion of the proteins in the second step. Quantitation of
individual proteins awaited better methods of separation so that mono¬
specific antisera could be produced. Eadial immunodiffusion of the anti¬
gen in antibody impregnated agar was introduced by ttancini (1965) and
Laurell (1967) used electrophoresis to drive the antigen into the bed of
antiserauu. This produced a flame shaped track (rocket) and the height of
the rocket was proportional to the concentration of the protein in the
sample. Comparison of these two methods showed close agreement (Becker 1967)•
These methods are time consuming and expensive and if Immunoelectrophoresis
could be made quantitative this should offer a better method of measuring
multiple proteins in a single sample.
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The first attempt to increase the resolution of protein separation
by Immunoelectrophoresis was by Ressler (i960) who introduced the concept
of two dimensional imnunoalectrophoresis. He separated the serum in starch
gel and then transferred a strip into a buffer-agar-an tiserum mixture for
a second dimension electrophoretic run at right angles. Laura11 (1965)
used the same technique except that agarose was used as the supporting
medium for both electrophoretic steps; Agar is a mixture of polysaccaridss
obtained from algae. Its carbohydrate sequence consists mainly of repeating
units of (1-4)-linked 3»6-anhydro-jC-L galactopyranosa and (l-3)-linked
pi -D-galactopyranose, It can be separated into two fractions, one of whihh
is almost neutral (agarose) and one which is charged due to the content of
sulphate groups and carboxyl groups (agaropsctin). This implies that
because of the fixed nature of the charged agar network there will be water
transport towards the cathode (electro-osmosis) with poor separation of the
slower moving proteins,and also the risk of interaction with the agar gel
(Wieme 1965). These problems are considerably reduced by using agarose.
Laurell's method was modified by Clarke and Freeman (19665 1968) so
as to make it quantitative for the plasma proteins. The whole of the first
dimensional strip was used in running the second dimension and they showed
that the area under any protein peak was directly proportional to the
concentration of that protein in the serum and inversely proportional to
the concentration of antibody to that protein in the antiserum to whole
human serum. As the titre of antibodies te the different serum proteins
differs greatly, the relative sizes of the precipitation arcs for the
different proteins are not an indication of their absolute concentration
in the serum and different serum samples are compared by reference to a
standard serum. This technique and a scaled down modification are used
in the present study.
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3. Plasma protein disturbances in liver disease
The realisation that disturbances in the plasma proteins occur in
liver disease is JO years old (Jolles 1902) and the finding of a low
serum albumin level was soon confirmed by other workers (Gilbert and
Chiray 1907? Grenet, 1907)* Initially the low albumin was attributed
to the suinp effect of the albumin-rich ascites but not all cases of
cirrhosis with low serum albumin had ascites and Crenet (1907) was later
proved correct when he said "nous conside'rons l'insufficsance hepatique
comme capable de determiner a elle seule une diminution des albumirtes du
serum sanguin". Later reports also noted a rise in the globulin fraction
(Salvessn, 1929? Abrami and Wallich 1929? Peters and Eisenman 1933? i-Syers
arid Keefer 1935? Tumen and Bockus 1937)»
Detailed observation was delayed until more sophisticated methods
of examination of plasma proteins became available. Longsworth et al
(1939) were the first to report their results with the Tiselius electro¬
phoresis technique and a flood of papers followed (Luetscher, 1940? Gray
and Barron 1943? Sterling et al 1949? Ricketts et al 1949)* All noted a
fall in albumin and a rise in gamma globulin and in addition in obstructive
jaundice there is a riss in beta globulin (Sterling and Eicketts 1949?
Kunkel and Ahrens 1949)* Results using paper electrophoresis were similar
but emphasized the frequent rise inJ^ and d ^ globulins but the patterns
were not sufficiently distinctive to differentiate the different types of
liver disease with any certainty (Wall, 1958? Osserman and Takatsuki 1963)*
Initial iamunoelectrophoretic studies were also of very limited diagnostic
use because the method was not quantitative, but a fall in the concentration
of prealbumin and a rise in caeruloplasmin, haptoglobin and</^ macroglobulin
were noted in some patients (Scheidegger and Sahnd, 1957? Bargob et al 1958?
Heremans 1959? Isam et al I960? Verain et al 1961).
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The measurement of certain individual proteins was found to be of
some diagnostic value. For instance very low levels of caeruloplasmin
were found to be very suggestive of Wilson's disease (Scheinberg and
Gitlin, 1952) although low levels may also be found in other types of
liver disease. High levels of haptoglobin were in favour of obstructive
jaundice rather than parenchymal disease (Owen et al 1961) and genetically
determined low levels of antitrypsin were first recorded in a patient
with liver disease in 19&7 (Ganrot et al, 19&7)*
The development of radial immunodiffusion allowed the measurement
of several individual plasma proteins in large numbers of patients with
liver disease (Muller and Muller von Voigt 19^71 Cleve and Strohraeyer
1967) but no attempt was made to use this information in differential
diagnosis. Quantitative Immunoelectrophoresis is a cheaper and more
convenient method of measuring a number of immunologically distinct proteins
in the same serum sample and it was chosen for the present studies for this
reason.
4« Liver as the Site of Plasma Protein Synthesis
Although the association of liver disease with plasma protein
abnormalities had been known for many years, the site of plasma protein
synthesis remained unknown until comparatively recently. Kerr et al (1918)
noted a definite lag in the restoration of the concentration of serum
proteins in Eck fistula dogs following acute plasma depletion or chemical
liver injury. Knutti et al (1937) reported observations over 2 years on
an Eck fistula dog which at times was unable to maintain normal plasma
protein concentration on various standard diets and they presented evidence
that its protein synthetic capacity was less than l/lGth normal. At
autopsy there were no abnormalities apart from the shrunken liver usually
found in Eck fistula animals. In a review of the literature in 1940
Madden and Whipple said "in debate about the source of albumin and
globulin hardly an organ or tissue escapes, unless it be the brain".
Tarver and Reinhardt (1947) studied the incorporation of methionine
labelled with radio-active sulphur into plasma proteins in the hepatectomised
dog and concluded that the majority of albumin, globulin and fibrinogen
synthesis occurred in the liver. The identification of the plasma protein
fractions containing radio-active label was limited by the techniques
available at that time. Miller et al in a series of papers (l951> 1954a?
1954b) provided the first unequivocal evidence that the liver is the major
source of newly synthesised albumin, fibrinogen, alpha and beta globulins.
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Experiments ware performed on the incorporation of C-lysine into protein
by the isolated perfused rat liverj in the initial experiments the
fractions were isolated by salt fractionation but in the later work by zone
electrophoresis on starch followed by elution of the protein fractions.
Perfusion of the anhepitic animal carcass showed that almost all the
protein synthesised was gamma globulin. Similar results and conclusions
were reached by Kukral et al (1961| 1963) studying the incorporation of
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^S—methionine into plasma proteins.
Recently more sophisticated radio-active tracer methods and protein
separation systems have demonstrated that the liver is the major if not
the only site of the synthesis of most plasma proteins. This evidence
will be presented later when the individual plasma proteins are discussed
in detail. The principles of the mechanism of plasma protein synthesis
?/ill now be illustrated by reference to albumin which, has been the most
closely studied protein.
Mechanism of Plasma protein synthesis
The mechanisms geared for the synthesis of plasma proteins consist
of 3 major classes of MA, messenger RNA (mMAJ ribosomal MA (r MA) and
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transfer MA (t EM) as well as structural protein and the endoplasmic
reticulum (EH).
The steps in the synthesis of plasma proteins have been studied
most closely for albumin (Munro 1970)• The synthesis of albumin takes
place in the cytoplasm through the interaction of the ribosome with mEM
and the EE, The ribosome is mad© up of two subunits. The smaller unit
consists of 18S RM plus protein making a 40S ribosome subunit and the
larger consists of 28S EM. plus protein making a 60S subunit. The
ribosomal proteins are synthesized in the cytoplasm, then enter into the
nucleolus and combine with r EEA to form the specific ribosomal subunits.
These then return to the cytoplasm subunit pool and are available for
attachment to mRlA. The larger subunit is attaohed in vertical alignment
to the microtubular structure of the EE and it is thought that the growing
protein chain enters the EE through the interior space of the 60S subunit.
As each specific amino acyl tREA, determined by a code of 3 nucleo¬
tides in the mRM, inserts its amino acid into the peptide chain, the
peptide is translocated from one spot to the next on the mEliA. The
ribosomes move along the mRM and at the end of the sequence when the
albumin polypeptide is completed, the ribosomes are disaggregated from the
mRM and dissociate into subunits mixing with the available old and newly
synthesized subunit pool.
Transport through the cell of newly produced albumin molecules has
recently been clarified. Peters et al (1971) have shown that following
the administration of a tracer dose of labelled amino acid, the specific
tRNA becomes labelled through the attachment of the labelled amino acid
and the amino acid is incorporated into the growing albumin chain within
a minute or less. At 1-3 minutes the labelled albumin reaches the rough
endoplasmic reticulum membrane which contains albumin of highest specific
activity. At 3-6 minutes the smooth endoplasmic reticulum reaches maximum
a r*1 b
specific activity and sifter 15-20 minutes the Golgi apparatus contains
the highest specific activity of albumin. Release of albumin is sensitive
to potassium concentration within the liver cell. When potassium content
is reduced, or when ouabain is present, the release of labelled albumin is
slowed, suggesting an active transport system (judah and liicholls, 1970)•
Geller et al (1972) have presented evidence for the existence of a molecule
larger than albumin in the liver cell and suggest that the conversion of
this polypeptide to albumin before secretion is rate limiting. The
carbohydrate unita of the glycoproteins are assembled stepwise by transfer
of monosaccharides to the completed polypeptide as it passes along the
rough and smooth endoplasmic reticulum (Redman and Cheriam, 1972). The
Golgi apparatus probably completes the addition of carbohydrate (Wagner
and Cynkin, 1971)•
As the plasma proteins are being continuously replaced it is
obvious that the plasma concentration represents the balance between
synthesis and catabolism and changes in either or both can alter the
plasma pool and concentration. It is therefore unwarranted and often
wrong to equate a low concentration of a plasma protein with diminished
synthesis. This has been clearly shown recently for albumin (Rothschild
et al, 1969). In 19 patients hospitalised with cirrhosis and ascites,
albumin synthesis measured with the "^C-carbonate technique was found to
be normal or elevated in 12 and reduced in only 7* There was no relation¬
ship between albumin synthesis and the serum albumin level.
Control of plasma protein synthesis
Quantitative control of the synthesis of any plasma protein can be
exercised by recruitment of new cells or by increasing the amount of protein
produced by individual cells. Evidence for an increase in the number of
parenchymal cells synthesizing a particular protein is given by Lane (1968)
and Peters and Alper (1966) for transferrin and haptoglobin respectively
using a fluorescent antibody technique. The assumption that the presence
of the protein in the cell is indicative of current synthesis is supported
by the observation that binucleate cells stained more frequently than
other cells when haptoglobin synthesis was stimulated by turpentine
injection. This suggests that some cells may be selectively stimulated
to synthesize haptoglobin.
Synthesis in the individual cell can be regulated in many ways.
Transcriptional control is effected by altering the rate of formation of
mRM by ISA polymerase from the MA template or by altering the transport
or degradation of mBNA. Transiational control acts at a ribososal level
involving the activation of amino acids, their binding onto tMA and the
microsomes and the subsequent events leading to release of the completed
protein. The addition of carbohydrate chains to glycoproteins, the cleavage
of a precursor molecule before release from the cells and the possible
existence of an active transport system for release all offer further post-
translational sites at which rotein synthesis could be regulated.
Evidence for transcriptional control usually relies on the effect of
actinomycin D to suppress the activity of an inducer. Since aetinoraycin
D inhibits DNA-dependent ETA synthesis, inhibition of induction implies
that the increased rate of synthesis is dependent on increased levels of
bSIA. This appears to be one mechanism by which hepatic enzyme induction
by drug© acts (Parke 1971). Evidence will also be given that the augmented
synthesis of the acute phase proteins (fleuhaus et al, 19665 Mating et al 1968
Sarcione, 1970) and the induction of caeruioplaensin by copper (Evans et al
1970b) may be mediated in this way. These examples will be discussed later,
There is not? good evidence that the state of aggregation of the
polyribosomes as assessed on sucrose density gradient analysis is a
sensitive index of protein synthesis within the cell (Sidransky 1972).
The polyribosomes are readily disaggregated by lack of amino acids, alcohol
and other toxins. The effects of fasting on protein synthesis have been
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extensively studied and coincident with the disaggregation of the poly¬
ribosomes, albumin synthesis rapidly decreases (Miller and John, 19?0|
Rothschild et al 1972). Befeeding results in reaggregation of the
polyribosomes and the synthesis of new albumin, even if aetinomycin 15
is given, suggests that the mRLA for albumin is stable. In the isolated
perfused liver taken from a fasted animal the addition of amino acids
to the perfusate results in an increase in albumin synthesis to above the
levels found in the fed control. This may be because in the fasted state
the shorter lived mR;.A for other proteins decreases and the long lived
mBHA for albumin has less competition for the limited ribosoaial population.
While overall reduction in amino acids has the maximum effect on protein
synthesis, a special role has been suggested for tryptophan, which in
addition to its ability to reverse the polyribosome disaggregation in
fasting, is also able to reverse the reduction in protein synthesis due
to alcohol (Rothschild et al 1971)• The exquisite sensitivity to trypto¬
phan may be due to the low levels of thd free amino acid in the liver and
plasma most of it is bound to albumin.
Hormones have a complex and poorly understood effect on protein
synthesis (Munro 1970)• In experimental animals thyroid hormone and
cortisone stimulate albumin synthesis in vivo and this effect of cortico¬
steroids has been well documented in patients with liver disease (Cain
et al 1970f Wesierga&rd et al 1972). The widespread changes which occur
in the concentrations of many plasma proteins in pregnancy and in women
on oestrogen containing oral contraceptives is well known. The pattern
of changes in these two situations is very similar and quite different
from the acute phase reaction (see below). There is a rise in the
concentration of oC 2-ciacroglobulin, eaeruloplasmin,d^-antitrypsin and
transferrin and a fall in orosomucoid and haptoglobin (Ganrot and Bjerre,
19^7} Laurell et al 1967 5 Home et al 1970s Mendenhall, 1970s Song et al
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1970)• Progestagens appear to indue© no change in protein concentrations
(Laurell et al 1969) but administration of 17-alpha alkyl anabolic
steroids is followed by a rise in orosomucoid,^^-antitrypsin, haptoglobin
and prealbumin but no change in transferrin or oaeruloplasmin (Barbosa
et al 1971)• This pattern is different from that produced by both
oestrogens and the acute phase reaction.
Protein Catabolism
The factors governing the removal of proteins from the circulation
are obviously important determinants of the plasma protein concentration.
A •suicidal' protein like haptoglobin is rapidly cleared from the
circulation after combining with haemoglobin and the two molecules of the
complex are catabolised together. However it seems that perhaps only
half of its catabolisss is related to haptoglobin carriage (iioyes and
Garby, 1967) and the factors which determine the removal of the other
molecules are unknown. Studies with radioactive labelled plasma proteins
indicate that for most proteins the catabolic process is indiscriminate
and it matters not whether the protein molecules had been present in the
circulation for a considerable period of time or had been newly synthesized.
Eecent work indicates that removal of the sialic acid residues from most
glycoproteins results in a greatly shortened plasma half life and the
proteins are rapidly taken up into the parenchymal cells of the liver
(lorell et al 197l)» However this seems unlikely to be of major physiological
importance as under normal circumstances the liver seems to be an
unimportant site of plasma protein catabolism (McFarlane, 19^95 Tavill
1972). Structually abnormal plasma proteins may be formed in certain
disease states and such subtle changes may alter the survival in the
circulation. Examples are the production of apocaeruloplasrain which is
rapidly cleared from the circulation in experimental copper deficiency
(Holtzman and Gaumnitz, 1970b) and an abnormal plasma orosomucoid in some
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patients with malignant disease (Rudman et al, 1972).
The biological half life of a protein in the plasma is inversely
proportional to the fractional catabolic rate which is the amount of
protein catabolised expressed as a percentage of the plasma pool mass per
unit time. For some proteins like fibrinogen (Freeman, 196?) the fractional
catabolic rate is constant regardless of the plasma concentration or pool
size. A degree of compensation is built into the system for a fall in
plasma concentration is accompanied by a reduction in the total amount
of protein catabolised. However in chronic liver disease the fractional
catabolic rate may increase due possibly to intravascular coagulation
(Tytgat et al 1971)• For other proteins such as haptoglobin the fractional
catabolic rate seems to be inversely proportional to the plasma concentration
(Freeman 1964). This means that a constant amount of protein is catabolised
daily and the system has no buffering capacity. In contrast the fractional
catabolic rate of albumin is directly related to its plasma concentration
and this means that the biological half life alters in response to the pool
size thus providing a sophisticated method of compensation (Kirsch et al
1968). The factors determining which pattern of cataholic process occurs
with any one plasma protein are entirely unknown and the usual relationship
between the plasma concentration and fractional catabolic rate may be disturbed
in disease states (Waldmann et al 1972).
Other routes of protein loss may be important in patients with liver
disease including leakage into the bowel (Takada et al 1970) and ascitic
fluid.
Some of the properties and functions of the plasma proteins studied
in the present work will now be mentioned briefly. The significance of the
pathological changes found in liver disease will be discussed later.
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6. Introduction to the proteins studied in the present work
Prealbumin (Prealb)
This protein was first isolated by Schultze et al (1956) who noted
it was rich in tryptophan and hence it is sometimes called tryptophan-
rich-preslbumin. Its sactecular weight has been shown to be 54,000 and the
molecule splits into 4 subunits in 6! guanidine (Branch et al 1971)• The
ability of prealbumin to bind thyroxine was first noted in 195C; by Ingbar.
There is one high affinity binding site for the thyroid hormones and 3
other weaker binding sites (Bilsson and Peterson, 1971)• Although about
3C$ of plasma thyroxine is bound to prealbumin, 10$ by albumin and 60$ by
thyroxine binding globulin, the molar ratios mean that less than 1$ of the
prealbumin molecules carry thyroxine (Smith and Goodman 1971)* The
significance of prealbumin in thyroid hormone metabolism is uncertain
but it is not thought to be an important determinant (Braverman et al 1971)*
More recently it has been shown that prealbumin plays a part in
vitamin A metabolism. Vitamin A as retinol is almost completely bound in
1»1 solar ratio in the serum to a retinol binding protein, which has been
isolated and shown to have a molecular ur<i^of 21,000 (Peterson 1971 )• The
great majority of the retinol binding protein is itself bound to prealbumin
and the complex with a molecular weight of 85,000 is too large to pass into
the glomerular filtrate and it therefore acts to retain vitamin A in the
circulation (Smith and Goodman 1971)•
B. A lpha-1-anti trypsin (•/-.-AT)
Serum has been known to inhibit the proteolytic action of trypsin
for 75 years (Camus and Gley, 1897) but j£-j-antitrypsin was not identified
as the stajor protein concerned till its isolation in 1962 by Schultze et
al. Its molecular weight is 54,000 and it contains 12$ carbohydrate. The
name is obviously derived from its action in inhibiting trypsin activity
but it also inhibits chymotrypsin, elastase and to a lesser extent plasmin
and thrombin (Fagerhol and Laurell, 1970), as well as proteolytic enzymes
derived from polymorphonuclear leucocytes and macrophages (Kueppers and
Bearn, 1966)• This latter property may be of great importance in under¬
standing the clinical manifestations associated with severely reduced
concentrations of this protein in the plasma. Two major types of clinical
disease are associated with deficiency of ^-antitrypsin. A relationship
with chronic lung disease was first noted Laurell and Eriksson (1963)
who found 3 cases of emphysema among 5 patients with low plasma levels of
06^-antitrypsin. Since this time many further reports have appeared con¬
firming the relationship (Jones and Thomas, 1971? Hutchison et al, 1972)
in up to 29^ of patients with severe emphysema. This high figure is a
reflection of patient selection. Sharp et al (1969) were the first to
point out the association between severs deficiency of ^ j-AT and cirrhosis
in childhood although a previous report had noted cirrhosis at autopsy in
adults dying with emphysema (Ganrot et al, 1967)• The role of this protein
in the causation of liver disease had not been clearly defined at the time
when the present studies were started.
The level of ^-antitrypsin in the plasma is under genetic control
and the data is consistent with multiple codominant alleles at a single
locus (Fagerhol and Laurell, 1970). Each allele has been assigned an
alphabetical letter on the basis of the electrophoretic mobility of the
variant it determines and the system is known as the Pi (proteinase
inhibitor) system. Twenty one phenotypes have been described so far using
acid starch gel electrophoresis combined with antigen antibody crossed
immunoelectrophoresis (Adarason et al, 1971)* Most individuals are homo-
Iff
zygous for Pi (phenotype MM) but up to 13^ carry variant genes. (P.Cook,
Personal communication). Most of these variant gene products occur in
M
serum at the same concentration as the product of Pi Taut lower concan-
P s w z
trations occur with Pi alleles Pi , Pi , Pi and Pi . By far the
z
commonest is Pi and the homozygous state (ZZ) is associated with the
lowest plasma ^-antitrypsin concentrations and can he identified hy
simple quantitative techniques. The other phenotypes can he expressed
in a range of serum concentrations of ^-antitrypsin and can he identified
only hy acid starch gel electrophoresis. The gene frequency varies among
different populations hut in Great Britain the frequency of homozygous
deficiency (ZZ) is about 0.03$ and 'heterozygous' deficiency mainly MZpu^A
SZ 2—3$ (P. Cook, personal communication). Whether or not patients with
intermediate deficiency (usually heterozygous for Pi ) are susceptible to
lung or liver disease remains undecided as the populations studied in
detail so far have not been randomly selected. (Hutchison et al 1972).
C. oC ^,-Group Component (GC)
was first described hy Hirschfeld (1959) who
noted an unknown o( globulin with 3 different precipitation patterns on
imraunoelectrophoresis of human sera. The 3 phenotypes were later shown
to he under genetic control (Cleve and Beam, 1962) and the protein was
isolated (Cleve et al 1963) and found to have a molecular weight of 5°»800
and a 3«3$ carbohydrate content. Eecent work suggests a single amino acid
chain structure (Kuusela and Pihko 1972). The function of this protein is
unknown at present.
3). d^-Macroslobulin (eyO
is the major component of the region on
electrophoresis. The protein was first isolated hy Brown, et al (1954)
and has a molecular weight of about 650,000. It hinds and inhibits the
proteolytic activity of a variety of proteases including trypsin and
chymotrypsin (Saunders et al (1971)> plasmin and thrombin (Ganrot 1967 )
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and kallikrein (Harpel 1970)• Thrombin and plasain have been shown to
compete for the sane binding site (Sanrot and Silehn, 196?) and it has
been suggested that d- ^macroglobulin may therefore play a central role
in maintaining the balance between blood coagulation and fibrinolysis
(Rinderknecht and Geokas, 1972). The action of ^gjaacroglobulin in
inhibiting the kinin system may also be important in this respect.
On immunoeleetrophoresis the precipitation arc is often asymmetrical
suggesting microheterogeneity (Ganrot and Laurel13 1966) and recent
studies using polyacrylamide electrophoresis of pure protein at pH 7.8
showed 5 bands, the fastest band being a complex with trypsin (Saunders
et al, 1971).
E. Caeruloplasmin (Caer)
is sua ^globulin which binds 90-95 of the
serum copper. It was isolated in 1948 by Holmberg and Laurell who found
the molecular weight to be 151,000 and the copper content C.34$. The
calculated copper content is therefor® 8 atoms per molecule. Human
caeruloplassin has also been found to have multiple binding sites for
divalent transition metal ions such as zinc and nickel but the physiological
significance of this is unknown, at present (McKee and Frieden, 1971)• Simons
and Beam (1969) have shown that human eaeruloplasmin is composed of two
different polypeptide chains, ot and A, and that the {T chain is heterogeneous a
There is some evidence that the protein exists in two forms which can ba
separated from each other by chromatography on hydroxyapatit© columns
(Trip and van Bruggen, 1972) but the physico-chemical differences between
these fractions are presently disputed.
The function of the protein in the body is not clear but it nay be
important in controlling the liver content of copper. After absorption
copper is bound to albumin, is then rapidly cleared by the liver and
reappears in the circulation within a few hours incorporated into
caeruloplasain (Gibbs and Walsh©, 1971)* High liver copper concentrations
are an invariable finding in untreated Wilson's disease in which plasma
caeruloplasmin levels are characteristically low. The pathogenesis of
the disease and the precise part played by caeruloplasmin are, however,
still uncertain (Gibbs and Walshe, 197l)« Copper is an essential component
of various enzyme systems including cytochrome C oxidase and tyrosinase and
caeruloplasmin may be of importance as a copper donor to the tissues.
Recently a further role for caeruloplasmin has been suggested by studies
in copper deficient animals which have very low levels of caeruloplasmin
(Roeser et al, 1970). These animals develop iron deficiency anaemia
despite the presence of abundant iron in the tissues, due to an inability
to release iron from storage. Caeruloplasiain increases the rate of
oxidation of ferrous iron by molecular oxygen and this promotes iron
mobilisation from the cell as the binding of ferric iron by transferrin
is more avid. The anaemia is rapidly corrected by an intravenous infusion
of caeruloplasmin. This function of caeruloplasmin seems to be rate
limiting only at extremely low plasma caeruloplasmin concentrations (< 5
normal) but unexplained iron deficiency was found in 5 out of 6 patients
with Wilson's disease whose serum eaeruloplasmin concentration was less
than 5 normal (Roeser, et al 1970J*
F. Haptoglobin (Hpt)
makes up about 25$ of the fraction seen on serum
electrophoresis. It was first described by Polonovski and Jayle (1938)
who noted that the combination of haemoglobin with a plasma constituent
increasad the peroxidase activity of the haemoglobin. Polymorphism of the
protein was noted by Smithies (1955) using starch gel electrophoresis and
this is due to the variable structure and combination of the 2 alpha and
2 beta amino acid chains which make up the protein. The Hp/ locus is
/
polymorphic with 5 known alleles. Haptoglobin type 1-1 consists of 2 alpha
and 2 "beta chains a molecular weight of ahout 100,000. The
2
allele causes polymerisation resulting in a series of different
molecules (Giblett 1968). 15 phenotypes have been described so far
(Braun 1971).
The main physiological function of haptoglobin is to combine in a
111 molar ratio with haemoglobin released into the circulation from red
cells. There are 4 binding sites on each haptoglobin molecule, 2 for
8ach haemoglobin dimer (lagel and Gibson, 1971)« This complex formation
prevents haemoglobin escaping through the glomerulus and may serve to
conserve iron as well as prevent renal tubular injury when there is
excess intravascular haemolysis. The haemoglobin binding capacity of plasma
is 50-150ag»/lOQml (Afrman 1959) which is at least a hundredfold greater
than the normal circulating plasma haemoglobin.
G. Haemopexin (Hpx)
The presence of a haem binding fo globulin was first noted in
eiectrophoretic studies by Neale et al (1958) and it was identified
immunologically by Grabar et al (i960) who suggested the name haeraopexin.
Its molecular weight is 57»000 (Seery et al 1972) and it binds haem in a
111 molar ratio (Keide et al 1964). Albumin also bindshaem (Fairley 1941)
the complex usually being known as methaemalbumin ^and this is the form
in which most plasma haem exists in haemolytic states. However the
affinity of haemopexin for haem is greater than albumin (Heide et al 1964?
Muller-Eberhard and Liem 1968) and haem is transferred to haeaopexin in
vitro and in vivo (Muller Eberhard et al 1969) when binding sites become
available. Haemopexin also binds a variety of porphyrins (Koskelo et al
1970? Morgan and Muller-Eberhard 1972).
The role of haemopexin in the metabolism of haem has been extensively
investigated in the past few years mainly by Muller-Eberhard and her
colleagues (Muller Iberhard 1970* Braun, 1971). '^hen haemoglobin is
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released into the circulation it is hound to haptoglobin and cleared from
the circulation (see above). If the plasma haptoglobin is depleted,
some o# the unbound haemoglobin dissociates into haexn and globin, the
iron now being in the ferric form, and this haem binds to haemopexin
and albumin. Studies with haem injections in experimental animals and
man (Sears and Huser, 1966; Muller-Eberhard et al 1969a; Sears, 1969?
Sears, 1970) show that the haem after binding to albumin and haemopexin
is rapidly cleared from the circulation with a biological half life of
7-8 hours and the plasma levels of haemopexin fall. Most of the radio¬
activity is found in the liver and reutilisation of haem iron begins
immediately. In the presence of haemopexin depletion more of the haem
binds to albumin and the clearance is much slower (Sears, 1970). This
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is explained by studies with I labelled albumin which show that the
biological half life is unaltered by haem binding (Muller- berhard et al,
1969a) and it seems most likely that albumin is acting merely as a
reservoir and transfers the haeia on to available haemopexin molecules.
Recent studies of the liver uptake of radioactive labelled haemopexin
and albumin with varying haem loads confirm the haem reservoir role for
albumin (Liem and Muller-Eberhard, 1972).
Autoradiographic studies of rat and rabbit liver at intervals after
injection of ^H-baem-haemopexin and ^^I-haemopexin-haem complexes showed
that all the radioactivity localised in the parenchymal cells (Muller-
Eberhard et al, 1970) and this was confirmed recently using an enzymatic
method of separating the Kupffer cells from the parenchymal cells (Hershko
©t al, 1972). There has been great interest in knowing whether both the
haem and the haemopexin are catabolised after uptake by the liver. Evidence
in favour of haemopexin being a "suicidal" protein like haptoglobin is the
depletion of blood levels which occurs with haem injections and the
localisation of the labelled protein in the liver. However little fall in
■blood levels often occurs despite a large h&er. load (Sears, 1966, 1970)
and this suggested either that the protein turned over very rapidly or
that it was merely transporting the haeai to the liver and then being
returned to the circulation. Becently haemopexin turnover studies in
the rabbit (Lane et al, 1972) confixia a rapid biological half life of
23 hours but this may be artefactually fast as the method of isolation
of the protein using perchloric acid may have altered some of the
characteristics of the protein. Preliminary information on the relative
rates of clearance of ^H-haam and I haemopexin in the rabbit (Liem
and Mu1 ier-Eberkard, 1972) suggest that haeiaopexin recycles back into the
circulation after carrying haem to the liver.
H, Transferrin (Trf)
a /3 globulin of molecular weight 74»0OO (Roberts
et al, 1966) was first isolated by Surgenor et al (1949)* In starch gel
electrophoresis 1 of 18 genetically determined slow and fast moving
variants can be demonstrated in a small proportion (about 2$) of the pop¬
ulation (Bowman, 1968).
The major function of plasma transferrin is to transport iron and
each molecule has 2 iron-binding sites, each binding 1 atom of ferric iron.
In health the plasma pool of 16 g transferrin (jarnum and Lassen 1961) is
one third saturated and binds about 5mg iron. Most of the iron is taken
up "by red cell precursors in the marrow and receptors on the red cell
precursors facilitate the iron transfer. Studies in vitro with reticulocytes
have shown that as their avidity for transferrin is much greater for
molecules carrying 2 atoms of iron than 1, the former binding sites are
preferentially stripped (Fletcher and Huehns, 1968) and the transferrin,
acting as a carrier molecule, is released back into the circulation
(Fletcher, 1970). biological half-life of the iron-transferrin complex
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is less than 2 hours and transferrin delivers 3G-4Gmg. iron daily to the
marrow for erythropoiesis. The biological half-life of the protein moiety
determined by labelling with radio-active isotopes is around 8 days (Katz,
19615 Jarnura and Lassen, I96I5 Awai and Brown, 1963) and this agrees well
with the survival of unlabelled protein infused into a child with severe
congenital transferrin deficiency (Goya, et al 1972).
Recently the role of transferrin in the body's defence mechanisms
against infection have been recognised (Bullen, et al 1972). Iron is
essential for bacterial growth and there is evidence to suggest that the
ability to acquire iron from the host is an essential feature of patho¬
genicity. Conversely the ability of the host to prevent uptake of iron
appears to be an important means of defence. There is now much experimental
evidence in vitro and in vivo to support this function of transferrin
(Bullen et al, 1972) and in clinical practice the well known susceptibility
to infection of malnourished children may be in part due to their very low
serum transferrin levels (McFarlane, et al 1970).
A possible role of transferrin in controlling iron absorption has
attracted attention for many years. Early studias (Hyde, 1957} Solvell,
i960) had suggested that iron absorption could be increased by raising the
circulating level of apotransfarrin by infusion and decreased by infusing
iron intravenously. However, Wheby and Jones (1963) showed that when the
transferrin saturation is increased above about 60^ in experimental
animals much of the iron is deposited in the liver on the first circulation
and examination of peripheral blood samples alone will give misleading
information about iron absorption. Using whole body counting techniques
these workers showed that raising the saturation of the iron-binding
capacity did not reduce iron absorption. More recently Schade et al (1969)
in experimental studies in the rat failed to influence iron absorption by
raising the concentration of unsaturated transferrin# A carrier protein
for iron in the intestinal mucosal cell has recently "been found and
although the identity is not yet proven it has certain similarities to
transferrin (Hueb et al, 1971? Pollack, et al, 1972). Levine et al (1972)
have studied the release of iron from mucosal cells by serum and their
results suggest that transport of iron out of the cell maybe aided by
the presence of unsaturated transferrin. However in agreement with the
findings of Schade et al (1969) they were unable to show that iron
absorption was increased in vivo by infusion of unsaturated transferrin.
In children with almost complete absence of plasma transferrin iron
absorption has been above normal (Heilmeyer, et al 1961? Goya et al 1972).
Clearly the part transferrin may play in the transport of iron across the
bowel wall is still uncertain.
I. Complement
The 11 plasma proteins which make up the complement system together
account for about 10$ of the globulin fraction of human serum (Muller-
Eberhard, 1969)# The third component (C3) is present in greatest amount
(l00-20Ctog/l00ml.) and is readily identified on Immunoelectrophoresis as
^ globulin. It was first isolated by Muller-i.berhard, et al (i960) and
has a molecular/eight of around 185»000. Genetically controlled poly¬
morphism is described and 9 phenotypes have been found so far (Alper, 1970).
C3 is converted to C3e in vitro and the electrophoretic mobility
changes from /^C to /j^A. Conversion starts within an hour and is
accelerated by coagulation and progresses at a variable rate dependent on
the storage conditions (Laurell and Lundh, 1967? Kroll, 1970). Conversion
is completely inhibited for up to 12 months by storage at -75°C. (Teisberg
1971) ^t occurs slowly at higher temperatures. While is the major
in vitro conversion product, Laurell and Lundh (1967) were able to find
others using crossed imnunoelectrophoresis and a range of conversion
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products occurs under different conditions including in vivo activation
and treatment in vitro by hydrazine, trypsin or zymosan (Alper, 1970).
Complement participates in antigen antibody reactions leading to
cell damage and lysis and apart from its role in defence against infection
it is likely that it is involved in a variety of disease states. It is
reduced in diseases in which there is evidence of antigen-antibody
reactions such as systemic lupus erythematosus and certain types of
nephritis ( sherson, 1960$ Lancet* 1972) and in these conditions levels
of C3 usually run in parallel with total haemolytic complement
(Klemperer, at al 1965). On the other hand raised levels are found in a
wide variety of inflammatory disorders ranging from myocardial infarction
to acute infection (fownes,
J. Lipoproteins
Hi© plasma lipoproteins can be separated into distinct classes by
several methods and the various classifications are based on the methods
of separation (Alahpovic, 1972). Ultracentrifugation in media of different
densities permits separation into 3 classes* high density (EDL, density
1.063), low density (LBL, density 1.006-1.063) and very low density lipo¬
proteins (VLDL, density less than 1.006). On paper or agarose electro¬
phoresis HDL migrate in the JL, zone, LDL in the p zone and ¥LDL in the
pre fj zone. U1tracentrifugal analysis has shorn that VLDL and LBL consist
of a population of macroiaoleoules whose molecular weights extend over a
continuous range of values, The protein composition of the different
ultracentrifugal classes has recently teen defined. HDL consists mainly
of apolipoprotein A, LDL is 50-60$ apolipoprotein B and ¥LDL is 40-50$
apolipoprotein C and 50-60$ apolipoprotein 2, but all apolipoprotein types
are present in each ultracentrifugal class of lipoprotein. Each of the
different ultracentrifugal lipoprotein classes contains triglyceride,
cholesterol and phospholipid but for VLDL the major lipid component is
triglyceride, for LDL, cholesterol and HDL phospholipid (Levy, et al 1972).
In the present work only lipoproteins with pmobility on electro¬
phoresis are considered,
K. Other Proteins
Other proteins which were regularly identified and measured in the
present studies were ^ easily precipitahle glycoprotein (PGP) which -was
first isolated by Schultze, at al (1963). Nothing is known about its
function. Protein 16 originally numbered 45 by Freeman and Smith (1970)
may be the same as antichyraotrypsin (Aronsen, »t al 1972; H.G.M. Clarke,
Personal communication). Protein 18 was originally numbered 41 and
protein 10 numbered 9 by Freeman and Smith (1970). Nothing is known about
the properties or functions of these proteins at present.
Introduction to the present work
Abnormalities in the concentration of several plasma proteins have
been described in liver diseases. Some like the deficiency of caerulo-
plasmin in Wilson's disease are of established diagnostic importance but
the significance of other changes is uncertain. The development of a
method of quantitative immunoelectrophoresis by Clarke and Freeman (l966,
1968) allowed for the first time a large number of individual proteins to
be measured easily on a single serum sample.
The present work was started in 1968 in collaboration with the late
Sr. Tristram Freeman by applying his technique to a series of patients with
haemochromatosis. This study produced some interesting results and because
at that time there were no detailed reports in the literature on the
changes in concentration of individual plasma proteins in patients with
clearly defined types of liver disease,it was decided to study the plasma
protein patterns in 3 further diagnostic groups of patient*(cryptogenic
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cirrhosis, alcoholic cirrhosis and active chronic hepatitis). A
collaborative programme of orthotopic liver transplantation with
Professor R.Y. Calne of the University of Cambridge also provided a
unique opportunity to study the detailed changes in plasma protein
patterns after operation.
The original method of Immunoelectrophoresis was costly because
of the large amounts of antiserum used and a modification requiring
smaller quantities of reagents was developed. This method was then
applied to the study of the plasma protein changes in patients with acute
viral hepatitis, extrahepatic biliary obstruction and primary biliary
cirrhosis. Because of the interest of the liver Unit in hepatic enzyme
induction and its clinical and biochemical consequences, a study was
undertaken of the changes in normal subjects during enzyme induction and
in highly induced epileptics receiving treatment with anticonvulsants.
The concentration of the proteins in the disease groups were com¬
pared with a control population and correlations were sought with the
clinical data and routine liver function tests. By studying the pattern
of plasma protein disturbance in the different types of liver disease it
was hoped to gain insight into some of the factors controlling plasma
protein synthesis. The possibility that some of the proteins measured
might be of value in differential diagnosis was explored by a computer





Two steps are involved, first simple electrophoresis in agarose
gel and then electrophoresis at a right angle driving the separated
protein fractions into a bed of antiserum to whole human serum in agarose
(Clarke and Freeman, 1968).
The first dimension plate was prepared by mixing 20ml. 2$ agarose
(melted by heating in a boiling water bath) with 20ml. 0.06M barbitone-
HCL buffer at 56°C, (Appendix A). The mixture was poured on to a glass
plate (16.3 x 11.8cm.) on a levelling table. These agarose covered plates
were kept in a damp airtight box at +4°C. for up to a week before use.
The plate was placed over a paper plan and a series of 7 holes l»5rm,
diameter were punched in the gel 20mm. apart at points indicated (Figure 1).
Serum (l ml.) was added to a standard amount of acetylated albumin
(Appendix A) with a trace of brcmophenol blue and the holes were carefully
filled with 4ul. of the mixture using a raicro-burette syringe (Microsietric
Instrument Co., Cleveland, Ohio). The plate was then placed in the
electrophoresis tank (Medical Biological Instrumentation Ltd. typo 260)
with the origin holes next to the negative electrode. The tanks were
filled with buffer diluted to half strength (0.C3M) and fresh solution
was used each day. Lint wicks were applied with the mat surfaces lying
on the gel. A potential difference of 12V/cm. was applied across the plate
for about 60 minutes using a Medical Biological Instrumentation Ltd. power
supply type 64. The exact length of time of the run was determined by the
position of the visible bromophenol blue tagged albumin. The platform of
the electrophoresis tank was cooled by circulating water and kept at
about 4°C.
Preparations for the second dimension were started immediately so that
the time interval between the two electrophoretic steps during which immuno¬
diffusion could occur, was kept as short as possible. A mixture consisting
of 2$ Molten agarose 9ml. and
0.06M Barbitone-HCL buffer 8ml. at 56°C.
was prepared for each plate and antiserum to whole human serum was added
immediately before the plates were poured. The antiserum was raised in
goats (Appendix A) and the precise volume added depended on the batch. At
the end of the first dimension the plate was placed over the paper grid (Fig.l)
and the gel was out with a long razor blade so as to isolate 7 strips each
containing one serum sample. Each strip was then transferred on to the edge
of a glass plate 11.6 x 11.6cm. on the levelling table and the plate was
completed by pouring on the agarose-buffer-antiserum mixture. Once the anti¬
body containing gel had set, the plates were transferred back to the electro¬
phoretic chamber and fresh wicks were attached. The direction of current flow
was reversed to minimise pH change in the buffer and a potential difference
of 2.5 to 3 volts/cm. was applied at right angles to the first run for excess
time (l8-24hrs.) driving the protein into the bed of antiserum. So cooling
was required.
After the second dimension run the slides were washed in physiological
saline for 24hrs. and then in deionised water for 30 minutes. They were
wrapped in Whatman Bo.l filter paper and dried at 37°C. before staining.
Modifications of the Method for uag with Miniplates (5 x 5cm.)
The agarose and buffer used were made up in the same way as for the large
plates. As the goat antiserum was no longer available, commercially available
antiserum to whole human serum raised in sheep was used (Paynes and Byrne Ltd.
Greenford, Essex) and the same batch (Bo. 551019) was used throughout.
Acetylated albumin (Paynes and Byrne Ltd.) was used as a reference protein and
this was made up in ampoules containing a fixed quantity to which was added
0.5ml. of test or standard serum. A different batch of acetylated albumin
Figure 1. Flan showing the position of the seven wells and the
lines for the razor outs to separate the agarose strips for
the second dimension run.
was used for some studies and to this was added a trace of bromophenol blue
S-cn VAyw*.
and 0.2ml. of test or standard serum. Freeze dried standard^batch no.
551019 Paynes and %rne Ltd.) reconstituted with lml. deionised water per
ampoule was used throughout.
The first dimension plate was prepared by mixing
2$ Molten agarose 2.6ml.
0.06M barbitone-HCL buffer at 56°C. 2.6ml
This was poured on to a level glass plate 5 x 5cm. and allowed to cool. The
plate was placed over the paper plan (Fig.2) and 4 holes 1.5mm. diameter were
punched in the gel and filled with approximately lpl. of the acetylated
albumin and serum mixture using a miorooap pipette (Drummond Scientific
Company). The first dimension was run at 7V/cm. without cooling until the
bromophenol blue marked albumin had travelled about 20mm from the front of the
origin hole. The gel was then cut as before and after transfer of the first
dimension strips to clean 5 x 5cm. slides the second dimension plates were
prepared by pouring on a mixture containing
2$ agarose 1.9ml
0.06M barbitone buffer 1.8ml
Antiserum 0.13ml.
The plates were stacked in piles of 3 on top of one another (Fig.3) and all
12 samples from the first dimension were accommodated in the same tank. The
current was reversed and a potential gradient of lV/cm. was applied at right
angles to the first dimension and the electrophoresis run for l6-20hrs (over¬
night). The 12 plates were placed in a projector slide carrier (Kodak) and
washed in physiological saline at 37°C. for 30-60 minutes and then deionized
water for 5-10 minutes. They were then dried as before.
Staining
Jlates were routinely stained with Amido blaok (Appendix A) for 5-10
minutes. The background stain was then removed with alcohol-acetic wash
(Appendix A)s rinsed in methanol and dried (Frontispiece and Fig. 4)«
Figure 2. Plan shoving four walls and tha lines for the rssor
outs to separate the agarose strips for the second dimension
run on the mini plates.
Figure 3» Three plates stacked on top of each other for the
second dimension run showing the arrangement of the lint
wicks.
Identification of individual Proteins
Initially as many proteins as possible were identified by immuno¬
logical methods and special staining. Many proteins were readily
recognised in all sera by their characteristic electrophoretic position,
distinctive shape of precipitation arc and avidity for stain. In
pathological sera the relative heights and positions of the arcs were
often altered and it was necessary to run each sample several times so
that different specific staining methods could b© applied.
A. Specific Staining of Individual Proteins
i) Caerulopjasmin
Th© plate was soaked for 15-20 minutes at 37°C. in an 0.08$ solution
i
of ferrous sulphate in 0.1M acetate buffer pK 5«7 (Appendix A). It
was washed in deionized water, dried and stained for about 1 minute
in a mixture of e<iual volumes 2$ potassium ferrocyanide and 0.2S HC1.
Caeruloplasmin turned blue and the plate was counterstained with
0.2$ solution PonceaiA red in 5 Trichloracetic acid (Fig. 5)«
ii) Haptoglobin and Haemopexin
These proteins stain only when binding haemoglobin or haea respectively
and staining can be intensified by adding a trace of haesolysed serum
to the sample. IQCmg. benzidine was dissolved in 5Ctnl. boiling
deionized water and while still hot 0.25ral. glacial acetic acid was
added. The solution was then cooled and O.lsnl. 30$ hydrogen peroxide
added. Plates were stained in this solution for 20-30 minutes and
haptoglobin and haemopexin stained black (Fig. 6).
i±L) Lipoproteins
The plate was stained for 2 hours in 0.5$ solution Oil red 0 in 50$
ethanol and then washed in 50$ ethanol. Lipoproteins stain red.
Alternatively Sudan Black was used (Appendix A). The plate was
soaked for 24 hrs. and then washed in 50$ ethanol. Lipoproteins
stain black (Fig. 7)»
Figure 4* Paines and Byrne standard serum run on mini plate
and stained with amido blaclc.
ft
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Figure 5* Plate stained for caeruloplasmin (blue) and counter-







Figure 6. Plate stained for haptoglobin and haesopexin (black)
and eounterstained with Ponceaj*. red.
Figure ?• Plate stained with Sudan black to show,, -lipoprotein.
An alpha lipoprotein precipitation arc developed with the goat
antihuman serum used in the early studies hut the sheep antiserum
used for the miniplates did not contain a significant titre of
antibodies to ^ lipoprotein and no precipitation arc formed,
lipoprotein is destroyed "by freeze drying and did not therefore
appear in the Paynes and Byrne standard serum (Pig. 4} hut it was
readily identified in all other samples (Fig. f),
3. Identification using pure Protein
Transferrin was identified by placing pure protein (Hoechst
Pharmaceuticals) in a second origin well. The protein fused with and
distorted the contour of the transferrin arc in the test serum (Fig. 8
and 9)»
C. Identification using Monospecific Antisera
^2 8^°UP component, microglobulin and ^-antitrypsin were identified
by this method. An equal volume of monospecific antiserum (Hoechst
Pharmaceuticals) was placed with the test serum in the origin well and
the specific protein was identified by reduction in area under the
precipitation arc. Other protein areas were either unaltered or increased
in area due to the adsorption procedure used to prepare the antiserum
(Fig. 10). Confirmation of identification came from the characteristic
shape of the group component peak in infants (Abraas and Freeman 1969)
and the marked reduction of the d^ antitrypsin peak in sera from patients
known to be homozygous deficient subjects (Fig. 11).
D. Other Methods
Tryptophan rich prealbumin is the only protein migrating faster than
albumin at pH 8.6. The small flat curve seen at the cathodal end of the
Paynes and lyrne acetylated albumin peak is a contaminant as it appeared





Figure 8. Pure transferrin ran against antiwhole human serum
showing single precipitation arc.
Figure 9« Pure transferrin in second origin hole producing distortion
of transferrin peak in standard serum.
Figure 10. Anti <^-wacroglobulin antiserum added to standard serum
in origin hole. Compare peak with figure 4*
Figure 11. Serum from patient. with severe deficiency of c( ,-
antitrypsin.
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Figure 12. Acetylated albumin run with antiserum to whole human serum.
Note small arc at the cathodal foot of the acetylated albumin.
provisionally identified in the ^ Toand and which were regularly measured
in normal and pathological sera were "^-easily pracipitable glycoprotein,
proteins 10, 16 and 18. These last three were originally numbered 9> 45
and 41 respectively (Freeman and Smith, 19?0). A-C (C3) was identified
because of the characteristic double contour and increasing proportion
of the faster moving component (/^A) on storage (Fig. 4). As the arc was
small and difficult to identify on the mini plates it was not measured.
Huraerous other precipitation arcs were seen but not positively
identified. Many were faint and none was sufficiently constant in
position for measurements to be reliable.
AETEFACTS
Two artefacts were encountered from time to time.
A. Doubling. (Fig. 13). The precipitation arc in the second dimension
is not perpendicular to the surface of the gel and after drying this
results in broadening or doubling of the line. This effect may be
due to failure to cut the first dimension gel at a right angle to
its surface or to drying of the gel surface in the first dimension.
Duplicate measurements on separate electrophoretic runs of the same
sample showed that valid results could be obtained by taking the mean
of the areas enclosed by the two lines. Certain protein arcs (/2
aaeroglobulin and /j lipoprotein) were frequently doubled when all
other protein precipitates on that plate were satisfactory.
B. Trailing . Albumin sometimes failed to migrate uniformly but left a
'trail' leading back to the origin hole (Fig. 14). The precipitation
arcs of other proteins were seldom disturbed and measurement on
standard serum with and without albumin trailing showed no difference
in the values for other proteins.
4 9
Figure 13. Plate showing doubling artefact.
Figure 14. Plate showing 'trailing' of albumin to the origin,
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Measurement of Protein Areas
The plats was placed in a photographic enlarger and the areas under
the peaks were measured using an electronic integrator designed by
J. Lewin of the National Institute for Medical Besearch and manufactured
by Chemical Electronics Co. (C.W.S. Hallt Durham Roads Birtley, Co. Durham).
The base line for all proteins except acetylated albumin was set from the
cathodal foot of the transferrin peak to the anodal foot of the albumin
peak (line A, Fig. 15) and was reset to measure the acetylated albumin
area (line 3, Fig. 15)• At least 3 measurements were made for each
protein and the mean calculated. The data were recorded on a laboratory-
work sheet (Appendix B).
Calculation of Results
The use of the acetylated albumin as an internal standard obviates
the necessity for accurate pipetting of microlitre quantities of serum.
As the same volume of serum was added on each occasion to the acetylated
albumin ampoules it follows that the ratio area of unknown protein
area of acetylated albumin
is constant and reproducible for any serum sample. This ratio was then
related to the ratio obtained for the same protein in a standard serum
Area of unknown protein (Y) Area of acetylated albumin
in standard serum
-— X — X 100
Area of acetylated albumin Area of protein Y in standard
on unknown plate serum
The unknown protein was thus expressed as a percentage of concentration
of the same protein in the standard serum. The value for the standard used
in the above calculation was taken 4s the mean of the readings on 20 standard
plates. A standard serum sample was included in most electrophonetic runs
and if the area for each protein fell outjwith the normal rang© established
from 20 standard plates run at different times9 the whole run was discarded.
51
Figure 15« Baseline for measuring plasma proteins (line A)
and for acetylated albumin (line B).
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8. Standard Sera
For the early part of this work on large plates a freeze dried
reference serum was obtained from the Department of Biological Standards,
National Institute for Medical Sesearch, Mill Hill (Cods No. 67/86).
It was derived from a pool of 416 mala blood donors. A sample of this
standard serum which had been stored at -20°€ for 4 years and -70°C for
1 year was later run with Paynes and Byrne antiserum on mini plates
(Table l).
The second freeze dried standard (Paynes and Byrne Ltd.) used in
the miniplate studies was derived from a pool of 20 male and female
donors and this contained no ^-lipoprotein (See above).
A third standard serum (Hoecitet Pharmaceuticals Batch no. 570) was
also studied and by comparing the areas of certain proteins with those
of the sane proteins in the Payhes and Byrne standard 3erum, absolute
values for these were derived.
9. Other Methods
A. Complement Studies using monospecific antiserum for Immunoelectrophoresis
Blood was taken into potassium edetata bottles and plain glass
containers and spun within 15 minutes. The immunoelectrophoretic
technique was modified so that 2.5ul. of the fresh serum and plasma
from the same patient were run one in front of the other on the same
first dimension strip. The second dimension plate was mad® up in the
usual manner but using 0.05ml. antiserum to /5^A~C (Hoechst
Pharmaceuticals).
B. Badial immunodiffusion
Haemopexin was measured by radial immunodiffusion on M Partigen plates
(Hoechst Pharmaceuticals) which were calibrated by using 4 dilutions
of a standard serum (Hoechst Pharmaceuticals) with a known concentration
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ffahle 1
Protein concentrations in Actional Institute for Medical Research
serum pool (Ho. 67/86). Mean value of 8 determinations expressed
as f> of acetylated albumin marker and $ Paynes and Byrne standard
serum.
Protein Mean Area S.D. * Pfnf f1standard serum
Prealb 290.9 5.1 85.O
^PGP 55.4 3.2 86.5
o<^AT 164.6 4.2 81.9
GC 174.6 6.9 84.6
32.3 2.1 91.3
Caer IO4.4 3.9 98.5
10 35.5 3-4 89.9
Hpt 336.0 26.8 90.5
Hpx 49.5 3.5 82.4
Trf 47.8 4.4 77.8
P 19.6 1.3 -
16 67.6 4.0 81.6
18 78.0 2.6 92.8
of haeroopexin. The diameter of the precipitin rings was measured
after 48hrs. and the squares of the diameter of the standard serum
and its dilutions were plotted on a linear seals. The concentration
of haemopexin in the unknown samples was then read off the straight
line calibration graph.
Plasma bilirubin levels for the enzyme induction study were
measured by Thompson's modification of Michaelsson's method (1969).
Urinary D-glucaric acid output was measured by the method of Hunter
et al (1971a).
Routine liver function tests were performed in the Department of
Chemical Pathology on an SMA 12 Autoanalyzer and protein electro¬
phoresis on cellulose epetate strips.
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VALIDATION OF THE TECHNIQUE USING 5 x 5cn. M INPLATES
1. Multiple Serum Dilutions
As a check that the technique was quantitative using the miniplates
and the volumes of serum and antiserum chosen, standard serum was diluted
with distilled water to contain 80, 66.6, 50 and 33.3/-' protein. Ten
proteins were measured at each of these dilutions and for each protein
there was a good linear correlation between area and serum dilution
(Figs. 16 and 17)•
2. Errors in repeated measurements of standard serum
A. Eepeated measurements of a single plate
i) Twelve proteins were measured on 6 occasions in one day
on the same plate without removing it from the photographic
enlarger or disturbing the base line setting. (Table 2).
ii) One plate was measured on 8 occasions in one day but it was
removed from the enlarger and the base line reset before each
series of measurements. This resulted in a larger coefficient
of variation in 9 of the 12 proteins measured (Table 2).
B. Agreement between plates in the same run
Twelve plates, each containing a sample from the same ampoule
of standard serum, were run simultaneously and the coefficient
of variation (Table 3) for all 12 proteins was larger than
?/hen a single plate was measured (section Aii above§ Table 2).
C. Agreement between plates in different runs
Twelve plates containing standard serum from different
ampoules were run on 12 different days. The coefficient of
variation was larger than those obtained in Section 23 for
each protein due to the introduction of errors in pipetting
CONCENTRATION OF STANDARD SERUM
CONCENTRATI ON OF STANDARD SERUM
Figures 16 and 17* Correlation bet-seen dilution of the standard serum
and area under the protein arc expressed as percentage of the
acetylated albumin area for nine of the proteins studied.
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Table 2
Error in repeated measurement of the area of 12 proteins in standard serum
(expressed as $ of area of acetylated albumin marker) on a single* 5 * 5®a«
plate.













Prealb 292.8 4*6 1.6 191.9 5.2 2.7
ix'jPGP 57.0 0.6 1.1 37.4 0.9 2.5
170.8 1.7 1.0 115.2 1.0 1.9
GC 179-5 1.6 0.9 114.0 3.0 2.6
34.3 0.5 1.3 21.7 0.8 4.1
Caer 110.7 3.2 3.0 54.5 2.0 3.7
10 38.1 1.6 4.2 22.7 2.2 9.8
Ipt 350.5 2.6 0.8 190.0 4.2 2.2
Spx 52.2 1.2 2.2 35.2 0.7 2.1
Trf 50.0 1.2 2.5 36.5 0.7 2.0
16 71.6 2.0 2.7 47.8 1.1 2.3
18 80.5 1.4 1.7 49.0 1.4 2.9
* A different plate was used for each of these two
experiments
Table 3
Error in measurement of multiple samples of the same standard serum run
simultaneously and at different times on 5 x 5m. plates. Area is expressed
as % of area of acetylated albumin marker.
Same run Different runs
Protein Mean S.D. Coefficient Mean S.D. Coefficient
Area of Area of
(n=12) variation (n=12) variation
Prealb 201.1 11.2 5.6 198.6 16.6 8.4
^POP 39.6 2.4 6.2 39.9 5.5 13.8
J^AT 121.8 4.3 3.6 122.5 8.6 7.0
GC 124.7 4.7 3.8 124.2 7.7 6.2
i/gM 21.0 1.3 6.4 22.6 2.0 8.8
Caar 63.3 2.6 4.1 57.7 4.5 7.9
10 23.2 2.1 9.1 23.5 4.5 19.1
Hpt 211.0 23,0 10.9 199.0 30.0 15.3
Hpx 36.3 1.3 3.6 37.1 3.7 10.0
Trf 36.5 2.0 5.4 38.8 3.9 10.0
16 49.4 1.79 3.5 47.6 4.8 10.2
18 51.2 1.7 3.4 49.4 4*8 9.7
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the standard serum into the acetylated albumin ampoules,
differences in the acetylated albumin content of the ampoules
and variation in the conditions of the eleetrophoretic run
from day to day.
Because of the variation in the standard serum protein values
in any one electrophoretic run, a mean value from 20 runs was
used when calculating the concentration of an unknown serum
as a percentage of the standard serum.
3. Comparison of Immunoelectrophoresis with radial immunodiffusion
Haemopexin was measured in 16 serum samples by radial immuno¬
diffusion and the result expressed in mg/lOOral. by reference to Hoachst
standard serum. The same serum samples were measured by Immunoelectrophoresis
on miniplates and there was close agreement (Fig. 18) between the results
by the two methods for most samples (r=0.9405 t=10.33? p<0.00l).
4. Effects of Storage of Serum
Serum was taken from two normal individuals, divided into 1 ml.
aliquots and stored at -20°C. without added preservative. Samples from
the store were tested 9 times at intervals over a 12 month period and care
was taken that they had not previously been thawed and re-frozen. There
was little overall change in the concentration of any of the 12 proteins
over the 12 month period with the exception of p lipoprotein which fell
in both subjects (by 30 and 50^). The variance of the concentration of
eqch protein was no greater (F Test) than that found on repeated measure¬
ments of the standard freeze dried serum and in some instances it was
significantly less (Table 4)»
Figure 18. Correlation "between haemopexin concentration in the same
serum sample measured by radial immunodiffusion and immuno-
electrophoresis (La*rell).
Table 4
Repeated, measurement over 12 months of stored sera from 2 subjects. Results
expressed as % of the acet.ylated albumin marker and the variance compared
with that of repeated measurement of standard serum.











PGP 42.78 1.39 #» 39.9 5-5
*
** 35.44 1.59
i^AT 111.22 2.73 ** 122.5 8.6 117.56 7.76
GC 151.78 8.14 124.2 7-7 120.44 10.17
<XM 20.56 1.24 22.6 2.0 20.11 3.06
Cher 70.11 1.76 ** 57.7 4.5 62.33 1.97
10 35.56 1.88 * 23.5 4.5 * 28.44 2.24
Trf 43.22 2.91 38.8 3.9 * 38.22 2.11
Hpx 39.00 2.74 37.1 3.7 35.33 2.40
16 57.78 2.23 * 47.6 4.8 * 47.78 2.11
18 63.78 2.39 49.4 4*8 58.ll 3.59
** P <0.01 * P <^0.05
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5. COMMEHT
The immunoelectrophoretic method using large plates which was
employed in the early studies was costly because of the large volumes
of antiserum needed. It was therefore decided to adapt the technique
to 5 5cm. plates which have the attraction of being suitable for
immediate display using a standard slide projector. The thickness of
the agarose gel wa3 kept to the minimum consistent with ease of handling,
in order to reduce the doubling artefact and volume of antiserum required.
The accuracy of the method is greatest when the precipitin lines are
faint (Laurell, 1972) and the volumes of the test serum and antiwhole
human serum chosen were influenced by this and the need to keep the
whole precipitation arc of the proteins to be measured on the plate. It
was not possible to measure all proteins on a single plate because some
peaks (e.g. albumin, alpha-l-aoid glycoprotein (orosomucoid) and alpha-
2-HS-glyeoprotein) ran off the agarose in the second dimension. These
proteins could however be measured by using less serum or more antiserum
but then the accuracy of measurement of other proteins was severely reduced
because of the small size of their precipitation arcs. This is the only
major disadvantage of the miniplates compared with the large plates but it
was regularly possible to identify and measure 13 proteins on one electro-
phoretic run. The voltage in the second dimension was chosen to produce
peaked arcs, and as little heating of the gel occurred, cooling was not
necessary. Using a lower voltage for a longer time allowed lateral
diffusion to occur and the peaks became broad and flat with loss of accuracy
in measurement. A similar scaled dorm modification of the original method
was later published by Davies et al (1971) and Stephan and Frahm (1971)•
With experience the recognition of the different precipitation arcs
presented little difficulty although in pathological sera, in which the
concentrations of many proteins were altered, several specific stains
ware often used to confirm identification. For some proteins (e.g.easily
precipitaMe glycoprotein, proteins 10, 16 and 18) identification is
provisional and based on a detailed fractionation study of human serum using
gel filtration combined with Immunoelectrophoresis (Freeman and Smith,
1972). As the same pool of antiserum was used for all the minipiate
studies, the identification and nomenclature is uniform throughout. It
is impossible at present to identify with certainty all the corresponding
proteins among those illustrated and numbered by Week© (1970b) who was
using a different antiserum. Because of electroendosmosis and the slight
migration of the immunoglobulins at pH 8.6, these cannot be measured
accurately by this method, but valid readings are possible after reacting
the proteins with potassium cyanate (KCIO) to increase their isoelectric
points (Weeke 1968). As /^A-C produced a small arc which was difficult to
identify and measure accurately on the miniplates, no values are given.
Storage of sera introduces a further variable error as the value for/) ^A-C
rises by up to 21$ as conversion to o^A occurs (Kohler and Mu1 ler-IT.berhard,
1967).
This immunoelectrophoretic method on large plates was shown to be
quantitative for each protein measured (Clarke and Freeman, 1966) and this
was confirmed in the present study on miniplates by using several serum
dilutions and by comparing the results of haemopexin measurements with those
obtained by radial immunodiffusion. The errors in the method were explored
systematically and the coefficient of variation for most proteins was less
than 10$ when the same standard serum was examined on different occasions.
This compares very favourably with the results on large plates (Clarke
and Freeman, I968). The use of acetylated albumin as an internal standard
eliminates the great potential error involved in delivering one microlitre
of serum into the first dimension well, but this method obviously depends
on the ampoules containing a fixed quantity of acetylated albumin and
accurate pipetting of 1 ml. serum into the ampoule. Other workers have
used carbamylated transferrin as a marker protein in the same way (Weeke,
1970)• The coefficient of variation for repeated measurements of protein
10 was larger than for other proteins probably because the arc was faint
and difficult to measure. The haptoglobin arc varied considerably from
plate to plate and others have also found high coefficient of variation
in its measurement (Clarke, Personal communication). Because there was
considerable variation in protein values between plates of the same serum
in the same run, the standard serum values taken for reference were based
on the means of 20 plates. A standard serum sample was included subse¬
quently with unknown sera in most runs and the concentration of all proteins
in the standard serura usually lay close to the mean value calculated
previously from 20 standard plates.
Storage of serum from two subjects for up to 12 months at -20°C. showed
a significant fall in the concentration of lipoprotein but the levels of
other proteins were unaltered. There is little information in the
literature on the effects of storage on protein concentrations but Cohnen
and Paar (19^9) found a 15-20$ fall in most proteins after 20 months at
-28°C. Repeated freezing and thawing of samples is far more damaging and
they found marked reduction in all protein levels after 8-10 cycles.
Similar results were reported recently by Weeke (1972) who noted a 10-15$
fall in most proteins after storage at -18°C. for 40 months. The addition
of sodium azide to the serum minimises the changes. The conversion of
^1C to and the increase in total area has been mentioned and similarly
caeruloplasmin changes to faster moving apocaeruloplasmin (Fig. 4)»
Measurement of both parts overestimates the total concentration and the
main peak alone gives the best approximation to the original value (Week®,
1972). The standard serum used in the large plate studies had been stored
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at -2C°C. for four years and -70°C. for 1 year before it was measured
on miniplates and this may account in part for the values of most proteins
being 10-15/S lower than those in the standard serum used in the miniplate
studies. Weake (1972a) has shown that plasma pools derived from large
numbers of healthy people differ little but the number of donors to the
miniplate pool was small (20 subjects) and included both sexes whereas
the large plate pool donors were males only. This difference in the
standard sera makes it difficult to compare the results from the large
plate and miniplate studies which are espressed as a percentage of their
respective standard serum pools.
The concentration of plasma proteins in animals undergoes circadian
rhythm (Scheving, et al, 19685 Bocci and Viti, 1971) and although there
is no information available for man there are likely to be changes because
of variation in blood volume particularly in those subjects with spleno¬
megaly (Blendis et al, 1970). Hard physical exercise has also been shown
to alter the concentrations of some proteins (Poortmans, 1971)• Because
many of the patients studied in the present work were out-patients, it
was not possible to standardise the timing of blood samples or to ensure
that the patients were fasting.
PAST 4
DESCRIPTION CP HOBMAL SUBJECTS ABB PATIENT
GROUPS STUDIED; STATISTICAL METHODS
DESCRIPTION OF NORMAL SUBJECTS AND PATIENT
GROUPS STUDIED AND STATISTICAL METHODS
NORMAL SUBJECTS
A. The hundred normal subjects used as a comparison group for the initial
studies performed on large plates were those published by Clarke and
Freeman (1968). Large plates were used in the studies on active chronic
hepatitis, alcoholic cirrhosis, cryptogenic cirrhosis, the first series
of patientswith haemochromatosis and the first transplant patient. All
other measurements were performed on miniplates.
B. The normal subjects for the miniplate studies consisted of healthy
numbers of the laboratory staff (15) and blood donors (55) who were
attending a Blood Transfusion Service donor session. Only subjects of
Caucasian origin were accepted and care was taken to exclude women who
were taking the contraceptive pill and those who had had an infection
in the preceding three weeks. There were 37 males and 33 females their
ages ranging from 20 to 69 years. The distribution of ages is shown in
Table 5» Sera*was separated within 6 hours of collection and stored
without preservative at -2G°C.
Table 5. Distribution of ages of normal subjects
Age Males Females Total
20-29 15 11 26
30-39 11 5 16
40-49 5 5 10
50-59 5 * 12
60-70 1 5 6
70
PATIEHT GROUPS
A. Acute viral hepatitis
There were sera from 12 patients with typical viral hepatitis all of
whom later made an uneventful recovery with return of liver function
tests to normal. The diagnosis was confirmed by liver biopsy in 10 cases.
Australia antigen was positive in 4 of the 10 cases tested. Details of
the patients and their liver function tests at the time of the serum
sample are shown in Table 6.
B. Active chronic hepatitis
There were sera from 20 patients with liver disease of greater than 3
months duration and biochemical evidence of disease activity (serum
aspartate aminotransferase at least twice normal and serum gamma globulin
>1.5g./l00ml.) (Murray-Iyon et al, 1972). Liver biopsy material was
obtained in 19 and all biopsies showed features of chronic aggressive
hepatitis with established cirrhosis in 13 cases. In one patient biopsy
was impossible because of persistent prolongation of the prothrombin
time. Antibodies to mitochondria and smooth muscle were detected in 3
and 6 cases resp#ctively and antinuclear factor was present in 13 cases.
All cases were negative for Australia antigen. All patients were included
in a prospective double blind trial comparing prednisone, 5®g. t.d.s. with
azathioprine, 75™g. daily (uurray-Iyon, Stem and Williams, 1973). At
the time the blood samples were taken 5 patients were receiving prednisone,
8 azathioprine and 8 were on no treatment immediately prior to inclusion
in the trial. Details of the patients and liver function tests at the
time of the serum sample are given in Table "J.
Serial samples from 4 further patients were taken before and at
frequent intervals during treatment. Details of these cases are given
in Appendix C.




Duration of jaundice (weeks)
Bilirubin (mg/lOOml)
LIVERFUNCTION Alkaline phosphatase (iu/l)
TESTS* Aspartate transaminase (iu/l)
Total protein (g/lOOml)
Albumin (g/lOOml)











































































































































































































































































































There were sera from 12 patients with established cirrhosis for which
there was no known cause (Murray-Lyon, et al, 1972). Liver biopsies in
11 showed little if any chronic inflammatory cell infiltrate (biopsy in
one cass was precluded by prolongation of the prothrombin time) and auto¬
antibodies were either negative or present in low titre. Clinical and
biochemical details of these cases are shown in table 8.
P. Alcoholic Cirrhosis
Sera were examined from 12 patients with long histories of excess!va
alcohol intake all of whom had biopsy proven cirrhosis (Murray-Lyon, et
al, 1972). Clinical details are given in Table 9«
E» Bxtrahepatio obstructive .jaundice
Sera from 12 patients who later had an extrahepatic cause for
obstructive jaundice demonstrated at laparotomy were studied. Clinical
and biochemical details are shown in Table 10. The group of diseases
represented is highly selected because of the interest of the Liver Unit.
F. Primary biliary cirrhosis
There were sera from 19 females and 1 male patient with primary
biliary cirrhosis. Liver biopsy material in each case was compatible
with the diagnosis (cirrhosis was established in 12 cases) and mito¬
chondrial antibodies were present in all patients. line have since died
with hepatic failure and the autopsy findings confirmed primary biliary
cirrhosis. Case 10 also had clinical features of scleroderma (Murray-
Lyon, Thompson, Ansell and Williams, 1970). Details of the patients at
the time of the serum sample are given in Table 11.
Cass
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58 42 55 62 51 44 78 52 58 80 81
340 600 550 410 290 330 330 820 290 520 580 N.I).
Table10.Clinicalandbiochemicaldeta lsof12p tientsw thctrahepatic obstructivejaundice. LIVERFUNCTIONTESTS Causeof obstructionDuration ofjaundice (weeks)BilirubinAlkaline wxoo.1)





























































































































































































































































































i) Sera from a series of 29 patients were studied on large plates
(Amin, Clarke, Freeman, Murray-Lyon, Smith and Williams, 1970)* Details
of the cases are given in Table 12. Except for case 10 all patients
were male, Nine had clinical or radiological evidence of arthropathy.
ii) A further series of 40 sera were examined on miniplates. These
included 12 subsequent specimens taken about 3 years later from patients
in the first series (Table 13). All cases except no. 38 were male.
Twelve of the 28 new patients had clinical or radiological evidence of
arthropathy. In cases 30-49 thirteen individual proteins were measured
in each oa&e but in cases 50-69 only serum haemopeiin was yuantitated.
Thus a total of 69 sera from 57 patients were examined. The diagnosis
was confirmed in each case by liver biopsy which showed grade IV iron
overload with extensive fibrosis (Soheuer, Williams and Muir, 1962).
Established cirrhosis with nodular regeneration was demonstrated
unequivocally in 38 of the 57 patients. Liver function tests were within
normal limits in the great majority of cases.
m.) Serial blood samples were obtained from cases^33-37 before and
at approximately monthly intervals during venesection.
H. Relatives of patients with primary haemochroaatoais
The sera from 14 first and second degree relatives were examined.
Cases 9» 12-14 had had a few pints of blood venesected 3 or more years
previously. None had clinical or biochemical evidence of liver disease
hut the serum iron was raised in some cases (Table 14).
I. Secondary iron overload
Sera from 15 patients with seoondary iron overload from a variety of
































Clinical and laboratory details of 29 patients in first series


















6 + 40 275 173 current +
7 + 235 260 1172 1/12
16 + 225 255 2021 current ♦
14 0 225 260 1027 3 +
5 0 205 215 1039 3 +
14 + 280 345 838 6/12
12 0 255 265 825 6 +
2 + 50 330 523 current +
8 + 140 230 512 6 +
2 + 100 255 455 1 +
7 + 172 315 249 6 0
8 + 145 210 537 6 +
2 0 190 205 1539 1/12 +
5 + 290 300 744 1/12 ©
10 0 230 340 837 8 0
11 0 280 360 268 1 0
6 ♦ 160 190 3029 0 ■f
3 + 235 240 1946 current ♦
4 + 95 315 310 current +
11 + 70 330 81 9/12 +
3 0 25 450 110 1/12 ♦
3 + 210 240 1444 5/12 +
1 + 215 235 1372 current +
7 + 145 285 120 4/12 +
15 0 310 350 463 13 +
2 + 180 285 791 current +
10 + 95 310 271 current 0
4 0 110 225 371 current ♦
8 0 155 400 302 1 0
* UFO - differential ferioxamine test. Normal <300 ^ug/fcg
Table 13« Clinical and laboratory details of the second series of






















30 61 8 ♦ 270 320 1633 4 +
31 54 4 0 250 300 1700 1 +
32 46 4 0 230 230 1692 0 0
33 62 2 0 170 180 >862 0 +
34 55 11 + 210 235 961 4 +
35 56 14 + 270 300 3303 0 +
36 71 1 0 380 380 719 0 0
37 (27) 64 14 ♦ 190 220 1196 3.5 0
38 84 4 0 260 280 1764 0 +
39 34 1 0 40 340 94 1/52 +
40 47 6 + 230 265 796 3.5 +
41 57 4 + 215 260 2040 0 ♦
42 52 16 + 290 315 1492 5 +
43 (19) 76 8 + 255 345 1212 4 +
44 37 2.5 + 260 325 636 current +
45 (21) 43 7 0 250 275 $09 3.5 ♦
46 (25) 73 19 0 270 310 I890 4 +
47 (24) 57 10 ■f 210 235 66 3 +
48 43 10 0 180 200 1500 0 +
49 (18) 41 6 + - - 284 2 +
50 69 1 ♦ 115 140 1012 0 +
51 68 18 0 215 300 947 3 +
52 49 12 + 220 250 418 3.5 0
53 40 4 0 255 280 762 3 0
54 40 1 0 - - 1154 current 0
55 61 5 0 50 240 419 3 0
56 48 3.5 * 280 300 847 1.5 ♦
57 (24) 57 10 + 210 235 66 3 +
58 62 2 0 200 220 1072 current +
59 51 7 + 245 350 797 3 +
60 38 3 0 290 295 796 9/12 +
61 67 19 0 120 175 902 2 0
62 78 8 ♦ 160 185 1457 4 +
63 60 11 + 245 325 1102 2 +
64 (23) 61 5 + 235 270 1347 2 +
65 (28) 53 7 0 225 270 750 4 +
66 (22) 69 7 + 95 220 838 3
67 (26) 53 6 + 245 250 1208 2.5 +
68 (20) 65 14 + 215 245 1025 4.5 +
69 60 l/l2 0 165 235 3131 0 +
































M Sibling 180 350 338
1 Nephew 145 325 431
M Son 105 315 208
M Sibling 195 295 263
M Nephow 100 265 151
M Son 95 310 -
M Nephew 155 400 302
M Son 145 295 266
M Son 140 250 117
It Father 70 350 -
F Mother 85 370 -
H Sibling 185 310 303
M Sibling 205 270 530
M Sibling 115 355 475
S)
Clinical and laboratory detail® on patients vrf.th
secondary iron overload











1 48 U Alcoholic
cirrhosis
105 270 1037 Liver biopsy
grade 2 iron
2 45 H Unknown 180 205 1012 Liver biopsy
grade 3 iron +
fibrosis
3 35 M Alcoholic
cirrhosis
60 310 513 Liver biopsy
grade 2 iron
4 58 f Cryptogenic
cirrhosis +
PCT
70 370 218 Being venesected
5 66 M Alcoholic
cirrhosis
105 250 434 Previously bled
6 60 M Unknown 195 235 867 Liver biopsy
grade 3 iron
7 66 Id Alcoholic
PCT
100 360 293 Previously bled
Liver fibrosis
8 31 M Unknown 220 250 219 Iron stores un¬
altered after 4
years
9 60 F Alcoholic
PCT
180 400 382 Previously bled
10 55 F Excess oral
iron
160 230 1013 Liver biopsy
cirrhosis* Grade
3 iron
11 57 M Chronic
active
hepatitis
225 340 942 Liver biopsy
Grade 2 iron
12 57 M Aplastic
anaemia
220 260 - Multiple trans¬
fusions (> 20 units)
13 12 F Aplastic
anaemia
210 397 - Transfused 21 units
blood
14 83 F Myelofibrosis 140 195 - .'ransfused 29
units blood
15 24 F Myelofibrosis 98 241 mm Transfused 30
units blood
PCT « porphyria cutanea tarda
Cases 2 and 6 ware not considered to have primary haemochromatosis as
there were no abnormal physical signs and the degree of hepatic fibrosis
was slight.
J. Controls and patients with autoimmune liver disease studied for
evidence of in vivo activation of complement
Three healthy laboratory personnel and 3 patients in the primary
biliary cirrhosis series (patients no. 5i 9> IS) were studied. In
addition there were 6 patients with biopsy proven active chronic hepatitis
including Cases 1, 3 and 4 (Appendix C) and Cases 5 and 18 (Table 7)*
Three of these cases were positive for Australia antigen and the othsr 3
cases had autoantibodies to smooth muscle, mitochondria or antinuclear
factor.
K. Liver transplant recipients
Serum specimens were studied before and at intervals following ortho¬
topic liver transplanation in 4 recipients. Detailed case histories are
found in Appendix D. Case 1 was studied using large plates (®urray-Iyon,
Clark), Freeman and Williams, 1970) and oases 2-4 using miniplates.
L. Patients with severe deficiency of plasma ^-antitrypsin
Serum samples from 7 adult subjects, 4 of whom had severe emphysema
were studied. Two were asymptomatic siblings (Table 16) and one elderly
had slight bronchitis hut no evidence of emphysema on detailed pulmonary
assessment- (Hutchison, et al, 1971). None had overt pulmonary infection
at the time samples were taken and none had clinical evidence of liver
disease. Ho patient had a family history of liver disease.
M. Effects of enzyme inducing drugs
i) Normal subjects
Serial blood samples were taken from 2 normal subjects before and at
?3







Age Sex Clinical state Liver function tests
1 (7) 42 H Severe emphysema Bilirubin 1.8mg/l00ml.
2 (5) 52 M Severe emphysema Normal
3 (*) 47 F Normal. Sib of Case 2 Normal
4 (4) 48 M Severe emphysema Normal
5 (4te) 53 M Normal. Sib of Case 4 Normal
6 (36) 72 M Slight bronchitis Normal
7 (6) 54 F Severe emphysema Normal
» los. referring to patients in article by
Hutchison et al (1971)
intervals following courses of Bucolome (Butymidinj Takeda Chemical
Industries, Ltd., Osaka, Japan) and H-phenylphetharbital (Phetharhital)
drugs which are said to induce a variety of hepatic enzyme systems. The
development of enzyme induction was assessed by serial measurement of
plasma bilirubin (Hunter, et al, 1971c) and urinary B-glucaric acid
excretion (Hunter, et al, 1971a).
ii) Epileptics on anticonvulsant therapy
Fifteen patients with severe epilepsy all of whom had been treated
with anticonvulsaint therapy for longer than a year were also studied.
In addition to serum samples for Immunoelectrophoresis and routine bio¬
chemical screening, urine was obtained for estimation of D-glucaric acid
excretion. Details of the patients are given in Table 17. To obtain a
measure of the total daily dose of anticonvulsant, a simple scoring system
was used, one unit being ascribed to every 30mg phenobarbitone, 5Qmg.
diphenylhydantoin, lOOmg. primidone, 250mg. ethosuximide.
8 5
Table 17. Clinical and laboratory details of 15 adult epileptic
patients on long term anticonvulsant therapy.
Case Ho* of different Amount of Alkalinet acid^utmrt
Age Sex anticonvulsant anticonvulsant phosphatase > .<£/» rL,
1 17 M 2 3 128 10.5
2 45 U 3 11.5 104 16.3
3 37 F 2 9 54 55.9
4 37 F 3 8 72 12.4
5 51 H 2 18.5 76 119.0
6 50 M 2 9 100 25.5
7 17 H 2 9 155 26.0
8 18 F 3 13 92 15.8
9 25 M 2 11.5 56 16.0
10 48 M 2 8.0 84 28.0
11 26 F 2 13.5 67 21.5
12 35 M 2 13.5 124 69.0
13 38 M 2 15.5 66 23.8
14 22 M 2 15.5 69 -
15 60 M 3 4 88 8.3
normal ranged- 30-85 iu/l + 6-10 yug/g creatinine
STATISTICAL METHODS
In the early studies using large plates clinical and laboratory data
was collected and categorised according to the protocol in Appendix E.
The values for all proteins except haptoglobin and haamopexin were log
transformed as the distribution of the protein levels was log-normal
(Healey, 1968). In the first study on patients with primary haemo-
chromatosis the protein levels for each patient were analyzed statistically
for correlations amongst proteins and between protein changes and all the
clinical and laboratory data recorded. In the subsequent large plate
studies the number of clinical and laboratory indicants used in the
correlation matrix was limited to those in Table 18.
Table 18
Clinical and laboratory data analysed for correlations with
the concentrations of each plasma protein in the large plate studies
Age
Duration of illness
Current treatment with corticosteroids
Skin stigmata of chronic parenchymal disease
Presence of hepatic encephalopathy
Presence of ascites







Presence or absence of cirrhosis on liver biopsy
Presence of autoantibodies
87
In the miniplate studies all protein values were log transformed
and the clinical and laboratory data analysed were restricted to the
age and sex of the patient, duration of history, liver function tests,
prothrombin time, albumin and total protein. Other data where relevant
to special groups of patients are shown in the tables.
Standard statistical techniques were used throughout with the aid
of the London University Computer and the Glasgow University Computer.
The diagnostic value of the protein values was assessed by the error
in reclassification of the patients using a stepwise discriminant
analysis (Dixon, 19681 Programme BMD07M) and a Bayesian model (Knill-
Jones, E.P.j personal communication). The error in reclassification






1. Protein concentrations in the control population and normal subjects
A. Kormal range
The mean and standard deviation (S.D.) of the concentrations of the
13 proteins measured in the 70 control subjects by the miniplate technique
ox'e given in Table 19# The values for lipoprotein are expressed as a
percentage of the acetylated albumin marker as lipoprotein does not
appear in the standard serum. All other proteins are given as a percentage
of the concentration of that protein in the standard serum.
3 subjects had ^-antitrypsin concentrations outwith the normal range
(63-133%) established on the group as a whole. Their serum was examined
by starch gel electrophoresis (Dr. P.J.L. Cook) and all 3 were heterozygous
deficient, their Pi types being MX (2) and SZ (l).
The coefficient of variation for most proteins lay between 10-20$ with
a greater variability for haptoglobin and caeruloplasmin.
The absolute value of the mean and normal range of 5 proteins measured
in the control population was determined by comparison with the results of
Immunoelectrophoresis of the Hoechst standard serum for which absolute
concentrations of certain proteins are provided. For each protein there
was a close agreement (Table 20) with the normal values obtained by a variety
of immunological methods given in the literature.
B. Variation in protein concentration with sex
The mean and standard deviation of the 13 proteins (expressed as per
cent acetylated albumin) were analysed for males and females separately
and significant differences were found for only 3#
Table 19. Normal range for 13 proteins measured, in 70 control
subjects and expressed as % standard serum.
Protein Mean S.D.
Normal range
Mean + 2 S.D.
Prealb. 111.1 23.2 64.7 - 157.5
PGP 103.0 15.5 72.0 - 134.0
tfjAT 98.9 17.2 63.5 - 133.3
GC 101.0 15.7 69.6 - 132.4
oCgM 120.6 28.7 63.2 - 178.0
Caer. 133.8 34.8 64.2 - 203.4
10 109.3 20.7 67.9 - 150.7
Hpt 65.1 27.4 10.3 - 119.9
Hpx 107.2 I8.4 70.4 - 144.0
Trf 108.5 17.4 74.7 - 143.3
LP 21.7 5.3 11.1 - 42.3
16 103.3 I8.4 66.5 - 140.1
18 108.9 13.8 81.3 - 136.5
* expressed as % acetylated albumin marker
Table 20. Absolute values (mg/lOOml) for 6 proteins in the 70 normal
subjects compared with normal values in the literature.
Present study Other series
Protein Mean Q _ Mean Q Author
(mg/lOCml) 3,D* (mg/lOOml) S,D#
Prealb. 26 5.5 25 7.5 Storiko (1968)
25 6 Rossi et al (1970)
25 6.5 Weeke and Knasilnikoff
(1972)
22 3 Ingenbleek et al (1972)
GC 23.4 3.5 39.8 - Cleve and Dencker (1967)
35 5 Storiko (1968)
25 - Hughes (1971)
27 5 Weeke and Knasilnikoff
(1972)
d2M 186 44 180 - Ganrot and Schersten
(1967)
200 24 Adham et al (1968)
240 55 Storiko (1968)
284 89 Housley (1968)
Hpt 87 36 160 (range 10-220) Storiko (1968)
- (range 55-357) Iyngbye and Kroll (1971)
147 (range 58-373) Weeke and Knasilnikoff
(1972)
Ipx 8l 12.8 - (range 66-100) Hanstein and Muller-
Eberhard (1968)
100 (range 80-130) Storiko (1968)
81 (range 59-103) Braun and Aly (1971)
80 (range 53-121 Weeke and Knasilnikoff
(1972)
Trf 2$2 38 270 45 Fiaschi at al (1969)
- (range 179-335) I^rngbye and Kroll (1971)
226 (range 152-336) Weeke and Knasilnikoff
(1972)
Table 21. Proteins with significant difference between mean
concentrations in males and females
Protei" Mean'^S.D. Significance
Prealb. 208.5 7.0 198.5 8.0 i>< 0.002
204.4 9.6 210.2 8.8 b<o.oi
Caer 207.5 8.5 215.7 10.9 b< 0.002
C. Variation with age
A plot of the concentration of each protein against age showed a
distinct trend for easily precipitable glycoprotein and haemopexin to
rise with age and there was a significant difference between the mean
values in the age groups 20-44 and 45-70 for both these proteins (p<0.002).
The concentration of the other proteins did not appear to vary with age.
D. Correlations between individual proteins in normal sera
Significant correlations (r>0.5j t><0.00l) were found between the














B. Variation in normal sera with repeated sampling
Repeated samples were taken from 5 members of the laboratory staff
over a period of 9 months. The values for each subject varied little and
remained within 2 S.D. of the mean established in 70 normals. In one
subject in whom 10 samples were #btained the variance of the readings
for most proteins was greater than the variance of repeated measurements
of the same protein in the standard serum. However, the difference was
statistically significant only for group component and caeruloplasmin
(Table 22).
F. Comment
The values for the 6 proteins expressed as ag/lOCml serum agree well
with the ranges determined hy immunological methods for normal subjects
given in the literature. Variation in the means in the different series
is to some extent a reflection of the purity of the standard protein used
to calibrate the system, for the use of an impure standard will give a
spuriously high reading for the protein in the serum being tested. The
10-20" coefficient of variation for most of the 13 proteins measured also
agrees well with the figure given by Clarke and Freeman (1968) and Ganrot
(1972). The range for haptoglobin and therefore its coefficient of
variation is well known to be large. The reason for this is not clear
but it may be due to variable polymerisation of the protein.
Differences in plasma protein values according to age and sex have
been studied in large numbers of subjects by Lyngbye and Kroll (1971) and
Weeke and Krasilnikoff (l97l)» The concentration of some proteins is
dependent on both age and sex and complex polynomial regressions have been
derived to express this variation ("eeke and Krasilnikoff 1971)• Protein
concentrations in infants (Abrams and Freeman, 1969) and children (Abraras,
1971) differ greatly from adults. Considering only adults the rise in
haemopexin with age in the present series is in agreement with Weeke and
Krasilnikoff (1971) although Clarke and Freeman (1968) found ho change
with age, but as in this study both groups found a rise in easily
precipitable glycoprotein. Most authors agree that prealbumin is slightly
higher in adult males than females and that ^-macroglobulin and caerulo¬
plasmin are higher in the female (Hossi et al, 19681 Stabilini et al, 1968j
Clarke and Freeman, 19685 Weeke and Frasilnikoff, 1971» Ganrot, 1972).
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Table 22. Variation in protein concentrations (expressed as per cent
acetylated albumin) in repeated samples taken from a normal
subject compared with repeated estimations of the standard
serum.







PGP 36.8 4.64 39.9 5.5
V 115.4 10.17 122.5 8.6
oc 125.3 19.2 ** 124.2 7.7
24.8 3.26 22.6 2.0
Caer. 67.9 9.77 * 57.7 4.5
10 25.1 3.93 23.5 4.5
Hpt 137.6 44-68 199.0 30.0
Hpx 36.8 4.18 37.1 3.7
Trf 38.5 5.3 38.8 3.9
16 54.3 5.68 47.6 4.8
18 54.2 5.43 49.4 4.8
* F - 4.8;^ 0.05 ** F«6.4ft> < 0*01
9!O
The present results are in agreement with these trends. However any
differences in the mean values between the sexes are not great and Iyngbye
and Kroll (1971) and Adham, et al (1971) found no differences for pre¬
albumin and A^macroglobulin respectively. Other factors which may influence
the concentration of some plasma proteins are whether or not the subject
is fasting, the time of day and the season of the year (lyngbye and Kroll
1971). It was not practical to take account of these factors in the
present study.
As the differences in the protein concentrations were shown to vary
little with age or sex the control group as a whole has been used for
comparison with the patient groups.
Various workers have published correlation matrices for the different
plasma proteins in normal subjects (Phillips and Blackmore, 1971 f Ganrot,
1972? Werner et al, 1972). Clearly because of the large number of
correlations examined a certain number will achieve conventional statistical
significance by chance. Therefore only those arising by chance less than
once in a thousand times are given. Ho ready biological explanation is
apparent for the findings and the pattern of correlations is different
in each of the 4 matrices examined.
2. PHOTSIB COBCSBTHATION IB DIFFERENT PATHOLOGICAL STATES
A. Halation to necrosis and inflammation
i) Acute viral hepatitis.
There were significantly increased concentrations of easily precipitable
glycoprotein and ^antitrypsin, caeruloplasmin, proteins 10 and £ lipo¬
protein. The levels of prealbumin, haptoglobin and haemopexin were
significantly reduced (Table 23).
Correlations were sought between the protein levels and the length
of history and liver function tests. There were significant negative
Table 23. Mean protein levels (+ S.D.) expressed as per cent standard
serum in acute viral hepatitis (miniplates) and active
chronic hepatitis (large plates)
Viral Normal Active chronic Normal
Protein Hepatitis subjects hepatitis subjects
(n-12) (n=?0) (n«20) (n=100)
Prealb. 56 (40)*** 111 (23) - -
PGEP 182 (44)*** 102 (15) 151 (42)*** 115 (19)
^AT 136 (20)** 99 (17) - -
GC 91 (19) 101 (15) 105 (35) 117 (15)
135 (41) 121 (29) 175 (51)*** 122 (25)
Caer. 179 (67)* 133 (34) 175 (45)*** 137 (25)
10 170 (55)*** 109 (20) 143 (57) 121 (17)
Hpt 56 (46)? 65 (27) 48 (52)** 103 (44)
Hpx 58 (38)*** 107 (18) 108 (38) 107 (13)
Trf 98 (22) 108 (17) 135 (39)** 110 (15)
/5LP f34 (11)* +21 (5) 175 (67) 177 (43)
16 131 (32) 103 (18) - -
18 112 (33) 108 (13) - -
^AC 185 (87)** 107 (24)
Alb.
(g/lOOEl)
3.46 (O.46) 3.2 (0.66) —
t Expressed as $ acetylated albumin




correlations (p <0.01) between haasaopexin and the serum aspartate amino¬
transferase and also the degree of prolongation of prothrombin time,
and between protein 16 and the serum aspartate aminotransferase. There
were significant positive correlations (p<O.Ol) between prealbumin and
haemopexin, prealbumin and protein l6t protein 10 and p lipoprotein,
proteins 10 and 18, haptoglobin and protein 16.
ii) Active chronic hepatitis
a) Single samples in 20 patients. Six of the 10 proteins measured
were significantly different from the values in the control population.
The concentrations of easily precipitable glycoprotein, ^-macroglobulin,
caeruloplasrain, transferrin and globulin were increased and haptoglobin
was decreased. An analysis of the protein levels with 15 indicants from
the clinical and laboratory data (Table 18) showed a significant correlation
only between both easily precipitable glycoprotein and transferrin and the
alkaline phosphatase (p<G.0Ql).
b) Serial readings in four patients. The effects of treatment
with azathioprine or corticosteroids were studied in 4 patients. Samples
were taken before and for soma moths after therapy was started. Details
of the individual cases are recorded in Appendix C and the protein
concentrations before treatment are given in Table 24.
Case 1. Before treatment 5 proteins were present at concentrations
above normal (easily precipitable glycoprotein, antitrypsin, cxCg-siacro-
globulin, caeruloplasmin and protein 10) and haemopexin and prealbumin
concentrations were reduced (Table 24). Treatment with large doses of
corticosteroids resulted in a fall in serum bilirubin to a minimum of
2.2mg/l00ml after 5 months and accompanying this improvement there was a
gradual rise in prealbumin and haemopexin concentrations into the normal
range and a fall in the concentrations of caeruloplasmin, ^-macroglobulin,
and protein 10 to just within the normal range (Fig. 19)« The concentrations
9 8
Table 24. Protein concentrations expressed as $ standard serum








mean + 2 S,
(n«70)
Prealb. 32 20 50 65 - 158
^PGP 175 108 128 63 72 - 134
*1AT 170 154 140 108 64 - 133
GC 103 36 95 34 70 - 132
"V 205 155 177 125 63 - 178
Caer 220 163 156 100 64 - 203
10 154 175 158 129 68 - 154
Hpt 61 18 3 0 10 - 120
Hpx 57 21 41 27 70 - 144
Trf 137 68 76 56 75 - 143
*Sw 40 28 35 13 11 - 42
16 135 73 54 86 67 I »-■ O
18 98 16 64 30 81 - 137
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Figure 19. Case 1. Concentration of five proteins at intervals















Figure 20. Case 2. Concentration of six proteins at intervals
during treatment with corticosteroids.
i o 0
of easily precipitable glycoprotein and ^-antitrypsin remained high.
During the subsequent deterioration in liver function the plasma protein
* ¥
pattern again became abnormal. The other proteins measured remained in
the normal range throughout the period of study.
Cass 2. Corticosteroid therapy resulted in gradual improvement
in liver function tests and the concentration of 4 or 5 proteins which
had been reduced (prealbumin, group component) haemopexin, protein 18 and
transferrin) (Table 24) rose to normal or above normal concentration
(Fig. 20). The concentration of haptoglobin also rose markedly. The
levels of s^-antitrypsin which had been increased returned to normal, but
protein 1C remained high. At the end of 5 months treatment liver function
was normal apart from slight elevation of aspartate aminotransferase
(82 I.U./l.), and all proteins measured were within the normal range
except for elevation of protein 10 and haemopexin.
Case 3. During treatment with azathioprine there was a slow fall
in serum bilirubin and the raised levels of protein 10 returned to the
normal rang© after 3 months but ^-antitrypsin remained elevated (Fig. 21).
Prealbumin, haptoglobin and haemopexin remained low but proteins 16 and 18
rose to normal concentrations after 3 months. Other proteins remained
within the normal range before and during treatment.
Case 4. Concentrations of easily precipitable glycoprotein, group
component, haemopexin, transferrin and protein 18 were low and haptoglobin
f
absent before treatment and there was little change over the next 6 weeks
despite a progressive fall in serum bilirubin (Fig. 22). 3 months when
the serum bilirubin had fallen to 1.2 mg/lOOml there was a striking rise
in the concentrations of most proteins and haptoglobin was present for
the first time. Levels of easily precipitable glycoprotein, o(ginacroglobulin



















Figure 21. Case 3. Concentration of five proteins at intervals
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Figure 22. Case 4» Concentration of five proteins at intervals
during treatment for active chronic hepatitis.
protein pattern was normal apart from raised levels of proteins 10 and 16.
At 11 months the bilirubin had risen to 4«8mg/l00ml and the protein
pattern had become more abnormal with high levels of ^-macroglobulin and
protein 10 and low levels of group component, haemopexin and protein IB.
In all 14 serum samples examined the configuration of the prealbumin
arc was abnormal with 2 or 3 subsidiary peaks trailing across the plate
to the origin (Fig. 23)• The shape was variable (Fig. 24) but never
returned to normal and the degree of abnormality appeared to be related
to the severity of disturbance in liver function. The latest sample
taken when liver function had again deteriorated was similar to Fig. 23.
Autoradiography was performed (Dr. H.M. Clarke) on a plate in which the
125
serum applied was mixed with ©,^uCi I thyroxine and this showed the
protein bound thyroxine throughout the length of the arc (Fig. 25).
Samples of serum from the patient's 2 children showed a normal pattern
with no disturbance of the prealbumin arc.
B. Relation to hepatic fibrosis
i) Inactive cryptogenic cirrhosis
Here *he only significant difference in the 11 proteins measured
from the normal values was a rise in oc^-^nacroglobulin and ^AC globulin
(Table 25).
ii) Alcoholic cirrhosis
There was a significant elevation of ^-macroglobulin -t ^AC globulin
and caeruloplasmin concentrations and transferrin was depressed below
normal. (Table 25).
In neither group were there any significant correlations between the
concentrations of any protein and the clinical and laboratory data in
Table 18.
Figure 23. Case 4. Serum sample 'before treatment. Note the
configuration of the prealbumin arc and absence of haptoglobin.
Figure 24. Case 4. Serum sample after seven months treatment.
Most proteins are present at higher concentration and prealbumin
arc is more normal.
Figure 25. Case 4» Autoradiograph of plate with added radioactive
thyroxine to show binding to the whole length ®f the abnormal
prealbumin arc.
Table 25. Mean protein levels (+ S.D.) as per cent standard serum








crfjIP 108 (28) 89 (tf) 127 (20)
o^PGP 139 (41) 140 (44) 115 (19)
C2GP 97 (37) 93 (20) 117 (15)
^2® 170 (51)** 171 (61)** 122 (25)
Caer 166 (69) 177 (53)** 137 (25)
10 94 (51) 118 (23) 121 (17)
Hpt 59 (84) 67 (63) 103 (44)
Hps 104 (36) 102 (29) 107 (13)
Trf 114 (33) 91 (27)** 110 (15)
f>LP 157 (38) 198 (77) 177 (43)
filAC 156 (65)** 185 (69)#** 107 (24)
Albumin
(g/lOOml)
3.5 (0,56) 2.9 (0.42) -
Statistical significance of difference 'between mean value
in clinical group and that of normal subjects
0.05 ** \> ^ 0.01 *** j5< 0.001
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C. Relation to biliary obstruction
i) Primary biliary cirrhosis
There were significantly reduced concentrations of prealbumin and
haemopexin and increased concentrations of easily praoipitable glyco¬
protein, <x^-antitrypsin,^g-macroglobulin, caeruloplasmin and protein 16,
(Table 26) (Fig. 26).
There were numerous correlations with the liver function tests.
Haeiaopexin was negatively correlated with the serum bilirubin, the serum
aspartate aminotransferase and the degree of prolongation of the prothrombin
time (p<0.0l). There were negative correlations (p <0.0l) between the
prolongation of the prothrombin time and the concentrations of easily
precipitable glycoprotein, group component and protein 18. Albumin was
positively correlated (p<0.01) with prealbumin, haemopexin and protein
18.
There were significant (p<O.Ol) correlations between easily preoipitable
glycoprotein and ^g-macroglobulin, and easily precipitable glycoprotein
and protein 18.
ii) Extrahepatic biliary obstruction
There were significantly reduced concentrations of prealbumin,haemopexin,
transferrin, protein 18 and lipoprotein and increased concentrations of
easily precipitable glycoprotein, ^antitrypsin, caeruloplasmin and protein
16 (Table 26),
Correlations with the clinical data and liver function tests included
negative correlations between the concentration of transferrin and the
duration of jaundice (p<O.Ol) and the serum aspartate aminotransferase
(p<0,01), and haemopexin was negatively correlated with the serum
cholesterol (p<O.Ol) and serum bilirubin (p<0.01).
There were significant correlations (p<0.01) between the concentrations
of prealbumin and group component, easily preoipitable glycoprotein and
1 9 7
Figure 26. Serum from patient with primary biliary cirrhosis
showing increased levels of d- (-antitrypsin (o^-AT), easily
preeipitable glycoprotein (PGP^ protein 16}caeruloplaamin
(Caer ^Hnacroglobulin (o^M^and reduced level of prealbumin
(prealbj.
Table 26. Mean protein levels (+ S.D.) as per cent standard serum in












Prealb. 44.7 18) *** 47 (22)*** 111 (23)
PGP 162 100 181 (19)*** 102 (15)
o^AT 160 39) *** 198 (75)*** 99 (17)
GC 99 58) 94 (23) 101 (15)
I69 47) **# 140 (51) 121 (29)
Caer 210 46) *** 230 (80)*** 133 (34)
10 109 30) 119 (41) 109 (20)
Hpt 68 41) 102 (47) 65 (27)
Hpx 82 37) * 58 (39)*** 107 (18)
Trf 103 42) 77 (21)** 108 (17)
*3 LP 19 (6) 16 (12)** 21 (5)
16 160 47)##* 211 (117)*** 103 (18)





3.01 0.74) 2.66 (0.65) —
+
Expressed as % acetylated albumin
* /> < 0.05
** p < 0.01
***f> < 0.001
protein 16, and protein 16 with "both ^-antitrypsin and protein 18.
D. Relation to iron overload
i) First series of 29 patients with primary haeiaochromatosi s
There was significant elevation of the mean concentration of
antitrypsin, group component, '^g-macroglobulin, caeruloplasmin, haerao-
pexin and ,^AC globulin. Other proteins measured were at normal
concentrations. (Table 27).
ii) Second series of haemochromatofeic patients
In the further series of 20 sera from patients with primary haeao-
chromatosis examined by the miniplate technique the only significant
abnormalities were the rise in the concentration of^?-macroglobulin
and a slight reduction in prealbumin and transferrin. All other proteins
were present at normal concentration (Table 27).
There were no significant correlations between the different proteins
and the serum iron, serum total iron binding capacity (TIBC) or chelatable
iron stores measured by the differential ferrioxamine test with the exception
of transferrin which was positively correlated with the TIBC measured
chemically (fl - 20, r - 0.753» P -<0.00l).
Significant correlations between pairs of proteins (p <0.00l) were
prealbumin with group component, haemopexin with protein 18, group
component with haemopexin and protein 18, haemopexin with protein 18.2
In a further series of 20 sera haemopexin alone was measured and the
mean concentration (119$ of the standard serum) did not differ significantly
from the mean in the normal subjects.
iii) COtL-.EffT
The striking difference in the results in the two series of patients
with haemochromatosis was disturbing and totally unexpected and various
possible explanations have been explored. The presence of an underlying
primary hepatoma or gall bladder carcinoma was discovered in 5 cases in
110
Table 27. Mean protein levels (+ S.D.) as per cent standard serum















Prealb. «a» - 79 27)* 111 (23)
PGP 142 (27) 115 (19) 106 27) 102 (15)
152 (39)#** 114 (18) 10? 29) 99 (17)
GC 138 (41)* 117 (15) 95 16) 101 (15)
M 215 (68)*** 122 (25) 193 50)*** 121 (29)
Caer 173 (59)#* 137 (25) 124 36) 133 (34)
10 - - 116 26) 109 (20)
Hpt 113 (71) 103 (44) 65 34) 65 (27)
Hpx 156 (49)*** 107 (13) 106 25) 107 (18)
Trf 119 (36) 110 (15) 78 17)** 108 (17)
jSLP 146 (85) 177 (43) *16 6) *21 ( 5)
16 - - 102 24) 103 (18)
18 - - 101 20) 108 (13)
^AC 155 (69)*** 107 (24) - -
Albumin
(g/lOOml)
3.6 (0,64) - 3.74 (0.88) -
+
Expressed as % acetylated albumin
*£<0.05 **p<o.oi ***j?< 0.001
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the first series up to 3 years after the serum was examined (cases 5, 10,
13, 17 and 18). It is known that raised haemopexin levels may occur in
malignant melanoma (Manuel et al, 1970) and. a variety of other tumours
(Muller and Muller von Voigt, 1967)• However the haemopexin levels in
our cases with malignant disease were 230, 186, 124, 183, 199^ of the
standard and the mean of this group (168$) does not differ from the
remainder (167$). The other patients remain well 4 years later apart
from 4 who have died (Cases 2 and 21 congestive cardiac failure, Case
24 cerebrovascular accident, Case 15 peripheral vascular disease).
The high haemopexin levels could not be accounted for by gross iron
overload before treatment or diabetes mellitus (Cleve et al, 1968).
Samples taken at the end of a venesection session might have raised^level
of most proteins due to gross congestion in the limb. However there was
no relation between raised haemopexin levels and current venesection
therapy. Further fresh samples taken from 12 of these patients were
examined 3sT to 4 years later by the miniplate technique and except for
Case 10 all were within the normal range.
It is noteworthy that haemopexin is but one of several plasma proteins
raised in the sera of patients in the first series. Review of the plates
showed that there was no error in the planometrio measurement but it seems
possible that the measurement of the serum sample or the acetylated
albumin was at fault. This would account for a general rise in the con¬
centration of all proteins on the plate and is supported hy the finding that
plates with normal haemopexin levels had normal concentrations of most
other proteins. The number of proteins apart from haemopexin present on
each plate at a concentration above the normal range (mean + 2 S.D.)
correlated closely with the haemopexin level (n => 291 r = 0.755! p<0.Q0l).
This is strong evidence that an artefact in measuring the serum volume or
acetylated albumin was responsible for the findings in this first series
of patients with, haemochromatosis.
The findings in the second series of patients with a rise in0^
macroglohulin and a slight fall in prealbumin and transferrin are more
in keeping with the findings in the other groups of patients with liver
disease. This minor abnormality is consistent with the low grade disease
process and the excellent liver function in these patients, and is
closely similar, as might be expected, to the findings in the patients
with inactive cryptogenic cirrhosis.
iv) Effeota of serial venesection in six patients
The initial serum concentrations of the 13 proteins measured are
shown in Table 28. There was little change in the concentration of any
protein over the next few months in the course of the venesection in any
patient, with the exception of the transferrin concentration which was
below the normal range in 2 patients and at the lower end of normal in 1
other before venesection started. During venesection there was a progressive
rise in concentration in these 3 patients. Representative readings in
patient 6 are shown in Fig. 27. Consistently low levsls of<* ^-antitrypsin
were noted in this patient and starch gel electrophoresis (Dr. P. Cook)
showed heterozygous deficiency associated with Pi phenotype MZ.
v) Relatives of patients with primary haemoohromatosia
The mean serum haemopexin concentration was 123 + S.D. 22$ of the
standard and did not differ significantly from the concentration in the
normal population. There was no correlation with the serum iron, TIBC or
iron stores. The mean serum transferrin concentration was 102 + S.JQ. 13* 5$
standard and this was significantly lower (p<0«0l) than the control
population. There was no correlation with the serum iron or chelatable
iron stores.
1 - J
Table 28. Protein concentrations as per cent standard semis in six









(Mean + 2 S.D.)
(n-70)
Prealb 72 110 143 49 87 79 65 - 158
o^jPS? 106 64 78 120 104 125 72 - 134
o^AT 97 121 97 135 85 54 64 - 133
GfC 83 127 107 81 93 97 70 - 132
«y< 210 150 173 261 195 205 63 - 178
Caer 114 160 88 144 95 156 64 - 203
10 94 139 172 134 139 129 68 - 151
Hpt 106 66 35 15 70 90 10 - 120
Hpx 112 140 140 90 117 114 70 - 144
Trf 50 62 108 90 77 82 75 - 143
*/5LP 15 23 17 14 19 14 11 - 42
16 93 146 66 100 94 112 67 - 140
18 95 136 89 99 97 114 81 - 137


















Figure 27. Concentration of four proteins at intervals during
regular venesection therapy in a patient with primary
haemochromatosis•
i i. 5
vi) Patients with secondary iron overload
The mean serum haemopexin concentration was 113.8 + S.D. 27$ of the
standard and this did not differ significantly from the control population.
E. Evidence of in vivo complement activation
Slight conversion of was seen in fresh plasma in 2 of the 3 normal
subjects (Fig.28), all 6 of the patients with active chronic hepatitis and
one of 3 patients with primary biliary cirrhosis. The degree of conversion
in each case was slight and no greater than that noted in the control
subjects.
F. Change in protein pattern following liver transplantation
Case 1. (Appendix D). The concentrations of some of the 18 proteins
measured before transplanation are shown in Table 29 and the levels of all
except protein 10 are raised. The changes in serum protein concentrations
observed after transplantation (Fig. 29) led to the definition of 2 principal
groups. Group (A) included those proteins which stayed at normal or
increased concentrations from the time of transplantation till death. These
included easily precipitable glycoprotein, oc^-aniitrypsin, group component
Cj-raacroglobulin, caeruloplasmin and haptoglobin. Levels increased in the
second post-operative week during the early rejection episode but were
normal by the 58th day when the concentrations of all the proteins measured
were in the normal range. Levels then increased again during the phase of
chronic rejection. Group (B) included those that gradually decreased in
concentration after the transplant, particularly after the 8C*th day. They
included albumin, protein 10, transferrin and haemopexin. The concentration
of /)jA-C globulin (C3) decreased in the first 17 days at the time of the
early acute rejection episode (Fig.29). At the beginning of the period of
chronic rejection the concentration was also greatly depressed but later









Figure 28. Two dimensional Immunoelectrophoresis pattern using antiserum
to p jAC with fresh plasma (left) and serum (right) from
a normal subject. Both / and ^gjAare seen in both specimens.
Table 29» Protein concentration as percent standard serum in 4





(Mean + 2 S.D.)
Prealb. - 17 52 50 65 - 158
^PSP 218 35 122 162 72 - 134
^1AT 236 97 157 214 64 - 133
GC 188 80 99 111 70 - 132
oXgM 183 123 114 146 63 - 178
Caer. 300 56 178 195 64 - 203
10 98 71 67 104 68 - 151
Hpt 565 0 137 140 10 - 120
Hpx 177 24 119 146 70 - 144
Trf 178 50 58 108 75 - 143
*/lp - - 18 20 11 - 42
16 - 58 235 241 67 - 140
18 - - 70 128 81 - 137
* Expressed as percentage of area of acetylated albumin
t Standard reference serum was National Institute for
Medical Research 67/86.
11 3
increased to normal. Prealbumin decreased initially at the time of the
marked increase in acute phase proteins and again during the second
increase in acute phase proteins after the 80th day.
Case 2. (Appendix D) Pre-operatively the concentrations of most
proteins were low but the levels of ^-antitrypsin, group component and
oC,-macroglobulin were within the normal range (Table 29). Following
transplantation the concentrations of ^-antitrypsin and protein 16 rose
to supranormal levels and easily precipitable glycoprotein, caeruloplasmin,
haptoglobin, and haemopexin rose to normal (Fig.30). Prealbumin and
transferrin rose slightly but remained low. Most proteins were at maximal
concentration on days 3 and 4 and fell slightly over days 5 and 6 when
liver function was deteriorating due to acute rejection of the graft.
Case 3. Before transplantation levels of ^-antitrypsin and protein
16 were raised and prealbumin and transferrin reduced (Table 29)•
Following transplantation (Fig. 31) prealbumin and transferrin rose to normal
andfkj-antitrypsin gradually fell. Protein 16 remained high and there
was also a rise in haemopexin, protein 10, easily precipitable glycoprotein*
•x^-macroglobulin to above the normal range in the second and third months.
Apart from ^-antitrypsin which rose again there was little change in the
concentration of other proteins. The last sample was taken when the patient
was weak and cachectic 2 months before her death from carcinomatosis. At
this time liver function tests were entirely normal and the concentrations
of easily preeipitable glycoprotein, ^-antitrypsin, -y ginacroglobulin, haemo¬
pexin and protein 16 were above the normal range. The concentrations of
the other proteins measured were normal.
Case 4. Before transplantation levels of easily precipitable glyco¬
protein, ^-antitrypsin, haptoglobin and protein 16 were high and pre¬
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Figure 29. Case 1. Serial concentrations of five proteins at

























Figure 31. Case 3. Concentration of five proteins at intervals
after orthotopic transplantation of the liver-
Figure 32. Case 4. Concentration of six proteins at intervals
aftsr orthotopic transplantation of the liver.
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arid after the 17th day it remained undetectable (Fig. 32). On the 19th
day when liver function was at its best the protein pattern was normal
apart from absence of haptoglobin and persistent elevation of protein 16.
Thereafter in association with the progressive obstructive jaundice the
protein pattern became increasingly abnormal with raised levels of easily
precipitable glycoprotein, -antitrypsin and protein 16. Levels of group
* X
component, ^-macroglobulin, caeruloplasmin, protein 10, ft> lipoprotein and
protein 18 remained normal but haemopexin and transferrin fell below the
normal range, the former being undetectable in one specimen.
G. Plasma protein pattern in patients with ^-antitrypsin deficiency
Apart from the strikingly low level of '^antitrypsin (Fig. 11) the
main change was a rise in thn mean level of ^macroglobulin (Table 30)
due to levels of 215 and 356$ in two patients. Concentrations were within
the normal range in the other 5 patients. There was a slight rise in
protein 10 but the concentration of other proteins measured were normal.
H. Influence of hepatic microsomal enzyme induction
i) Formal Subjects
Levels of all plasma proteins measured were within ths normal range in
both subjects before treatment. The 5 day course of bucolome (Butymidin,
Takeda Chemical Industries Ltd., Japan) 600mg b.d. did not result in a
significant change (Figs.34» 34)* However there was probably no significant
induction of hepatic enzumes for there was no rise in urinary D-glucaric
acid excretion and the fall in plasma bilirubin in one subject was slight.
On the other hand the seven day course of K-phenylphetharbital (phetharbital)
200mg t.d.s. was accompanied by a fall in plasma bilirubin and a rise in
D-glucaric acid excretion in both subjects but in neither subject was there
a change in the concentration of any of the plasma proteins measured
(Figs.33, 34).
Table 30* Mean protein levels (+ S.D.) as percent standard serum








Prealb 106 (23) 111 (23)
POP 112 (9) 102 (15)
^1AT 20.9 (6.8)*** 99 (17)
GC 100 (21) 101 (15)
186 (80)*** 121 (29)
Caer. 150 (34) 133 (34)
10 150 (28)** 109 (20)
Hpt 88 (32) 65 (27)
Hpx 109 (18) 107 (18)
Trf 109 (25) 108 (17)
VLP 25 (6) 21 (5)
16 105 (17) 103 (18)
18 106 (15) 108 (13)























Figure 33» Serial concentrations of six proteins in a normal subject
during induction of hepatic microsomal enaymes with phetharbital.

































Figure 34. Ssrial concentrations of six proteins in a normal subject
during induction of hepatic microsomal enzymes with phetharbital.
Rote the rise in urinary glucaric acid excretion and the fall in
plasma bilirubin.
ii) Epileptics
The mean level of ^-antitrypsin, group component, o^-macroglohulin,
caeruloplasmin and protein 16 were all significantly ( ^<0.001) raised
above control values (Table 31)•
The D-glucaric acid exoretion was raised in 13 of the 14 patients in
whom it was measured (Table 17) and there was a weak positive correlation
between the glucaric acid excretion and the number of units of anti¬
convulsant taken (r = 0.611} t « 2.72} f? < 0.02/*<).01). There was no
significant correlation between the serum calcium, alkaline phosphatase,
D-glucaric acid excretion or number of units of anticonvulsant taken and
the concentration of any of the proteins measured. There were significant
correlations (f^CO.Ol) between easily precipitable glycoprotein and^-
antitrypsin, protein 10 and protein 18 and between protein 16 and
antitrypsin and caeruloplasmin.
Comparison of protein concentrations in different disease groups
The mean concentration of each protein in seven of the diagnostic groups
examined (viral hepatitis, active chronic hepatitis, primary biliary cirrhosis,
extrahepatic obstruction, alcoholic cirrhosis, cryptogenic cirrhosis and
haemochromatosis) was compared with the concentration in the other groups in
addition to the control population (Table 32). is the reference standard
serum and control population for the miniplate studies were different from
those used in the initial large plate studies, comparisons were made only
between diagnostic groups examined by the same technique. The significance
of the differences between the means of the groups was calculated from the
overall F value by the lewman-Keul's method (Winer, 1962). As Fisher's F
value from the analysis of variance was greater for the logged protein values,
only logged data was used. When the mean protein values for the throe groups
of subjects studied on large plates (cryptogenic and alcoholic cirrhosis
/ \ J!gable 32. Protein concentrations mean (+ S.D.) expressed as % standard in seven diagnostic groups and control subjects.




























Prealb 56(40)*** 47(22)*** 44.7(18)*** 79(27)* 111(23) - - - -
PGP 182(44)*** l8l(79)*** 162(48)*** 106(27) 102(15) 139(41) 140(44) 151(42)*** 115(19)
^Af 136(20)** 198(75)*** 160(39)*** 107(29) 99(17)
- - - 114(18)
GC 91(19) 94(23) 99(58) 95(16) 101(15) 97(37) 93(20) 105(35) 117(15)
oyi 135(41) 140(51) 169(47)*** 193(50)*** 121(29) 170(51)** 171(61)** 175(51)*** 122(25)
Caer 179(67)* 230(80)*** 210(46)*** 124(36) 133(34) 166(69) 177(53)** 175(45)*** 137(25)
10 170(55)*** 119(41) 109(30) 116(26) 109(20) 94(51) 118(23) 143(57) 121(17)
Hpt 56(46)* 102(47) 68(41) 65(34) 65(27) 59(84) 67(63) 48(52)** 103(44)
Hpx 58(38)*** 58(39)*** 32(37)* 106(25) 107(18) 104(36) 102(29) 108(38) 107(13)
Trf 98(22) 77(27)** 103(42) 78(17)** 108(17) 144(33) 91(27)** 135(39)** 110(15)
fjLP +34(11)* +16(12)** +19( 6) +16( 6) +22( 5) 157(38) 198(77) 175(67) 177(43)
16 131(32) 211(117)*** 160(47)*** 102(24) 103(18) - - - -
18 112(33) 85(65)*** 106(24) 101(20) 108(13) - - - -
AO - - - - mm 156(65)** 185(69)*** 185(87)** 107(24)
Albumin
(g/lOOml)
3.46(0.46) 2.66(0.65) 3.01(0.74) 3.74(0.88) - 3.5(0.56) 2.9(0.42) 3.2(0.66) —
+
expressed as $ acetylated albumin
* < 0.05
** |? < 0.01
*** ^ < 0.001
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and active chronic hepatitis) were compared with the values from the
miniplata control population rather than the original large plate control
population, many of the significant differences were no longer found.
This i« probably attributable to differences between the standard reference
sera used for the large and small plate studies and no attempt was therefore
made to compare the results of Immunoelectrophoresis in patient groups
studied on large and small plates.
Prealbumin. There was no significant difference between the levels in
hepatitis, primary biliary cirrhosis or extrahepatic obstruction
but the level# in each disease was significantly lower than in
haemochromatosis (p<0.00l).
Easily precipitable glycoprotein. There was no significant difference
between the levels in hepatitis, primary biliary cirrhosis or extra-
hepatic obstruction but the level in each of these diseases was
significantly higher than in haemochromatosis (p<G.00l). There was
no significant difference between the cryptogenic cirrhosis, alcoholic
cirrhosis or active chronic hepatitis groups.
-^-antitrypsin. The concentration in hepatitis was significantly less
than in extrahepatic obstruction (p<0.05) but higher than in
haemochromatosis (p < 0,05). There was no difference between the mean
level in primary biliary cirrhosis or extrahepatic obstruction but
the level in both these diseases was significantly higher than in
haemochromatosis (p<0.00l).
Group component. There was no difference in concentration between any of
the seven diagnostic groups.
r-macroglobulin. The levels in haemochromatosis were significantly higher
than in hepatitis and extrahepatic obstruction (p<0.005) but there was
no difference between haemochromatosis and primary biliary cirrhosis
(p <0.05). There was no difference between the levels in cryptogenic
cirrhosis, alcoholic cirrhosis or active chronic hepatitis.
Caeruloplasmin. The levels were significantly higher in primary biliary
cirrhosis and extrahepatic obstruction (p<0.001) and hepatitis
(p^O.Ol) than in haemochromatosis and the levels in extrahepatic
obstruction were greater than in hepatitis (p<0.05). There were
no differences between the three groups studied on large plates.
Protein 10. The levels in hepiitis were significantly greater than in
primary biliary cirrhosis, haemochromatosis (p <0.00l) and extra-
hapitic obstruction (p <0.005). There was no difference between the
levels in cryptogenic and alcoholic cirrhosis and active chronic
hepatitis.
Haptoglobin. The mean concentration in hepatitis was significantly lower
than in extrahepatic obstruction (p <0.005) and haemochromatosis
(p<0.05). There was no difference in the concentration in crypto¬
genic and alcoholic cirrhosis and active chronic hepatitis.
Haemopexin. The mean concentration in hepatitis and extrahepatic obstruction
was significantly lower than in primary biliary cirrhosis (p <(0.05)
and haemochromatosis (p<0.Q0l) and the level in primary biliary
cirrhosis was lower than in haemochroraatosis (p<( 0.05). There was no
significant difference between the levels in cryptogenic and alcoholic
cirrhosis and active chronic hepatitis.
Transferrin. The mean level in extrahepatic obstruction was lower than in
primary biliary cirrhosis and hepatitis (p<0.05) and that in alcoholic
cirrhosis was lower than in active chronic hepatitis (p<0.00l).
/^-lipoprotein. The mean level in hepatitis was significantly greater than
in extrahepatic obstruction and haemochromatosis (p<0.00l) and primary
biliary cirrhosis (p <0.Q05). There were no differences in the levels
in cryptogenic and alcoholic cirrhosis and active chronic hepatitis.
Protein 16. The mean lsvel in primary biliary cirrhosis and extrahepatic
obstruction was significantly greater than in haemochromatosis (p <0.001)
and hepatitis (p<0.0l).
Protain 18. The mean level in extrahepatie obstruction was significantly
lower (p<0.001) than in primary biliary cirrhosis, haemochromatosis
and hepatitis.
^AG globulin (C3). There was no significant difference between the
concentration in cryptogenic and alcoholic cirrhosis and active chronic
hepatitis.
Diagnostic value of the plasma protein concentrations studied by discriminant
analysis. Comparison with cellulose acetate electrophoresis
A sequential Bayesian function and a stepwise discriminant function
based on the logged values of 13 proteins in patients studied by the mini-
plat® method were used to reclassify 134 patients into their 5 diagnostic
groups (controls, primary biliary cirrhosis (PBC), extrahepatic obstruction
(E.H.Qbs.), Viral hepatitis (Hep), and primary haemochromatosis (tiaem)).
Because the data from the large plate studies were not strictly comparable
with the miniplata studies (see above) the groups with active chronic
hepatitis (ACH), alcoholic cirrhosis (Ale) and cryptogenic cirrhosis (Crypt)
have been analysed separately.
(i) Immunoelectrophoresis results studied by sequential Bayesian function.
The results cf reclassification of the 134 cases according to this
function are shown in Table 33• The overall error was 12$, and the
errors for the individual groups are given. The order of variables
selected by the computer and the average reduction of uncertainty of
the diagnostic group is also shown.
Reclassification of the patients studied on large plates into their
3 diagnostic groups was achieved with an error rate of 34$. Ho control
group was included and values for 8 proteins only were used (Table 34)*
Reclassifying the miniplate patients using the same eight proteins was
achieved with an error of 17$ (Table 35)•
Table 33 lieclassification of 134 patients into the five diagnostic
groups using a Bayesian function based on the logged values




■^^ontrols P.B.C. E.H.Obs. Hep. Haem. Errors Errors /
Controls 10 0 7 8/70 11
P.B.C. 0 0 0 0 0/20 0
E.H.Obs. 0 2 1 0 3/12 25
Hep. 0 2 0 2/12 17
Haem 1 110 \17^\3/20 15
Overall error in reclassification 16/134 - 12/
Order of the variables chosen and
of uncertainty of the diagnosis.
average reduction
Hpt .24 18 .16
Prealb .24 Caer .13
^6 LP .21 Trf .12








Table 34. Reclassification of 41 patients into three diagnostic groups
using a Bayesian function based on the logged values of the




-\^Crypt Ale ACH Error Error /
Ciypt ^ 0 7 ?/H 64
Ale 0 4 4/10 40
ACH 1 2
_ 3/20 15
Overall error in retiassification 14/41 » 34/
Order of the variables chosen and average reduction
of uncertainty of the diagnosis.
Trf .2 Caer .04
10 .13 2* .03
PSPO .05 Hpt CMO•
GC .04 Hpx .01
132
Table 35« Reclassification of 134 patients into fivs diagnostic
groups using a Bayesian function based on the logged values




Controls F.B.C. B.H.Obs. Hep. Haetn Error Error /
Controls v 2 1 0 4 7/70 10
P.B.C. 1 \14^-^4 1 0 6/20 30
E.H.Obs. 0 2^^ 2 1 5/12 42
Hep 0 2 OX. 10\ 0 2/12 17
Haem 1 1 0 1^ \3/20 15
Overall error in reclassification 23/134 - 17/
Order of the variables chosen and average reduction
of uncertainty of the diagnosis.
PGP .29 Caer .13
Hpt .28 oC2M .12
Hpx .2 10 .07
Trf .14 GC .04
133
(ii) Immunoelectrophoresis results studied by stepwise linear discriminant
function.
Reclassification of the 134 patients into the 5 diagnostic groups
based on this function is shown in Table 36. The overall error in
reclassification using the group of 8 proteins was 19.1$ and the
individual errors and the rank order of the variables in reducing
the diagnostic uncertainty are shown. The error in reclassifying
41 patients with cryptogenic, alcoholic cirsbsis and active chronic
hepatitis using 8 proteins was 31$«
(j$L) Cellulose acetate electrophoresis results
There were data available for 85 patients in 7 diagnostic groups.
Seven readings were used from each cellulose acetate strip (total
protein, albumin, total globulin, o^,oCg, ^ and X globulins). Using
a stepwise linear discriminant function the overall error in
reclassification was 51^ (Table 37)•
Table 37» Error in reclassifying 85 patients into seven diagnostic groups
using a stepwise discriminant function based on the 7 logged
values derived from the cellulose acetate electrophoresis strips.
Diagnostic group Error Error $
Cryptogenic cirrhosis 6/11 54
Alcoholic cirrhosis 6/10 60
1° Haemochromatosis 6/10 60
Chronic active hepatitis 8/20 40
Acute hepatitis 6/11 54
E.H. Obstruction 3/8 38
1° biliary cirrhosis 8/15 53
Overall error 43/85 51
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Table 36. Reclassification of 134 patients into the five diagnostic
groups using a stepwise discriminant function based on the




Controls P.B.C. i-j.H. Obs • Hep. Haem. Errors Errors
Controls \62 0 0 6 8/70 11.4
P.B.C. \3 2 1 8/20 40
E.H.Obs. 2 ON^7 \ 2 1 5/12 42
Hep. 1 1 \1 3/12 25
Haem. 2 0 0 ^18 \2/20 10
Overall error in reclassification 26/134 » 19*4$







When only 44 patients with 4 diseases were considered (haemochromatosis,
viral hepatitis, sxtrahepatic obstruction and primary biliary cirrhosis)
the error in reclassification was 36$ (fable 38). This was greater than
the error in reclassifying the same 44 patients on the basis of 8 proteins
values derived from Immunoelectrophoresis, the combination of those 8
values together with the 7 cellulose acetate electrophoresis values, the
13 proteins derived from Immunoelectrophoresis, and the total groip pf 20
values derived from both Immunoelectrophoresis and cellulose acetate
electrophoresis. Each patient was assigned to the correct diagnostic
group when all 20 protein values were used (table 38). The equivalent
values using a sequential Bayesian function are also shown. The rank
order of the variables according to their importance in reducing the
diagnostic uncertainty is given in Table 39s both for the group of 13
proteins and the group of 20 values.
The error in reclassifying 41 patients with alcoholic and cryptogenic
cirrhosis and active chronic hepatitis is shown in Table 40.
Table 38. Percent error in reclassification of 44 patients with 4
diseases using a sequential Bayesian function and a stepwise
linear discriminant function based on logged data derived
from Immunoelectrophoresis and cellulose acetate.sb\dp,
Protein data Bayesian Linear
used in analysis function discriminant
al functionh 4,'Wv't i/
7 values from
cellulose acetate strip 37 36
8 proteins from
immunoelectrophoresis 29*5 23
15 values above 18 4*5
13 proteins from
immunoelectrophoresis 16 23




Table 39. Hank order of variables in reducing the diagnostic
uncertainty for 44 patients with 4 diseases analysed
by a stepwise linear discriminant function.
13 proteins + 7
13 proteins from values from
Immunoelectrophoresis cellulose acetate
electrophoresis




5 PGP Total protein
6 Protein 10 Protein 10
7 Prealb. Hpt
8 Hpx Trf
9 Trf y globulin
10 Protein 18 globulin
11 cf1AT PGP









Table 40. Percent error in reclassification of 41 patients
with cryptogenic cirrhosis (11;, alcoholic cirrhosis
(10) and active ohronic hepatitis (20) using a
sequential Bqyeslan function and a stepwise linear
discriminant function based on logged data derived

















15 values above. 12 9.7
Table 31» Mean protein level (+ S.D.) as percent standard serum






Prealb. 126 (31) 111 (23)
PGP 93 (15)* 102 (15)
^AT 132 (22)*** 99 (17)
GC 130 (17)*** 101 (15)
175 (48)*** 121 (29)
Caer. 180 (33)*** 133 (34)
10 ■rCM£H 109 (20)
Hpt 83 (45) 65 (27)
Hpx 115 (17) 107 (18)
Trf 94 (19) 108 (17)
+/LP 25 (11) 21 (5)
16 139 (33)*** 103 (18)
18 111 (17) 108 (13)
+
Expressed as % acetylated albumin
*^<0.05 ** fK0.001 ***/?<0.001
PART 6
DISCUSSION AND WORK FOR THE FUTURE
1 4 1
DISCUSSIOH
The pattern of the changes in the plasma protein concentrations
is very similar in each of the liver diseases studied, although the
degree of abnormality is variable. The changes are least marked in the
patients with haemochromatosis and cryptogenic cirrhosis, these being
the two groups studied with the least disturbance of liver function.
The relationship between the protein changes and the degree of disturb¬
ance of liver function is strengthened both by finding significant
correlations in most patient groups between different parameters of liver
function and individual plasma proteins, and the serial studies on the
patients with active chronic hepatitis and liver allografts which, in
general, showed that as liver function improved the concentration of
many of the proteins returned to normal. However, even with entirely
normal liver function tests, if there was underlying chronic liver
disease, some proteins tended to remain at abnormal concentrations.
Relationship of changes in plasma proteins to the "acute phase reaction".
The terms "acute phase reaction" is used to describe the changes in
the concentration of several serum proteins in response to tissue injury.
The stimuli responsible for these changes include surgical trauma (Werner
and Cohnen 1969? Clarke et al, 1971) myocardial infarction, infection and
neoplasia (Muller and Muller von Voigt, 1968 a, b). The changes in the
plasma protein pattern are monotonously predictable and in no way diagnostic
for the responsible underlying disease process.
The changes are perhaps best illustrated by considering the results
of surgical trauma. Detailed studies have been made of the concentrations
of several plasma proteins before and for 2 to 3 weeks following a variety
of types of operation (Werner and Odenthal 1967} Crockson et al, 1966}
Werner and Cohnen, 1969} Clarke et al, 1971} Aronsen et al, 1972>. The
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results agree closely although there is some indication that the degree
of disturbance of plasma proteins is proportional to the extant of the
surgery. The concentrations of C-reactive protein, orosomucoid, hapto¬
globin and <a&-antitrypsin rise rapidly to a maximum at 3-4 days and there
is a smaller and less marked rise in the concentrations of haemopexin,
caeruloplasmin, C3 and fibrinogen at the end of the first post-operative
week. In their study on patients after hernia repair Clarke et al, (1971)
also noted a rise in group component, easily preoipitable glycoprotein, and
protein 16. There is a consistent fall in albumin, o<^ lipoprotein,
prealbumin and transferrin. Levels of o<g-macroglobulin and IgG show
little change. The protein pattern has usually returned to normal by 14-
18 days post-operatively unless infection prolongs the stimulus for the
acute phase reaction (Werner and Cohnen, 1969)*
Since the introduction of immunological methods of determining
individual plasma proteins, a wide variety of disease states have been
studied and although there are minor differences, the basic pattern out¬
lined above is found to hold true. Examples include myocardial infarction
(Muller and Muller von Voigt, 1968bj Johansson, et al, 1972} Agostini,
et al, 1970) ulcerative colitis and Crohn's disease (Weeks and Jarnura,
1971) rheumatoid arthritis (Muller and Muller von Voigt, 1968b} Clarke
et al, 1970b) tuberculosis (Muller and Muller von Voigt, 1968a} Clarke at
al, 1970a) and a wide variety of malignant diseases (Muller and Muller
von Voigt, 1968a, b.).
Understanding of the mechanisms involved in the expression of the
acute phase reaction has advanced in recent years. The fall in albumin
after surgery is attributable in part to loss into the wound site
(Mouridsen, 1967) but in experimental induction of the acute phase reaction
by chemical irritants albumin synthesis has been shown to be reduced
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(Gordon, 1970)* A reduction in synthesis is also thought to account for
the fall in prealbumin concentration (Bernstein, et al, 19^7)• Increased
catabolisa may also play a part and is a major factor determining the fall
in transferrin at least in infections (Jarnum and Lassen, 1961). The rise
in globulins was at first attributed to release of protein from the ground
substance of connective tissue (Bole and Leuta, 1967) but the reduction in
the response which was noted to occur in man when partial hepatectonjy was
performed (Wollheim et al, 1969) suggests rather that the liver may be the
site of increased synthesis. This effect of partial hepatectomy in reduc¬
ing the acute phaBe response had been shown previously in the rat by
Darcy (1965) wbo studied a specific acute phase -^globulin (^AP globulin)
later shown to be produced in the liver (Weimer, ©t al, 1965)« The
perfusion experiments to increase tenfold after injury (Sarciona, 1970)
and there is similar evidence (Miller and John, 1970) that increased
synthesis of other proteins accounts for the rise in plasma concentration
in the acute phase reaction. Further evidence for the importance of de
novo synthesis of acute phase proteins comes from the effects of aotino-
mycin D and other inhibitors of protein synthesis which prevent the rise
in haptoglobin and other acute phase globulins usually seen after laparotomy
or subcutaneous injection of turpentine in rats (leuhauseet al, 19665 Maung
et al, 19685 Sarcione, 1970).
The nature of the signal which increases hepatic synthesis of some
proteins and decreases that of others is not known and experiments in which
rats livers were perfused with blood from injured animals have not given
conclusive evidence for a circulating factor (Gordon and Koj, 19685 Gordon,
1970). Experiments involving gland ablation and replacement therapy have
shed little light on the mechanisms except that foro^AP globulin in the
rat it has been possible to demonstrate an absolute requirement for
hepatic synthesis of another acute phase rat globulin shown in
14 4
Uorticosterone (Weimer and Benjamin, 19665 Weimer and Cog^shall, 1967).
Koj and Allison (19^9) suggested that lysosomal disruption by injury might
be the trigger for the acute phase reaction, but intravenous injection
of lysosomal enzymes produced no change in plasma protein concentrations
and there was no clear relationship between the events of the acute phase
reaction after irradiation injury or turpentine injection in the rat and
blood levels of various lysosomal enzymes (Koj, 1970).
Various factors are known to modify the acute phase reaction. Eat
liver perfusion experiments emphasize the importance of good nutrition
and the presence of Cortisol and insulin for maximal production of protein
(John and Miller, 1969I Miller and John, 1970) and studies in 6 strains
of rats indicated that genetic differences were important (Weimer et al,
1972). The previous history of the animal was also important for a second
stimulus will usually bring about a greater increase than the first and a
third produced a different pattern of response (weimer and Humelbaugh, 1967).
The importance, if any, of the acute phase reaction to the individual
is not known but the localization of acute phase proteins in damaged tissue
(Agostini et al, 1972) and experimental granulomata (Menninger et al, 1970j
5ayle et al, 1971) has led to the suggestion that the proteins may be
important in the repair process possibly by supplying a source of amino
acids for the synthesis of new protein.
The pattern of the changes in the groups of patients with liver disease -
a fall in the concentration of prealbumin and transferrin and a rise in
easily precipitable glycoprotein, c^-antitrypsin and oaeruloplasmin is
similar to the acute phase reaction already described. The most striking
differences are the rise in ^-macroglobulin in all groups with chronic
liver disease, the absence of a large increase in haptoglobin, and a fall
in some groups of serum concentrations of haesopexin. These findings
suggest that the basic disturbance may indeed be the non-specific acute
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phase reaction hut that its full expression which depends on the presence
of normal liver function, is modified by the limitations to synthesis
imposed by the underlying liver disease which evoked the acute phase
reaction. This suggestion is supported by the serial readings in Case 4
with active chronic hepatitis. Initially the concentrations of most
proteins were reduced and it was only when liver function had improved
substantially that hepatic synthesis was presumably adequate to increase
the synthesis of the plasma proteins which take part in the acute phase
reaction.
The changes in the individual proteins studied in the different
disease groups will be discussed separately together with the relevant
available information on the mechanisms controlling their plasma concen¬
trations.
Prealbumin
is mainly if not wholly produced by the liver (Citlin and Biasucci,
1969? Kaighn. and Prince, 1971) and its turnover seems to be relatively
fast. Studies with radioactive labelled protein showed the biological half
life lay between 1.9 and 2.7 days (Oppenheiraer et al, 19651 Soeolow et
al, 1965).
The factors controlling turnover are not fully understood but the
higher levels in men than women, confirmed in the present study, suggests
that hormonal influences may be important. Serum concentrations are
increased by the progestogen ethinyl nortestosterone (Plorsheim and Paircloth,
1964), norethandrolone (Braverman et al, 1971) and large doses of prednisone
(Oppenheimer and Werner, 1966). Levels fall in pregnancy (Stabilini et al,
1968) and in common with albumin and transferrin in protein-calorie mal¬
nutrition (ingenbleek et al, 1972). The rapid and invariable fall in
concentration in the acute phase reaction discussed already is probably due
to reduced synthesis although this is inferred from studies of catabolism
of the protein (Oppenheimer et al, 19651 Socolow et al, 1965) and in some
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patients the fractional catabolic rate may be increased.
Studies in patients with liver disease are unanimous that the plasma
protein concentration is reduced. This was also our experience in hepatitis
(Muller and Muller von Voigt, 1967? Smith and Goodman, 1971? Kindmark and
Laurell, 1972), and in primary biliary cirrhosis (Weeks, 1973). The same
is true in alcoholic cirrhosis (larasini et al, 1968$ Hallen and Laurell,
1972? Weeke, 1973) cryptogenic cirrhosis and active chronic hepatitis
(Smith and Goodman, 1971? Hallen and Laurell, 1972J. There are no kinetic
data available for prealbumin in liver disease but the close correlation
between prealbumin and albumin, haemopexin and other proteins whose concen¬
tration also fell suggests synthetic failure may be the cause.
The functional implication of the profound fall in prealbumin in liver
disease is not entirely clear but the prealbumin thyroxine binding capacity
must fall with a consequent redistribution of thyroxine onto thyroid bind¬
ing globulin and albumin (Oppenheimer, 1968). Depending on the levels of
thyroxine binding globulin a rise in the percentage plasma free thyroxine
may occur (Hollander et al, 1967)* However the absolute value of plasma
thyroxine and the absolute thyroxine uptake into the tissues in liver disease
are usually normal (Inada and Sterling, 1967)* Low plasma levels of
vitamin A have been recognised in liver disease for many years (Popper et
al, 1943) and this is obviously due to the low levels of the 'binding proteins
in the blood. However tissue levels are seldom much reduced unless there
is malabsorption of the vitamin due to biliary obstruction and clinical
deficiency is rare (Wright and Wright, 1971)•
v^-antitrypsin
The liver is the major if not the only site of ^-antitrypsin synthesis
(Wada et al, 1970? Kaigfab and Prince, 1971) and the most striking evidence
comes from human liver transplar&tion which restored blood levels to normal
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in a homozygous deficient subject (Sharp, 1971)* We also noted a change
in ^-antitrypsin phenotype in one of our transplant recipients.
The greatly raised plasma levels of ^-antitrypsin in the patients
with primary biliary cirrhosis agrees with the findings of Weeks (1973).
Raised levels were also found in acute hepatitis by Muller and Muller von
Voigt (1967) and Kindmark and Laurell (1972). No data was found in the
literature on ^-antitrypsin concentrations in patients with extrahepatic
biliary obstruction but in view of the wide range of stimuli which increases
plasma ^-antitripsin levels this finding is perhaps not unexpected. In
the second series of patients with haemochromatosis, in the great majority
of whom liver function tests were entirely normal,oc -antitrypsin concen¬
trations were normal. Review of the large platss from the series of patients
with cryptogenic and alcoholic cirrhosis and active chronic hepatitis showed
that the levels were normal or high in all patients although accurate
quantitation was impossible because the protein had run off the plate in
many cases. However high levels were found in the patients with active
chronic hepatitis who were studied serially on miniplates and reports in
the literature indicate that raised levels of<^-antitrypsin are a common
finding in patients with alcoholic cirrhosis (Marasini et al, 1972} Weeks,
1973} Hallen and Laurell, 1972), in cryptogenic cirrhosis (Hallen and
Laurell, 1972), groups of patients with poorly characterized or a mixture
of types of cirrhosis (Muller and Muller von Voigt, 1967} Rrezin et al,
1971} Weeke, 1973) and chronic hepatitis (Muller and Muller von Voigt,
I967). We found no case of homozygous ^-antitrypsin deficiency in screening
our adult patients who presented with various forms of liver disease. The
finding of one patient with heterozygous deficiency is fewer than expected
from the known gene prevalence in the community and other cases probably
passed undetected by the present technique as the serum concentration may
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have "been raised to normal by the stimulus to synthesis which liver
disease seems to represent.
The stimulus for the increased plasma concentration in liver disease
is unknown but it seems to occur in those groups of patients with the great¬
est disturbance in liver function. Similar increases are found due to a wide
variety of non-specific stimuli as part of the acute phase reaction as has
already been discussed.
The association of liver disease with •^-antitrypsin deficiency was
first reported by Ganrot et al, (1967b) who found two oases of cirrhosis
and one primary hepatoma in a series of 50 adult patients with homozygous
deficiency. None of these three cases had clinical pulmonary disease. No
such cases were found in the present series and it appears that clinical
liver disease in adults is rarely associated with ^-antitrypsin deficiency.
Sharp et al, (1969) described 10 children in 6 families who had cirrhosis
in association with severe ^-antitrypsin deficiency and examination of
their sera later confirmed Pi ZZ patterns (Aagenaes et al, 1972). Since
then there have been several further reports of the association of liver
disease in children with severe oc^antitrypsin dnfloienej- (Johnson and
Alper, 1970} Sharp, 1970? Aagenaes et al, 1972} Porter et al, 1972).
Most of these children were jaundiced in the first few weeks of life with
either a hepatitic or cholestatic biochemical picture and then, although
liver function improved, slowly progressed to cirrhosis and portal hyper¬
tension. Two older children reported by Glasgow et al (1971) also developed
emphysema. Several adults with emphysema as their presenting complaint
have also been found to have cirrhosis (Pedersen et al, 1969} Berg and
Eriksson, 1972} Cohen et al, 1973) "but in most adult cases with emphysema
associated with "^-antitrypsin deficiency there is no clinical evidence of
liver disease although like one of the cases in the present series liver
function tests may be slightly disturbed (Aagenaes et al, 1972} Be Lellis
et al, 1972). However, histological examination of the liver often shows
focal fatty change, mild portal fibrosis and bile duct proliferation
(Gherardi, 1971f Lieberman et al, 1972} De Lellis et al, 1972} Gordon
et al, 1972) or true cirrhosis. In 14 homozygous deficient adults, of
whom at least 10 had proven emphysema, severe fibrosis or true cirrhosis
was found on liver biopsy in 8, and all of them ?rere over 50 years old.
It is of great interest that of these 8 no less than three had primary
liver tumours (Berg and Eriksson, 1972). In the present cases it was not
possible to obtain liver biopsy material.
Sharp et al, (1971) first demonstrated amorphous PAS positive staining
globules in the hepatocytes of children with cirrhosis associated with
■^-antitrypsin deficiency and by specific fluorescent tagged antibody
staining showed that these were deposits of ^-antitrypsin. These findings
have been Confirmed in homozygous adults with emphysema and minimal liver
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disease and also in adults with heterozygous (Pi*J , Pi , and Pi ) deficiency
(Lieberman et al, 1972} De Lellis et al, 1972, Gordon et al, 1972}
Aagenaes et al, 1972). The amount of^-antitrypsin demonstrable in the
liver cells was much greater in the homozygous deficient subjects but there
was no correlation between the amount of oT^-antitiypsin in the liver and
the degree of hepatic damage. Electron microscopy of these livers showed
masses of electron dense material lying with-ithe rough endoplasmic reticulum.
These appearances suggest that the primary abnormality may be an inability
of the hepatocyte to release the protein from the cell, but whether this is
related to changes in the carbohydrate moiety or to alterations in the
amino acid sequence must await further investigation. Recent work on the
release of rat albumin from the liver cell suggests that a larger precursor
molecule is split before albumin appears in the plasma (Geller et al, 1972)
and failure of such a releasing mechanism might apply to ^-antitrypsin
deficiency. Attempts to increase plasma levels by treatment with
phenobarbitone, corticosteroids (Porter et al, 1972) oestrogsns and
typhoid vaccine have been unsuccessful (Sharp, 1971J Lieberman et al,
1972). The plasma survival of transfused radio-active labelled ^^-anti¬
trypsin in these patients is normal but the biological half-time of 4-6
days is too short to make this a practical form of therapy (Kueppers and
Fallat, 1969? Makino and Seed, 1970)• The plasma half-life of the
abnormal ^-antitrypsin phenotypes has not been determined.
Detailed evaluation of other liver produced plasma proteins in the
present series of 7 homozygous adult subjects showed no significant
changes except that °<2-macroglobulin was greatly raised in 2 cases. This
was also the experience of Ganrot et al, (1967b) in a series of 50 homo-
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zygous deficient (Pi ) patients in whom the mean ^-macroglobulin
concentration was 135^ of the value in the standard serum. There was no
difference between the levels in patients with advanced pulmonary disease
and those who were clinically well and one cannot postulate that the
antitrypsin activity of high concentrations of^g-macroglobulin (Ganrot,
1967) is exerting a protective effect. In the present cases th4 highest
serum oc^-raacroglobulin level occurred in a patient severely disabled by
emphysema. It is not known whether the raised levels of °^2-macroglobulin
were a reflection of hepatic fibrosis or cirrhosis.
The clinical presentation of patients with homozygous deficiency of
-antitrypsin ranges from hepatitis in neonates which often progresses
to cirrhosis, to pulmonary emphysema or occasionally cirrhosis in adults.
Some patients remain asymptomatic throughout their lives but sub-olinical
changes in both lungs and liver are prcbably common. Patients with both
pulmonary and hepatic symptoms occur both in childhood and adulthood but
are rare as are families with both types of disease (Sharp et al, 1969).
The factors governing the clinical expression of^-antitrypsin deficiency
are unknown but smoking seems to be important in the pathogenesis of
emphysema (Hutchison et al, 1972). Porter ©t al (1972) found Australia
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antigen in the serum of 3 of 5 children presenting with hepatitis and
suggested this might he an important trigger factor hut other groups have
failed to substantiate this in larger series (Sharp, 1971I Aagenaes et
al, 1972). It would be of great interest to know whether the clinical
outcome of viral hepatitis, drug or alcohol induced liver injury was
different in adult homozygous deficient patients from control subjects with
normal or raised levels of "^-antitrypsin.
Group component
The liver was shown to he the site of formation of group component
by Prunier et al (1964) who cultured human tissue biopsies in vitro with
radioactive labelled amino acids and then performed immunoelectrophoresis
of the supernatant followed by autoradiography of the plate. No other
tissue tested synthesised group component and this conclusion is supported
by the complete change in protein phenotype which accompanies transplant¬
ation of the liver (Kashiwagi et al, 1968).
It is therefore not surprising that low plasma concentrations have
been reported in severe hepatic failure (Kitchin and Bearn, 19651 Cleve
and Dencker, 1967) but in cirrhosis and acute and chronic hepatitis with
less severe damage levels were normal (Cleve and Dencker, 1967)* In the
present studies the concentration of this protein was normal in all
diagnostic groups studied. Minor increases have been noted in some patients
with rheumatoid arthritis (Cleve and Dencker, 19^7) and malignant disease
(Hughes, 1971) but the concentration of group component changes little in
response to inflammation and other stimuli provoking the 'acute phase
reaction'.
cx^-Macroglobulin
was raised in all groups of patients with chronic liver disease
in the present study but not in those with hepatitis or extrahepatic
obstruction* The first report of raised levels in chronio liver disease
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was in a group of patients with active chronic hepatitis (Zlotnick and
Rodnan, 1962) and this finding has been confirmed many times in different
types of cirrhosis (Cleve and Strohmeyer, 1967; Housley, 1968; Brezin et
al, 1971; MoSween et al, 1972; Hallen and Laurell, 1972; Weeke, 1973)*
However normal values were found by Marasini et al (1972) in J1 patients
with alcoholic cirrhosis and lay Muller and Muller von Voigt (1967) in a
series of patients with poorly characterised chronic hepatitis and
cirrhosis. The normal levels in our patients with hepatitis are in agree¬
ment with the findings of Cleve and Strohmeyer (1967)» Muller and Muller
von Voigt (1967) and Kindmark and Laurell (1972) who measured ^-macroglobulin
serially during the course of the illness in 23 patients. The concentration
of this protein is not subject to large fluctuations like the acute phase
reactants and serial readings in our patients with active chronic hepatitis
showed little change although the concentration of other proteins altered
strikingly.
Liver has been shown to synthesise ^-eiacroglobulin (Hochwald et al,
1961; Prupier et al 1964)• The maintenance of a high plasma concentration
in the face of severe liver disease suggests the possibility of an extra-
hepatic site of synthesis and this v?as shown by Prunier et al (1964) who
studied the incorporation of radio-active amino acids by biopsies of human
skeletal muscle. However the ability of ^C-macroglobulin to bind small
molecules which may be synthesised by the tissue in question throws serious
doubt on the significance of these results (Stecher and Thorbecke, 1967)*
Turnover studies with iodinated ^-macroglobu1in indicated a biological
half life of between 8 and 11 days (Kluthe et al, 1967) But as the protein
was not pure this must be regarded as an approximation. A more recent
attempt to obtain /alid kinetic data shows similar results but again the
preparation of the protein was unsatisfactory (Forberg et al, 1970)*
Little is known about the factors controlling its concentration in the
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plasma. It doss not take part in the acute phase reaction (see above).
Although it was not affected by oestrogens in a series of men given high
doses for carcinoma of the prostate (Adham et alf 1968), most series,
including the present one indicate that plasma levels are slightly higher
in women than men (James et al, 1966} Ganrot and Schersten, 1967} Muller
et al, 1970) and levels rise by about 20$ in pregnancy (Ganrot and Bjerre,
1967} Mendenhall, 1970) and in women taking the contraceptive pill
(Laurell et al, 1967} Horne et al, 1970). Greatly elevated levels are
common in renal disease with proteinuria but there is disagreement about
whether there is a correlation with the degree of urinary protein loss
(Hedfors et al, 1971} Horne et al, 1972). Increased plasma concentrations
of ^p-macroglobulin are also found in patients with diabetes mellitus
(Ganrot et al, 1967a} Muller et al, 1970) especially in association with
longstanding disease and proteinuria.
The factors leading to the increased levels of ^-macrogiobulin in
liver disease are unknown but it is a feature only of chronic disease.
U'hether this is related to the long time course or to the nature of the
disease is unknown. The finding of raised ^g-ciacroglobulin levels in a
patient with a prolonged abnormality of liver function tests following
acute viral hepatitis would suggest the development of active chronic
hepatitis and might be of diagnostic value. In chronic liver disease
there is evidence for both increased intravascular coagulation and more
rarely increased fibrinolysis (Roberts and Cederbaum, 1972) but whether
the rise in o^-macroglobulin concentration contributes to the inbalanoe
because of the increased plasma binding capacity for both thrombin and
plasmin in speculative. In a study of plasma proteins and the fibrinolytic
system in patients with chronic glomerulonephritis (Wardle et al, 1970)
no correlation was found between the diminished fibinolytic activity and
the rise in ^-macroglobulin.
Low plasma levels are uncommon "but were seen in one patient dying
of fulminant hepatic failure not included in the present series and have
"been reported after infusions of streptokinase which converts plasminogen
to plasmin (Kilehn and Ganrot, 1967). The plasmin combines irreversibly
with ^-macrcglobulin and the complex is removed from the circulation
probably by the reticuloendothelial system as has been shown in experi¬
mental animals for the trypsin-^-saacroglobulin complex (Ohlsson, 1971)*
Low levels of ^-macroglobulin persist for up to 16 days which is in
keeping with the relatively slow turnover of this protein. A drop in
=<2~ti;acroglobulin concentration has recently been reported following bone
surgery in children and it was suggested that this was due to the formation
of complexes of ^-macroglobulin with proteases released into the circulation
by the bone trauma (Dickson and Manning, 1972). Animal experiments suggest
that severe reduction of -macroglobu1in levels may be dangerous for
further release of proteases which cannot be bound and inactivated will
result in massive fibrinolysis (Ohlsson et al, 1971). It is possible that
this mechanism may account in part for excessive fibrinolytic activity
which is found in some patients with acute hepatic failure (Gallus et al,
1972).
Caeruloplasmin
The liver seems to be the major source of serum caeruloplasmin. This
is based on evidence from in vitro incorporation of radioactive labelled
amino acids (Hochwald et al, I96I5 Frunier et al, 1964)* localisation by
specific immunofluorescence and release of the protein from liver slices
which was prevented by inhibitors of protein synthesis (Neifakh et al, 1969).
Although copper can be removed and recombined with the protein in vitro
(Schelhberg and Stornlieb, i960), there is no evidence for exchange in vivo
and the copper atoms are incorporated before rehase of the protein from the
liver (Sternlieb et al, 1961; Holzman and Gaumnitz, 1970a). There is now
evidence using immunological techniques that a small proportion (10-20$)
of caeruloplasmin in normal human serum is devoid of copper oxidase activity
(Carrico et al, 1969). This apocaeruloplasmin has slight antigenic and
electrophoretic differences from holocaeruloplasmin and conversion occurs
slowly with storage of serum and can he produced by removing the copper
in vitro with potassium cyanide. Abnormally high concentrations of plasma
apocaeruloplasmin may occur in Wilson's disease (Carrico et al, 1969) and
will be detected by immunological techniques but not by the oxidase method.
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The biological half life of caeruloplasmin whether labelled with I
(Kekki et al, 1966), with 64Cu (Sternlieh et al, 1961) or 67Cu (Waldmann
et al, 1967) was closely similar at between 4 and 6 days. Turnover studies
with apocaeruloplasmin in the rat showed the half life was much shorter than
the holoprotein (Holzman and Gaumnitz, 1970b) and Morell et al (1971) have
also shown that removal of sialic acid residues considerably reduces the
biological half life. Little is known about the sites of catabolism under
normal circumstances but losses in bile (Aisen et al, 1964)* the gastro¬
intestinal tract (Waldmann et al, 1967)» and. urine are minor.
Several factors are known to influence the concentration of plasma
caeruloplasmin including various hormones. Oestrogen administration causes
a strikin rise (Suss and Raymunt, 1956) and this effect explains the
increased plasma concentrations found in women on the oral contraceptive
pill and during pregnaney (Laurell et al, 1967I Song et al, 1970) as
progestogens alone have no effect (Laurell et al, 1969? Briggs et al, 1970)•
Removal of either the adrenals or the thyroid gland in rats results after
4 weeks in a sustained increase in caeruloplasmin levels which are restored
to normal by hormone replacement (Evans et al, 1970a). Several studies in
the developing countries have shown that caeruloplasmin levels fall early
(like transferrin and prealbumin) in protein calorie malnutrition (Reiff
1
and Schnieden, 1959) tout levels may be misleadingly normal if synthesis is
stimulated by infection which is so often part of the clinical picture
(Gopalan et al, 1963 J Ismadi et al, 1971)* The prominent part played by
caeruloplasmin in the acute phase reaction has been mentioned already.
Evidence that liver copper concentration might have a specific influence on
caeruloplasmin synthesis came from the studies on endocrine gland ablation
in which raised serum copper levels were found to accompany the rise in
caeruloplasmin (-vans et al, 1970a). In a recent study using the incor¬
poration of radioaotive labelled lysine direct evidence for the induction
of caeruloplasmin synthesis by copper has been presented (Evans et al, 1970b)
This effect was blocked by inhibitors of protein synthesis including
actinoraycin D suggesting that copper was acting at the level of transcription
In a child with copper intoxication due to absorption of copper sulphate
applied to burns a rise in caeruloplasmin concentration was noted and was
tentatively attributed to the copper load (Holtzman et al, 1966). However
the child had a general systemic upset with disturbance of liver function
and a haemolytic anaemia and as no other specific proteins were measured
it is impossible to rule out an acute phase response.
Serum caeruloplasmin levels were significantly raised in all groups of
patients in the present study except those with cryptogenic cirrhosis and
primary haemochromatosis. The most strikingrrise was seen in primary biliary
cirrhosis and ©xtrahepatie obstructive jaundice and it is interesting that
liver copper content is usually greatly raised in both these conditions
(Smallwood et al, 1968). Very hi.;h levels of plasma caeruloplasmin have
been noted before in obstructive jaundice from whatever cause (Beam and
Kunkel, 1954} Pineda et al, 1962} Hauftova and Slavicek, 1963, Ventura et
al, 1967} Gfault et al, 1966$ Prellwitz et al, 1969) and also in active
chronic hepatitis (Beam and Kunkel, 1954)• The mean level in patients
with alcoholic cirrhosis was significantly raised although there was a wide
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scatter of readings and similar results are reported by other workers
(Cfuhler et al, 1957 J Ventura et al, 1967) whereas Hauftova and Slavioek
(1963) found normal or low values in 19 alcoholic patients. Many alcoholios
are malhourished and this may have influenced the findings. The normal or
only slightly elevated levels in the patients with hepatitis and crypto¬
genic cirrhosis agree with the results of other workers (Pineda et al, 1962?
Hauftova and Slavicek, 1963j Cault et al, 19665 Trip et al, 1969)* In
severe acute or chronic liver disease with parenchymal cell failure, low
levels of caeruloplasmin may he found and this may then cause diagnostic
confusion with Wilson's disease (Walshe and Briggs, 1962) Gault et al,
1966). However levels may rise to normal if liver function improves.
Caeruloplasmin can he split into two fractions on a hydroxyapatite
column, type I constituting ahout 86$ in normal people (Trip et al, 1969)*
Fractionation of sera with differing total concentrations of plasma caerulo¬
plasmin from patients with liver disease showed that the proportion of type
I was reduced and it was suggested that only this fraction was synthesised
in the liver. This observation requires further study.
Haptoglobin
The liver has been cleqrly shown to be the major site of haptoglobin
synthesis by a variety of methods including incorporation of radioactive
leucine and galactose by the isolated perfused rat liver (Krauss and Sarcione,
1964) and liver slices in vitro (Prunier et al, 1964) Wada et al, 1970a).
Using Immunoelectrophoresis of the incubation fluid followed by autoradio¬
graphy to study the labelled proteins the latter group showed that human
spleen and rat spleen and lymph nodes also appeared to synthesiee hapto¬
globin although the quantities are probably small. Ho haptoglobin synthesis
could be demonstrated by Alper et al (1965) in the hepatectomised dog and
following transplantation in man the haptoglobin type was shown to change
to that of the donor (Merrillet al, 1964) Kashiwagi et al, 1968). Ho
evidence for persistence of the patients previous haptoglobin type was
found in follow up studies over 64 days (Kashiwagi et al, 1968). A study
with fluorescent anti-haptoglohin antibody demonstrated fluorescence largely
in the parenchymal cells although some was also present in the Kupffer cells
(Peters and Alper, 1966). Immunofluorescence is, of course, no proof that
that cell is synthesising the protein.
fhe mean biological half life of the protein labelled with radioactive
iodine in two series of normal subjects was 4.5 days and 3«7 days (Moretti
et al, 19635 Bottiger and Molin, 1968). This agrees closely with data
derived by Noyes and Garby (1967) from the rate of return of haptoglobin
plasma levels to normal after an injection of free haemoglobin and the
reduction in specific activity of haptoglobin after in vivo pulse labelling
with "^C-glucosamine or ^S-methionine (Dobxyszycka et al, 1969). Freeman
(1964) showed in a series of anaemic patients, some of whom had shortened
red cell survival and markedly reduced plasma haptoglobin concentration,
tbat although the fractional catabolic rate (the percentage of the intra¬
vascular pool catabolised/day) varied greatly the absolute catabolic rate
(the weight of the protein catabolised daily) did not vary significantly.
Hence the liver did not increase haptoglobin synthesis in response to the
low plasma concentration. On the other hand the absolute and fractional
tu rnover was greatly increased in the series of patients with raised hapto¬
globin levels studied by Dobryszycka et al (19^9) after burns and other
trauma.
The life span of the normal red blood cell is about 120 days and this
means that 6-7g. of haemoglobin are released for catabolism daily. When
this is compared with the weight of haptoglobin catabolised per day (about
1.5g/day) and the total plasma haemoglobin (about 0.3mg/l00ml) it is obvious
that the majority of haemoglobin breakdown must be extravascular and the
major site is thought 1d be the reticuloendothelial system (Bunn, 1972).
15 9
The hap toglobin-haemoglobin complex disappears rapidly from the
circulation with a biological half time of 10-30 minutes (Oarhy and Noyes,
1959$ Freeman, 1964)• Experiments ip animals injected with radioactive
labelled haemoglobin have shown that the liver is a major site of uptake
with lesser amounts in the spleen and bone marrow (Keen® and Jandl, 1965)*
Because of the distribution of radioactivity and by analogy with the
site of removal of damaged red blood cells it has been widely assumed that
the haptoglobin-haemoglobin complex is taken up by the reticuloendothelial
system (Mulier-Sberhard, 1970 J Bunn, 1972). However histological proof
was not provided arid blockading the reticuloendothelial system with
colloidal carbon did not alter the kinetics of clearance (Franklin et al,
i960). In the autoradiographic study of rat liver after injection of
radioactive labelled haptoglobin-haemcglobin complexes reported by Wade
et al (l970b) radioactivity was detected mainly in the Kupffer cells but
the dose of protein injected was unphy3iological and the finding of large
amounts of radioactivity in the renal tubules suggests that the preparation
may have been unsatisfactory. On the other hand Goldfischer et al (1970)
demonstrated haemoglobin in the hepatic parenchymal cells By a histo-
chemical technique following injection of varying doses of unlabelled
free haemoglobin. Two more recent and critical studies have demonstrated
clearly that the great majority of haemoglobin whether free or complexed
with haptoglobin is removed by the parenchymal cells. Bissell et al (1972)
identified the hepatic cell types by enzyraic disruption of the liver and
fractionation into pure isolates of parenchymal cells and sinusoidal cells.
After injection of radioactive labelled haemoglobin 85-95^ of the radio¬
activity was associated with the parenchymal cells and levels of micro¬
somal haem oxygenase, the first enzyme in the chain responsible for
degradation of haemoglobin to bilirubin, were greatly increased. The other
study by Finch's group (Cook et al, 1972) confirmed these results using a
different technique.
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The liver therefore plays a central role in th© synthesis and
catabolism of haptoglobin. Plasma levels rapidly Increase as part of
the acute phase reaction and following treatment with cortisone and anabolic
steroids (Krauss, 1968? Barbosa et al, 1971)* On the other hand oestrogens
and pregnancy result in a fall in plasma concentration (Laurell et al,
1967s Song et al, 1970) but progestogens alone have no effect on plasma
levels (Laurell et al, 1969)*
In diseases of the liver either reduced or increased plasma concentrations
of haptoglobin may be found and this was originally suggested as the basis
of a diagnostic test (Owen et al, 1961). However interpretation of the
individual result is difficult because of the wide scatter of values both
in patients and normal subjects. Levels were not significantly different
from normal in the present series of haeraochromatotic subjects and this
agrees with the findings of Williams et al (1961) and Bock et al (1969)*
Both these groups and the present study and also Zlotnick and Eodnan (1962)
found much reduced levels in active chronic hepatitis and in several of
our patients there was no visible precipitation arc. There is disagree¬
ment in the literature about the findings in acute viral hepatitis and this
probably stems from the variable times in the course of the illness that
samples have been taken. Serial readings show that levels are normal or
high in the first week or two but they tend to fall below normal as the
serum bilirubin rises to a peak (Owen et al, 1961$ Williams et al, 1961$
Kindmark and Laurell, 1972). The mean in the present series was normal
although in 4 samples the concentration was low. Other series in which
only one sample has been studied have given normal (Nyman, 1959$ Muller
and Muller von Voigt, 1967$ Prellwitz et al, 1969) or low mean values
(Kallai et al, 1966). Nyman (1939) noted that in Infectious mononucleosis
with hepatitis the levels were consistently low possibly due to the haemo¬
lysis which sometimes occurs in that disease. In alooholic cirrhosis low
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levels were found although the mean did not differ significantly from
normal and low values have also been reported by Uyman (l959)» Weeke
(1973) and Marsini et al (1972). In none of these cases was there frank
haemolytie anaemia. There are reports of low levels in non alcoholic
cirrhosis (Nyman, 1959? Williams et al, 1961? Kallai et al, 1966?
Prellwitz et al, 1969? Hallen and Laurell, 1969? Brezin et al, 1971)
but the exact type of disease is not clearly identified in most reports.
Some cases would probably have been classified as active chronic hepatitis
in the present study and low values are common in that disease.
In primary biliary cirrhosis levels were normal in the present series
in agreement with Williams et al (1961) and Weeke (1973) But in extra-
hepatic obstructive jaundice the mean level was raised although there was
a wide scatter of individual results. Raised levels in about half the
cases of extrahepatic obstructive jaundice have been reported by several
authors (Nyman, 1959? Owen et al, 1961? Kallai et a3, 1966? Prellwitz
et al, 1969) but as raised levels are found with both calculous and malignant
obstruction the finding is of no help in differential diagnosis.
The mechanism of these changes in liver disease is uncertain. Most
authors have failed to find a significant correlation with any of the liver
function tests although Owen et al (1959) found some correlation between
haptoglobin and serum albumin suggesting that the low levels were related
to impaired hepatic synthesis. No turnover studies with radioactive
labelled protein have been made in liver disease to settle this point.
There does, however, seem to be some relation to disease activity and
serial levels in patients with active chronic hepatitis showed that
haptoglobin levels rose with improvement in liver function tests and a
similar pattern has been shown in acute viral hepatitis. An alternative
explanation for the low levels is that the catabolic rate of haptoglobin
is increased by shortened red cell survival. However, Williams et al,
(1961) were unable to demonstrate any correlation between the red cell
survival and haptoglobin level. In some patients with obstructive
jaundice the plasma haptoglobin level was high although red cell life
was severely shortened. Obviously the plasma level is the resultant of
synthesis and catabolism and both may be altered to a variable degree.
The present results support Hyman's (1959) comment that a high haptoglobin
concentration argues for obstructive jaundice while the normal or low
concentration is ofllittle diagnostic value.
Haemopexin
The human foetal liver (Gitlin and Biasucci, 1969) and the isolated
perfused rat liver (M. Rothschild, personal communication) have been shown
to produce haemopexin and no other tissue was shown to incorporate radio¬
active amino acids into haemopexin in vitro (Thorbecke et al, 1973)• The
factors controlling synthesis are largely unknown. A slight rise has
been reported in pregnancy (Ganrot, 1972) but the effects of oestrogens
alone are unknown. Although the concentration may increase slightly as
part of the 'acute phase reaction' (see above) this is seldom a striking
finding (Kushner et al, 1972).
Low values are regularly found in haemolytic states in which there
is severe depletion of haptoglobin (Sears, 1968; Hanstein and Muller-
Eberhard, 1968; Muller-Eberhard et al, 1968; Braun and Ali, 1971; Eyster
et al, 1972) and may occur in haemorrhagic pancreatitis without a fall in
haptoglobin levels due to release of free haem into the circulation (Sears,
1968). This unusual finding of depletion of haemopexin with normal levels
of haptoglobin has also been described in porphyria cutanea tarda possibly
due to combination of haemopexin with the raised blood porphyrins (Meiers
and Ippen 1968). Raised levels are described in diabetes mellitus (Cleve
et al, 1968) myelomatosis (Rentsch 1969)» an& Hodgkin's Disease (Korinek,
1969), Crohn's disease (Week© and Jamujn, 1971) and active tuberculosis
(Clarke et al, 1970a).
The raised levels in the first series of patients with haemochromatosis
have been discussed previously and it seems likely that this was due to a
technical error. Normal levels in close relatives and the patients with
secondary iron overload are against there being either a genetic disturbance
in haemopexin metabolism or a relationship with excess body iron stores.
In general low levels of haemopexin were found in those liver diseases
with the most marked disturbance in liver function. The low levels in
acute viral hepatitis are in agreement with other authors (Muller and Muller
von Voigt, 1967? Braun and Aly, 1971? Kindmark and Laurell, 1972) and
low levels were also found in small series of patients with extrahepatic
obstruction (Braun and Aly 1970, 1971) and primary biliary cirrhosis
(Weeks, 1973). In alcoholic and cryptogenic cirrhosis both normal and
reduced levels are reported possibly reflecting the degree of decompensation
of liver function in the different series (Muller and Muller von Voigt, 19<>7?
Braun and Aly, 1970? 1971? Brazen et al, 1971? Hallen and Laurell, 1972?
Weeke, 1973)* The cause of the fall in haemopexin concentrations in liver
disease is not clear but reduced synthesis seems more likely than consumption
due to haemolysis as the haptoglobin levels, except on rare occasions, were
not depleted and the fall in haemopexin was significantly correlated with
reduction in the levels of other liver produced proteins. The point can
only be settled by turnover studies with radioactive-labelled haemopexin.
Haeaopexin and other plasma proteins in hepatic engyme induction
Many foreign compounds such as drurs and insecticides stimulate the
activity of enzymes in the endoplasmic reticulum of the liver, an effect
known as enzyme induction (Conney, 19&7? Kuntaman, 1969)* Strictly inter¬
preted the term "enzyme induction" implies a selective increase of an
enzyme relative to the concentration of microsomal protein in the call,
lot all microsomal enzyme systems are stimulated, hut particularly th®
microsomal mixed function oxidase system. This consists of HABPHg,
cytochrome and a linking electron transport system consisting of
cytochrome reductase and EABPE cytochrome C reductase (Parke, 1971)*
The system has diverse activities and is particularly concerned with the
oxidation of drays and hormones, biosynthesis of cholesterol, oxidation
of fatty acids and prostaglandins. Many drugs and chemicals are known to
stimulate the system and they have in common the property of being fat
soluble and the tendency to localise in the endoplasmic reticulum. At
least two kinds of inductive process can be distinguished - one by pheno-
barbitone and most other drugs which act as inducers and the other by th©
polycyclic hydrocarbons. Phenobarbitone-tike inducers cause increases in
M32PH cytochrome C reductase and cytochrome and this increases the
amount of the cytochrome^-substrate complex and its rate of reduction.
Polycyclic hydrocarbons such as 3-«ethy1eho1anthrene (3-M.C.) induce the
formation of a variant of cytochrome *450 wkich has different affinities for
the various drug substrates than does the normal form. This kind of inducer
does not increase either SAEPH cytochrome C reductase or the rate of cyto¬
chrome £450 reduction (Gillette, 1971)•
The mechanism of enzyme induction is not known but it almost certainly
involves the synthesis of new protein a© incorporation of radioactive amino
acids into microsomal protein has been shown in vivo and in vitro, and the
induction process can be inhibited by puromycin and actinomycin D (Parke,
1971)* Most inducers have also been shown to increase the level of hepatic
A amino laevulinic acid synthetase (ALA synthetase) (Tschudy and Bonkowsky,
1972) which is the rate limiting enzyme In the biosynthesis of haem (Granick,
1966) and this increase in haem maybe required for the increased synthesis
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of the haem containing enzymes cytochrome P^-. and cytochrome h^. This
concept is supported hy the fact that when haem synthesis is partly inhibited
by 3 amino 1,2,4-triazole (aminotriazole} induction of cytochrome Pby
phenobarbitone and 3»4-benzpyrene is inhibited (Baron and Tephley, 1969a,
1969b}. Triazole inhibits ALA dehydratase, the second enzyme in the haem
synthetic pathway, and has no effect on protein synthesis in general as is
shown by the finding that phenobarbitone increased the levels of NADPH
cytochrome C reductase in the usual manner. The sequence of events in the
induction of microsomal enzymes therefore seems to be induction of ALA
synthetase, Increased incorporation of glycine into microsomal haem and then
increased activity of cytochrome P^^ and other oxidases (Tephly et al,
1971)* However not all haem formed is incorporated into haem containing
enzymes and there is evidence for a hepatic free haem pool (Gamer and McLean,
1969; Druyan and Kelly, 1972). The control of ALA synthetase has attracted
much attention and there is good evidence that haem, the end product of the
pathway controlled by ALA synthetase, controls this enzyme by an induction-
repression mechanism (Granick, 1966? Tschudy and Bonkowsky, 1972), although
as haem also inhibits the enzyme directly in vitro there is also the
possibility in some circumstances of feedback inhibition.
3-M.C. allylisopropylacetamide (AIA) and phenobarbitone, all of which
are potent enzyme inducers, have been shown also to induce the synthesis
of haemopexin in rabbits (Boss and Muller-Eberhard, 1970a) resulting in a
twofold rise in the concentration of this protein in the blood. That this
effect is due to de novo protein synthesis was shown by the inhibitory
effects of ethionine (Boss and Muller-Eberhard, 1970a, b) and cyclohexamide
(Smibert et al, 1972). It was established that the induction of the protein
was not dependant on the simultaneous synthesis of haem by studying the
effects of aminotriazole and lead acetate and 3,5-dicarbethoxy-1,4-dihydro-
collidine (DDC) which inhibit ALA dehydratase and ferrochetalase
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(Goldberg, 1972). Haemopexin whose role in haem catabolism has been
discussed has been shown in vitro to prevent the inhibitory effect of
high haem concentrations on ALA synthetase (Warnick and Bumham, 1971)
and to remove haem in vitro from the microbial enzyme cytochrome P^q
resulting in a reduction in activity of this enzyme (Mu11er-Eberhard et al,
1969b). It has been suggested therefore that haemopexin may serve to
regulate the drug metabolising enzymes by binding excess haem produced by
synthetase induction. This surplus haem, if haemopexin were not present
to bind it, would otherwise inhibit the metabolism of drugs and hormones
resulting in the accumulation of toxic substances (Smibert et al, 1972).
There was no evidence of induction of haemopexin synthesis reflected
by increased plasma levels either in the two normal subjects taking
phetharbital, a non-hypnotic barbiturate, nor in the induced epileptics.
However, a minor increase might not have been reflected in a detectable
increase in plasma levels because of the distribution of the protein in the
extravascular space as well as the plasma compartment (Lane et al, 1972).
Equally an increase in synthesis may have been balanced by increased
catabolism. An answer to this problem must await turnover studies with
radioactive labelled protein. The evidence that hepatic enzyme induction
had been achieved in the two groups of subjects rests on the fall in plasma
bilirubin in the two normal subjects (Thompson et al, 3.969) and the raised
urinary D-glucaric acid excretion in both groups (Hunter et al, 1971a).
Evidence for hepatic enzyme induction based on these grounds has been given
before both for normal subjects and patients treated with phetharbital
(Hunter et al, 1971c) and epileptics on long-term anti-convulsant therapy
(Hunter, 1971b). Bucolome has been reported to reduce the plasma bilirubin
levels in patients with Gilbert's disease (Yamasoto and Sakamoto, 1971?
Yamamoto et al, 1972) and studies in rats showed increased activity of
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para-nitrophenol glucuronyl transferase and proliferation of the smooth
endoplasmic reticulum. It was not possible, however, to show increased
"bilirubin glucuronide formation (Tamamoto and Sakamoto, 1971). We found
no evidence of hepatic enzyme induction by bucolome with the dosage
schedule used.
It is now known that treatment with phenobarhitone and other enzyme
inducers has far reaching and varied metabolic effects (Conney, 19671
Kuntzman, 1969) not only in the liver but also in other tissues. For
instance phenobarbitone administration in the rat has been shewn to be
followed by an increase in the smooth endoplasmic reticulum in the small
bowel (Thomas et al, 1972a) and increased activity of several enzyme systems
including those incorporating acetate into cholesterol (iSiddleton and
Isselbacher, 1969)* It has also been shown to increase iron absorption
in the rat possibly by increasing the synthesis of a carrier protein
(Thomas et al, 1972b). The hepatic microsomal metabolism of Cortisol
and sex hormones is increased (Parke, 1971)*
Adverse clinical consequences of hepatic enzyme induction are being
increasingly recognised. These include osteomalacia in epileptics on
long-term anti—convulsant drugs (Hunter et al, 1971bJ Sotanienu et al,
1972) thought to be due to accelerated eatabolism of ekolecalciferol
(vitamin D) and 25-hydroxycholecalciferol leading to diminished circulating
and tissue levels of biologically active vitamin S metabolites (Hahn et al,
1972). It was of interest that these authors found the rise in serum
alkaline phosphatase was due to the liver isoenzyme in the first few
months of treatment. The serum alkaline phosphatase was raised in 6 of
the 15 patients in the present series but the isoenzyme pattern was not
determined. lo patient had hypocalcaemia but the series is small and the
prevalence ox hypocalcaemia in adult epileptics on long-term anti—convulsant
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therapy may be as low as 19/S (Halm et al, 1972). It is probably related
to the dietary vitamin D intake. No attempt was made to assess any radiolog¬
ical changes in the skeleton in the present patients.
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No systemic study of the effects of hepatic enzyme induction on the
concentration of a range of plasma proteins has been published but Ross
and Muller-Eberhard3(1970a) found no change in the concentration of
transferrin at a time when the haemopexin levels were greatly elevated. In
the present study on the two normal subjects no protein was found to alter
significantly but the course of treatment may have been too short. In the
epileptics, all of whom had been on anti-convulsant therapy for more than
a year, the raised urinary D-glucaric acid excretion is consistent with
hepatic enzyme induction in 13 of the subjects and in agreement with Hunter
(1971a) w® found a correlation between the dosage of anti-convulsant taken
and the amount of glucaric acid excreted. The 5 proteins which were present
at highly significantly increased concentration form an unusual grouping
quite unlike that found in the acute phase reactions. The mechanism and
significance of the change is quite unknown. In a similar study of 9
epileptics (Clarke et al, 1970c) mean levels of oc^-antitrypsin, caeruloplaemin
and group component were raised but only the latter reached statistical
significance. Details of drug treatment were not given. Raised caerulo-
plasmin levels in epilepsy were also noted by Abood et al (1957) and
Vuyze and Visser (1966). Grob and Herold (1972) have reported low levels
of IgA and /^AC globulin in a group of patients taking hydantoins and Cantu
and Schwab (1966) found the caeruloplasmin levels were higher in 17 patients
on phenytoin than in the controls. Serial readings in 5 patients showed
the levels had risen significantly after two weeks treatment and Brunia
and Buyze (1972) have recently reported a significant elevation in serum
copper in epileptics being treated with hydantoin but not those taking
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ethosuxamide. A variety of plasma protein disturbances have also been
reported in functional psycoses such as schizophrenia (Fessell, 1961$
Seal and Eist, 1966) but the relationship, if any, of these observations
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to hepatic enzyme induction is uncertain. There is need for a systemic
survey correlating the concentration of various plasma proteins with
other metabolic parameters including glucari© acid excretion in a larger
group of patients receiving long-term anti-convulaant treatment.
Transferrin
The liver is the major site of transferrin synthesis but lymphoid
tissue is also active. Several groups of workers have shown incorporation
of radioactive labelled amino acids into transferrin by liver and lymphoid
tissue in vitro using both human and animal tissue (Hochwald et al, 196I}
Prunier et al, 1964? Steoher and Thorbecke, 19673 Morgan, 1969$ Soltys
and Brody, 19?3). The ability of lymphoid tissue to make transferrin has
been confirmed many times perhaps most strikingly by Phillips and Thorbecke,
(1966) who found that chimeras produced by injecting rat marrow into
irradiated mice developed rat transferrin in the circulation. The liver
of these animals produced only mouse transferrin. Lane (1968) has demon¬
strated transferrin in the liver by imsunofluoreseance and the increase
in the degree and extent of staining which follows acute blood loss was
taken as evidence in favour of hepatic synthesis. Using a perfused isolated
calf liver Goldsworthy et al (1970) showed incorporation of radioactive
labelled amino acids into transferrin and calculated that the liver was
probably the major site of production in vivo. This conclusion is in
agreement with the results of Morgan (1969) studying the synthetic capacity
of rat tissues in vitro.
The intracellular events in transferrin synthesis by hepatocytes have
recently been studied by Morgan and Peters (1971b). Using the incorporation
of ^C-leucine they showed that molecules of transferrin were complete in
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2 minutes but that they remained in the microsomal fraction till their
release from the cell started at 30 minutes. As the mean time of release
after giving the label was at 80 minutes the rate of transit through the
cell is substantially slower than for albumin where the mean transit time
is 23 minutes.
The factors controlling transferrin synthesis are still incompletely
understood and are confused by apparent differences between species of
experimental animal and in the older literature by the measurement of total
iron-binding capacity rather than transferrin. There maybe quite major
differences between these measurements as will be discussed later. There
are two main theories to account for the facts known about the regulation
of transferrin synthesis, either that it is related to the plasma iron or
body iron stores or that it is influenced by the balance in the body between
oxygen supply and the oxygen demand of the tissued. An older view that the
influence of erythropoetic activity is important has not been supported by
more recent work (Morgan, 1962| Awai and Brown, 1963)*
Weinfeld (1964) presented evidence that there was a correlation between
iron stores in the liver and marrow (measured directly in biopsy specimens)
and total iron-binding capacity (TIBC) of the plasma. In keeping with this
relationship was the finding that the TIBC was higher than predicted from
the curve in non-anaemic blood donors and patients who while not anaemic
had had a recant haemorrhage. He also explained the lowered TIBC found in
the anaemia of infection as being due to the increased iron stores which are
found. In keeping with this hypothesis is the depression of the TIBC found
in iron overload with or without secondary haemochromatosis (Bothwell and
Finch, 19$2| Earry et al, 1968? Johnson, 1968). However, Morgan (1966j
1969) and Tavill and Kershenobich (1972) were unable to show any change in
transferrin synthesis in the rat following iron overload although the latter
workers did show that in nutritional iron deficiency intravenous iron
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reduced transferrin synthesis without altering the haemoglobin level.
Prom observations of the inverse relationship between serum iron and
TIBC in a variety of clinical situations, Lane (1966) suggested that the
plasma iron level might control the regulation of transferrin synthesis.
In a series of animal experiments Morgan (1962, 1969 ) has suggested
that the balance between oxygen supply and demand is the chief factor
controlling transferrin synthesis. However he was unable (1970) to show
that the TIBC rose in human subjects subjected to reduced atmospheric
pressure for up to 4 days although there was a reticulocyte response. It
is obvious that plasma transferrin concentration is a resultant of
increased synthesis and eatabolism and as these two processes may be
controlled independently interpretation of static plasma concentrations
may be misleading and it is essential to study both components simultaneously
to gain a true picture. Furthermore there is evidence from distribution
and turnover studies with radioactive labelled protein that a rise in plasma
transferrin may sometimes be due at least in part to a shift from the
extravasoular to intravascular pool (Morgan, 1966). Factors of a more
general nature may also be important in controlling synthesis. Protein
deprivation reduces transferrin as well as albumin synthesis (Morgan and
Peters, 1971a) and this has its clinical counterpart in kwashiorkor where
low serum transferrin concentrations are a prominent feature (McFarlane et
al, 1970)0 In inflammatory states the low plasma iron and iron-binding
capacity are well known and studies in man (Jarnum and Lassen, 1961) and
in the rat (O'Shea et al, 1971) sbow that while synthesis is well maintained
fractional catabolism is increased reducing the plasma pool. Oestrogen
therapy is accompanied by a rise in serum transferrin (Laurell et al, 1967}
Jacobi et al, 1969} Song et al, 1970) and levels also rise in the last
trimester of pregnancy but in this situation iron deficiency may also play
a part (Mendenhall, 1970). Ababolic steroids do not affect plasma levels
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(Barbosa et al, 197l)« Extremely low synthetic rates may he found in the
rare cases of congenital deficiency (Heilmayer et al, I96I5 Goya et al,
1972) although the possibility of failure of release of the protein from
the liver analogous to the situation in ^-antitrypsin deficiency has not
been explored. Excessive loss of the protein in the urine may rarely
severely reduce plasma concentrations (Heilmayer et al, 1966).
It has recently been reported that in normal subjects a small propor¬
tion of the serum iron is bound to other proteins (van der Heil, et al, 1972)
and amino acids (Prasad and Oberleas, 1971) but the error in most circumstances
in assuming that the fIBC is a measure of plasma transferrin is small
(stokceski et al, 19651 Dobrilla et al, 19#7)« However in disease states
in which the plasma protein and amino acid pattern is greatly disturbed
this may be a source of error. In addition the usual method of measuring
TIBC which depends on removing excess unbound iron with magnesium carbonate
will not precipitate out iron in the form of ferritin. The extremely high
serum iron levels sometimes found in acute hepatic necrosis and in haemo-
chromatosis (Brendstrup, 1953? Bothwell and Finch, 1962) are due in part to
circulating ferritin (Reissmann and Dietrich, 1957? Jacobs et al, 19?2)
and the measurement of TIBC may overestimate the true serum transferrin
concentration. This has been shown by Dobrilla et al, 1967J Fiasahi et al,
1969} Cartei et al, 1970, but the spectrophotometry method used for
measuring TIBC may not have been entirely satisfactory.
The true levels of serum transferrin in haemochromatosis were low in
the second series of patients in this sfcudy and this is in keeping with
reports by Blanc and Vannotti (1966), Dobrilla et al (1967)» Fiaschi et
al (1969) and Cartei et al (1970). The latter two groups have also
reported that levels rose to normal during venesection but it is difficult
to know to what extent this may be due to the improvement in liver function
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which generally occurs (Williams et al, 1969) rather than to removal of
iron in particular. A rise in serum transferrin concentration during
venesection was seen in throe patients in the present series. Studies on
the effects of regular plasmapheresis in normal volunteers showed that
removal of about 1.21 plasma per week had no effect on the concentration of
transferrin and other proteins (Shanbrom et al, 1972) but removal of 5b. per
week did reduce plasma protein levels (Kliman et al, 1964).
The transferrin levels in the 14 relatives of the patients with
haemochromatosis in the present serieB were significantly lower than the
control population. There did not appear to be any relationship with the
serum iron or iron stores. Blanc and Vannotti (1965 ) noted that 4 brothers
of a patient with primary haemochroiaatosis had low plasma transferrin
levels in addition to raised levels of serum iron and Dobrilla et al (1967)
found 5 relatives of one of their patients had raised serum iron levels and
low concentrations of plasma transferrin. However the normal range for TIBC
is wide and the number of cases studies is small and although the mean TIBC
was lower than in controls in 23 relatives studied by Williams et al (1962$
1965) and 52 relatives by Powell (1965) the differences were not significant.
The mean TIBC in those relatives with significant iron overload assessed by
a chelation technique was lower than in those with normal iron stores but
the difference did not achieve statistical significance (Powell, 1965).
In agreement with other published studies we found normal or only
slightly reduced transferrin levels in acute viral hepatitis (Muller and
Muller von Voigt, 1967$ Kindermark and Laurell, 1972),<in primary biliary
cirrhosis (Hallen and Laurell, 1972). Normal or slightly reduced levels
were found in cirrhosis of unspecified type or in a mixture of types by
Muller and Muller von Voigt (l967)» Dobrilla et al (1967) Brezin et al (1971)
and Weeke (1973). In patients with alcoholic cirrhosis in the present series
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low transferrin levels were found and similar results are given by Fiaschi
(1969) and Aron et al (l97l)« Normal levels were found by Hallen and
Laurell (1972). The poor nutritional state of many alcoholic patients
may contribute to the low levels and it is noteworthy that the serum albumin
level was lower in this group than in the other types of cirrhosis studied.
The fall in transferrin in obstructive jaundice is in keeping with the
fall in TIBC reported by Lange and Oberhoffer (1958). The raised levels
of transferrin in active chronic hepatitis were unexpected and habe not been
commented on in the literature. However in Hallen and Laurell*s (1972)
series of patients with acute hepatitis raised levels were found in over
half the cases at 5-8 weeks when liver function was recovering. Such an
increase, presumably due to increased synthesis, was also seen in 1 of the
4 cases of active chronic hepatitis followed serially during treatment and
was also found in various experimental inflammatory states (Morgan, 1969)*
Cartei et al (1970) and Horne and MacSween (1971) have commented on the
close correlation between albumin and transferrin febth in normal subjects
and in patients with liver disease. In the present studies it was not
possible to confirm this observation but it is interesting that the two
groups with the lowest mean serum albumin (patients with alcoholic cirrhosis
and extrahepatic obstructive jaundice) were those which also had a low
mean serum transferrin concentration.
The low levels of transferrin in the patient;with haemochromatosis,
alcoholic cirrhosis and extrahepatic obstructive jaundice may not be of
any pathophysiological importance. Certainly there did not seem to be any
marked tendency to infection. It is interesting howfver that iron overload
is a feature of the two chronic states. No assessment of the body iron
stores of the patients with alcoholic cirrhosis was made but a moderate
degree of iron overload is common in this condition (Williams et al, 1967)*
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In a study of hepatic siderosis in patients with chronic liver disease
(Williams et al, 19^7) it was not possible to relate the degree of iron
overload in the liver to increased absorption, degree of disturbance in
liver function or serum iron. However the percentage saturation of the
TIBC was significantly higher in those patients with siderosis reflecting
a reduction in serum transferrin levels. The low level of transferrin
must mean that for a given serum iron a higher proportion than normal of
the transferrin molecules carry 2 atoms of iron and recent work by Fletcher
(1971) has shown that iron in this state is preferentially delivered to
the liver. This confirms earlier observations by Wbsby and Jones (1963).
Thus the low transferrin levels might be a factor in the development of
iron overload in chronic liver disease.
& Lipoprotein
There is now good evidence from studies on the incorporation of radio¬
active labelled amino acids and lipids that the liver is the major site
of lipoprotein (LDL) synthesis, with lesser amounts arising from the
intestine (Hatch et al, 1966$ De Jong and Marsh, 19685 Marsh, 1971$
Stein et al, 1972). The presence of LDL peptides in the VLDL fraction
raises the question of whether the LDL are secreted as such by the liver
or whether the peptides first appear as VLDL. This is at present unknown
(Sarah, 1971). The plasma concentration of f' lipoprotein is influenced
both environmental and genetic factors as saturated fats raise the serum
cholesterol and LDL when fed by isocaloric substitution for carbohydrate
and other fats(and elevated levels are commonly familial (Lewis, 1971)•
Hyperbetalipoproteinaemia is also found in hypothyroidism, idiopathic
hypercalcaemia and the nephrotic syndrome. A slight drop in concentration
occurs as part of the acute phase reaction.
In liver disease the changes in lipoprotein concentration found depend
on the methods of investigation used. Early work with moving boundary or
paper electrophoresis shewed an increased globulin fraction in obstructive
jaundice which was attributed to lipoprotein (Sterling and Ricketts, 1949?
Kunkel and Ahrens, 1949? Kunkel and Slater, 1952)# When agarose electro¬
phoresis is followed by lipid staining there appears to be a reduction in
lipoprotein and pre-betalipoprotein (Papadopoulos and Charles, 1970?
Wollenw8ber and Kahlke, 1970? Seidel et al, 1972). However HDL can be
demonstrated immunologically in the serum and ultracentrifugal analysis has
shown that the VLDL is also present but has f> mobility on electrophoresis.
This pattern of changes is found in all types of liver disease and Seidel
and his co-workers (1972) have shown that it is due to an abnormality in
the apolipoprotein A. This results in decreased lipid binding by the HDL
and absence of the usually small quantity of the apolipoprotein A from the
VLDL is accompanied by a change in mobility from pre-beta to beta. Ultra-
centrifugal analysis of LDL in obstructive jaundice has shown increased
levels associated with raised serum cholesterol and phospholipid levels.
Early work (Eder et al, 1955) based on the composition of Cohn fractions
of plasma from patients with obstructive jaundice had suggested the presence
of an abnormal lipoprotein and this protein has recently been more closely
characterised and shown to account for much of the increase in the LDL
fraction (Switzer, 1967? Seidel et al, 1969). This abnormal lipoprotein
known as lipoprotein-X (LP-Xj has a unique composition and is rich in
phospholipid and unesterified cholesterol. The protein moiety consists of
albumin and apolipoprotein C. (Seidel 1972).
It is not possible to be certain what ultracentrifugal classes of
lipoprotein were being measured as ft lipoprotein by the present method.
As apolipoprotein B is the major protein component of both the VLDL and LDL
and has one antigenic determinant (Alaupovic, 1972) the fi lipoprotein arc
may represent both ultracentrifugal types. However it is unlikely to
include LP-X which contains mainly apolipoprotein C and does not react
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with antiasra to normal lipoprotein. Hence, although the LDL fraction
increases in obstructive jaundice the rise is due largely to lipoprotein-X
and it is therefore not surprising that & lipoprotein levels measured
immunologically in the present study were normal in primary biliary cirrhosis
and low in sxtrahepatic obstruction. The change in the eleetrophoretic
mobility of the VLDL from prebeta to beta which occurs in liver disease
might be expected to alter the configuration of the precipitation arc but
no difference was detected between normal subjects and patients with liver
disease.
Levels of ft lipoprotein were normal in all groups of liver disease
studied except for acute viral hepatitis where the concentration w^s
significantly raised. Xindmark and Laura11 (1972) using the same immuno-
electrophoretic technique noted normal or raised levels in patients with
qcute viral hepatitis but no details were given. Other studies of
lipoprotein measured by immunological methods in liver disease showed
normal levels in alcoholic cirrhosis (leeke, 1973) raised levels in a
small series of patients with primary biliary cirrhosis (leeke, 1973) and
low or normal levels in unspecified or mixed types of cirrhosis (Muller
and Muller von Voigt, 1967J Brezin et al, 1971| Weeke, 1973)*
Third component of complement (C3)
Evidence that C3 is made in the liver comes from studies on the in
vitro incorporation of amino acids (Kaghn and Prince, 1971) and immuno¬
fluorescence in liver slices produced by fluorescein tagged specific
antibody (Johnson et al, 1971)* la addition there is abundant evidence
in experimental animals and also in man that cells of the lymphoid series
have the capacity to synthesis© this protein (Hochwald et al, 1961| Phillips
and Thorbeoke, 1966| Stecher and Thorbecke, 1967; Glade and Chessin 1968).
However the change in C3 phenotype following liver transplantation is strong
evidence in favour of the liver being the primary site of synthesis (Alper
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et al, 1969).
ICohlar and. Mu1ler-Eb®rhard (1967) measured total C3 AC) levels
by immunodiffusion at intervals over 60 days during conversion at 20°C
and found the total amount rose by 21t. This was due to the loss of the
B antigen on conversion to SjA and the immunoprecipitin ring formed by the
JjA precipitating with anti A antibody is larger giving an apparent increase
in the concentration of 03 in the serum (Laurell and Lundk, 1967? West et
al, 1967)0 This artefact would influence the results of /5% AC measured by
the present technique because the serua samples were stored for variable
periods of time# The conversion could have been run to completion by
incubating the serum at 37°C# for 3 days but this might have altered the
concentrations of other plasma proteins. In the first transplant patient
where the storage of serum was brief and comparable with the control sera,
the values for the concentration of/5 ^AC globulin are probably valid. The
50-80$ increase in the concentration of /£, AC globulin in the patients with
cryptogenic cirrhosis, alcoholic cirrhosis and active chronic hepatitis may
in part be due to the storage artefact but this increase is more than can be
attributed to conversion to S-A alone. Because of the small size of the
precipitation arcs on the miniplates no attempt was made to measure^ AC
globulin.
There have been several studies recently of C3 levels in liver disease.
In acute hepatitis there is often a fall initially and when the jaundice
reaches its peak the levels are normal or above normal (Onion, et al, 1971?
Kosraidis and Leader-Williams, 1972? Alpert at al, 1972). This suggests
consumption of complement possibly due to antigen-antibody complexes but
it occurred in both Australia antigen positive and negative cases and the
pattern was the same whether or not there were symptoms such as arthritis
suggesting immune complex disease. Reoent evidence supporting consumption
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of complement "by immune complex formation comes from studies in this Unit
on patients with Australia antigen positive chronic liver disease, who
have been given an intravenous infusion of gamma globulin containing a
high titre of antibodies to Australia antigen. Following the injection
there was a fall in total haemolytic complement, C3 and C4 with evidence
on immunoelectrophoresis of in vivo conversion of C3 (Drs. A. Sddleston
and W. Reed, personal communication).
C3 levels are also low in massive hepatic necrosis and gradually rise
with improvement in liver function. Here it is likely that impaired
hepatic synthesis is responsible for the changes (Fox et al, 1971)* In
all types of chronic liver disease most reports Comment on the wide scatter
of values (Agostini et al, 1968} Grob et al, 1971)• In patients with
high levels Kaboth and Arnold (1969) found evidence of marked chronic
inflammatory cell infiltrate and suggested the rise in C3 was part of the
acute phase reaction. Other authors have not commentedoon this but have
found no relation to auto-antibodies or ^globulin levels (Grob et al, 1971}
Finlayson et al, 1972). Low values tend to occur in patients with severely
disturbed liver function tests and "both Kaboth and Arnold (1969) and.
Finlayson et al (1972) found a positive correlation between C3 levels and
coagulation tests. Measurements of Cl^, which is synthesised outside the
liver, were normal in 11 cases of liver disease of which 8 had low levels
of total haemolytic complement C3 or C4 (Finlayson et al, 1972). This is
further evidence for diminished hepatic C3 synthesis as the cause of low C3
levels but activation of the alternate pathway (Peters et al, 1972) will
not affect Cl^ levels and complement fixation.by immune complexes remains
a likely explanation at least in some cases.
Thus it appears that there are at least 2 mechanisms for the finding
of low serum complement in liver disease. One mechanism is the activation
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of serum complement by immune complexes and the other is a low rata of
synthesis in severe hepatocellular disease. The latter mechanism has been
confirmed in a few cases of advanced cirrhosis by measuring the plasma
disappearance rate of I labelled C3 (Pets 1971)* Increased C3 turnover
can of course be compensated for by increased synthesis so that plasma
concentrations are normal (Carpenter et al, 1969} Sliwinski and Zvaifler,
1972).
An alternative and easier method of detecting increased complement
utilisation is to look for breakdown products as evidence of in vivo
activation. These were first shown in vivo in certain types of glomerulone¬
phritis by Soothill (1965) and further reports (Soothill, 1967} West et al,
1967} Alper and Rosen, 1967} Peters et al, 1972).have confirmed this.
However the significance of these products in vivo is still not clear for
some cases had normal C3 catabolic rates in vivo using radioactive labelled
C3 (Peters et al, 1972) and serum from these cases contains a factor (termed
nephritic factor) which breaks down C3 in normal human serum. The present
studies failed to show evidence of significant conversion of C3 in vivo
in active chronic hepatitis or primary biliary cirrhosis. However these
results are open to criticism on the grounds that the commercially available
antiserum used had only antibodies to the A and B antigens so that (C3d)
and other products could not be visualised. However in the great majority
of cases in which in vivo complement conversion has been found has been
present. Furthermore the breakdown products may be found intermittently
and it is advised that repeated samples be examined (Versey et al, 1972).
l'eisberg (Personal communication) has found C3 breakdown products in fresh
plasma from some patients with both active chronic hepatitis and primary
biliary cirrhosis but was unable to relate this to the degree of abnormality
of liver function tests or the presence of auto-antibodies or Australia
antigen. Chandra (1970) found altered C3 components in 21 out of 30 patients
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with Indian childhood cirrhosis and in all cases 63 levels were severely-
depressed.
Most "but not all studies in renal transplantation have shown hyper-
catabolism of C3 with a fall in plasma concentration at the time of
rejection (Carpenter et al, 1967; Carpenter et al, 1969; Yokoysma et
al, 1972) and both immunoglobulin and complement are found in relation
to vascular endothelium of the rejected organ (McKenzie and Whittingham,
1968; McPhaul et al, 1970; Ngu et al, 1971)* This has also been shown
in liver allografts (Andres et al, 1972). The findings in the first
hepatic transplant patient studied were in favour of C3 consumption at
the time of the early rejection episode and high levels were found later
when the degree of impairment of liyer function was considerably greater.
Torisu et al (1972$ have recently confirmed a fall in C3 and C4 concentration
with acute rejection in 5 liver transplant recipients and shown that there
was no change in the concentration with biliary obstruction. Similar
results were obtained using total haeaolytic complement (CH^q) in 4 other
patients in the King's College Hospital transplant series (Pagaltsos et al,
1972) and it does seem that serial measurements of C3, C4 or ®ay be of
value in the differential diagnosis of jaundice at least in the first month
after liver transplantation.
Other proteins
There are few data in the literature on easily precipitable glyco¬
protein (PGP) but it appears to be an acute phase protein and shows a rise
after surgery (Clarke et al, 1971) and in patients with rheumatoid arthritis
(Clarke et al, 1970b) tuberculosis (Clarke, et al, 1970a) ulcerative
colitis and Crohn's disease (?/eeke and Jarnum, 1971)* It was significantly
raised in the present series in patients with hepatitis, extrahepatic
obstruction and primary biliary cirrhosis, this latter finding being in
agreement with Weeke (1973). This author also found raised levels in
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alcoholic cirrhosis and a group of 26 patients with cirrhosis which
included 7 cases of active chronic hepatitis. Although levels were also
found to be raised in patients with cryptogenic cirrhosis, alcoholic
cirrhosis and active chronic hepatitis, it was only in the latter group
that this reached statistical significance.
Protein 16 also appears to be an acute phase reactant and rose after
hernia repair (Clarke et al, 1971) and in a subject who developed
influenza. Aronsen et al (1972) noted raised levels of antichymotrypsin
after surgery and they suggested that this protein was identical with
protein 16 as identified by Clarke and Freeman (1968). Recent work confirms
the identity (Clarke, H.G.M.; personal comrnunication). Kindmark and
Laurell noted slightly elevated levels of antichymotrypsin in some patients
with acute hepatitis which may correspond with our findings but there are
no reports in the literature on concentrations in other forms of liver
disease. By contrast protein 18 was at normal concentrations in three of
the four groups of patients studied and the low mean value in the extra-
hepatic obstruction group was due to apparent absence of the protein from
4 of the 12 sera. The concentration of protein 10 tends to fall with
surgical trauma (Clarke et al, 1971) "but in the present study it waa
elevated in patients with acute bapatitis and also those with active chronic
hepatitis although in this group it did not reach statistical significance.
The coefficient of variation of this protein in the normal population is
large probably due in part to difficulties with measurement as it gives
rise to a small faint arc on iamunoelectrophoresis. However, the rise
which was found only in the two forms of liver disease with the greatest
inflammatory component was quite striking. Further studies of this protein
in a range of conditions are needed.
Transplantation 18 3
Following transplantation of the liver an early rejection episode
occurred in three of the four cases and this was accompanied by the changes
of the acute phase reaction. This was almost certainly at least in part
due to the preceding surgical trauma for following operation the plasma
protein pattern does not return to normal for about two weeks (Werner and
Cohnen, 1969? Clarke et al, 1971)* In the 3 survivors liver function
improved and the protein pattern returned towards normal. In case 1
the concentration of all proteins measured was normal on day 56 and 3 to
5 weeks post-operatively there were only minor abnormalities in the plasma
protein pattern in cases 3 and 4* However further deterioration in the
plasma protein pattern occurred in all 3 cases due to chronic rejection
(Case l), carcinomatosis with hepatic deposits (Case 3) and extrahepatic
obstruction (Case 4)* In each case the changes, which were those of the
acute phase reaction, were qualitatively very similar although variable
in degree and there were no unusual features except the extent of the rise
in protein 16 which was 3 times above the normal level in cases 3 and 4*
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Measurements of albumin and fibrinogen synthesis rates made by the C-
carbonate method in two other patients at intervals up to 13 months after
transplantation at a time when liver function was normal, gave normal or
high values for both proteins indicating excellent synthetic capacity
(Rake et al, 1970).
The changes in plasma protein fractions following liver transplantation
in the dog were studied by Kukral et al (1966) who showed a rise particularly
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in the globulins with increased incorporation ofS~methionine suggest¬
ing increased synthesis. Ischaemic damage to the graft (JCashiwagi et al,
1968) was followed by a fall in the concentration of many proteins including
caeruloplasmin, o^-macroglobulin and C3» These workers were unable to
detect any consistent changes accompanying rejection but the iminunoelectro-
18 4
phorstic technique they were using was only semi-quantitative. There
are no reports of the changes in plasma protein patterns following liver
transplantation in man with the exception of studies on the complement
system (see above).
A change in the haptoglobin type of the recipient to that of the
donor following liver transplantation has been reported by Merril et al
(1964) and Kashiwagi et al (1968). This change had occurred within 2
days and persisted for the 64 day period of observation. A change in
group component type was also reported by the latter group. We have
examined sera before and after transplantation in 8 patients and demonstrated
a change in haptoglobin type in 1, in group component type in 5 end in
<^l-antitrypsin type in 1. (Dr. Peter Cook). This is confirmatory evidence
that the liver is the major source of these plasma proteins.
In a detailed study of the changes in 21 serum proteins following
renal tranplantation (Weeke, 1971b»c) the usual post-operative changes
occurred. During late rejection episodes in 4 patients only slight and
statistically insignificant changes occurred. Bo details are given of
liver function tests which may be disturbed in renal graft recipients
([Evans et al, 1968).
Value of plasma protein measurements in the differential diagnosis of
liver disease
The wide range of functions performed by the liver has invited the
introduction of a large number of different liver function tests over the
years and it has long been appreciated that the use of more than one test
improves diagnostic accuracy (laclagan 1947J Wang, 1953f Hill and Zieve,
1957). Measurement of total protein, albumin and globulin (Sherlock, 1946)
or the standard 5 electrophoretic fractions when considered alone (Owen and
Robertson, 19565 Wall, 19585 Osserman and Takatauki, 1963) proved of little
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help in the differential diagnosis of liver disease although the results
of discriminant analysis might suggest that this technique has "been tinder-
rated. Heremans et al (1955) used the values for the ^2 and ^
globulin fractions obtained from paper electrophoresis expressed as a
percentage of the total protein in a discriminant function to reclassify
24 cases of hepatitis and 16 eases of obstructive jaundice into their
diagnostic groups. This was achieved with an error of only 4*5$ hut no
attempt was made to test the system with new cases. Charbonnier et al
(1955? cited by Heremans) in examining the discrimant value of protein
electrophoresis in the differential diagnosis of 19? oases of jaundice
used a combined value for albumin and oC^ globulin as they were unable to
separate these fractions clearly and they discarded values for X globulin.
Their error in reclassifying the cases into obstructive and hepatocellular
disease was 45^* This is similar to the results in the present study where
a larger number of diagnostic groups was examined. There have been other
attempts to use various forms of discriminant analysis in the differential
diagnosis of the jaundice patient using clinical and laboratory data which
included xfesms protein measurements. Burbank (1969) used the total globulin
and Begon and Dhumeaust (l9?l) used albumin and V globulin in fhik* Bayesian
model but there is no indication of the discriminant value of these
particular measurements. In a multivariate discriminant analysis study
employing 9 liver function tests in 17 patients with cirrhosis and 19
controls the combination of BSP transport maximum and $ globulin were found
to give maximum separation between the two groups (Bamso© et al, 1970).
The development of simple methods for identification of individual
plasma proteins has given rise to diagnostic tests for Wilson's disease
arid the liver disease associated with deficiency antitrypsin but
until recently there were no studies on the discriminant value of the
numerous other plasma proteins in the differential diagnosis of liver
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diseases, teener et al (1972) using a stepwise discriminant analysis
compared the accuracy of paper electrophoresis with the immunological
measurement of 14 plasma proteins including IgG, IgA and I# in allotting
normal subjects and patients with one of 6 diseases including hepatitis
and cirrhosis to their correct diagnostic category. There was little
difference between the accuracy of the two methods. The five most
discriminant specific assays (igA, albumin, IgG, A-acid glycoprotein
and 1^1) taken together were no better than the 5 electrophoretic fractions
but the combination of both methods did improve the diagnostic effectiveness.
It was not stated how the two methods compared when considering only the
patients with hepatitis and cirrhosis nor which individual proteins had the
most discriminant value.
In the present study the error in reclassifying the normal subjects
and the 4 miniplate diagnostic groups was haikf as large as the error in
reclassifying the patients with alcoholic and cryptogenic cirrhosis, and
active chronic hepatitis. This is perhaps not surprising as the latter
three groups are more similar in terms of the pathological process and the
pattern of disturbance of liver function than are the other four groups
studied. No individual protein emerged as being of particular diagnostic
importance and the rank order of proteins selected to reduce the diagnostic
uncertainty varied not only between the analyses of the group of four diseases
fcnd the group of three diseases but also between the two discriminant
functions used. The use of 13 proteins rather than 8 in th® discriminant
function slightly further reduced the error of reclassification.
It is obvious that cellulose acetate electrophoresis alone is of no
value in the differential diagnosis of the 7 liver diseases studied here.
However, as one might expect, when the diagnostic choice is reduced to
groups of 3 or 4 diseases the results are improved and agree fairly closely
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with the results of reclassification using 8 protein values from Immuno¬
electrophoresis. The addition of information from cellulose acetate
electrophoresis and 13 proteins from immunoelectrophoresis gives the best
diagnostic accuracy and this underlines again the well recognised need for
a battery of liver function tests for accurate diagnosis. It is interesting
to note that when the cellulose acetate and Immunoelectrophoresis results
were combined the first 4 variables in rank order were immunologically
distinct proteins. It seems likely that the inclusion of values for the
immunoglobulins would further improve the diagnostic accuracy*
The two methods of statistical analysis gave similar results when up
to 8 variables were included but as the amount of information increased
the error using the stepwise linear discriminant function was less. This
may be because this, unlike the Bayesian function, takes account of the
correlations between proteins.
183
WOBK FOR THE FUTUBE
It seems unlikely to "be profitable to extend this research to further
diagnostic categories of liver disease in view of the essentially similar
pattern of disturbance found so far in the different disease groups. However,
the present work has raised various problems of interest worthy of further
stu^y.
The analysis of the results indicates which plasma proteins are of
value in assigning individual patients to their correction diagnostic group.
The present method of measuring these proteins simultaneously in a single
sample, while it has the advantage of being fairly cheap, is too time consuming
and technically difficult for routine application. It is easier and more
practical to use radial immunodiffusion. The value of these measurements
compared with the other clinical and laboratory data in reducing the
diagnostic uncertainty will be assessed in a prospective manner with the
sequential Bayesian diagnostic model currently in use in this hospital.
The low serum transferrin levels in patients with primary haemochromatosis
and their relatives will be investigated further and an attempt made to
correlate the serum levels with iron absorption and the degree of iron over¬
load assessed by serum ferritin levels. This may be a better guide than the
differential ferrioxamine test. Turnover studies with radio-iodine labelled
transferrin before and after venesection in patients with primary haemochroaa-
tosis may give useful information on whether body iron stores indeed play a
significant part in controlling transferrin synthesis.
The finding of abnormal concentrations of several proteins in the
epileptic patients is of great interest. It is intended to do further serial
studies in individual patients over a longer period of time with measurement
of urinary glucaric acid excretion as an index of hepatic microsomal enzyme
induction. Increased plasma protein synthesis may be demonstrated by
performing radio-active iodine labelled protein turnovers before treatment
and after a steady state has been reached. Here it will be of particular
interest to study haamopexin in view of its postulated role as an intra¬
cellular haem-binding protein possibly controlling tbe activity of several
intracellular enzyme systems. The pathophysiological implications of the
disturbances in protein concentration have not been explored but for
instance the high oC^ macroglobulin levels may upset blood coagulation
homeostasis and increase the risk of venous thrombosis. There is
certainly much further work to be done on the long-term clinical effects





From the review of the literature it is concluded that the liver
is the major source of the plasma proteins and changes in the
concentration of individual proteins occur in liver disease,
Clarke and Freeman's method of crossed Immunoelectrophoresis is
an accurate and reproducible method of measuring up to 14 individual
plasma proteins in a single 4ul. sample,
The micro-modification described in Part 2 is quantitative and
reproducible and has the advantage of being considerably cheaper
because of the small amount of antiserum needed.
Storage of serum samples at -20°C. for up to "12 months does not
alter the concentration of the proteins apart from /^-lipoprotein
which showed a fall of 30-500.
The mean plasma protein concentrations in a control population of
70 subjects and the variation with age and sex found in the present
work agree closely with the published literature. This supports
the validity of the present method of measurement.
Plasma protein concentrations in healthy individuals show little
variation over an interval of several months.
Changes in the concentration of many plasma proteins occur in
patients with liver disease. The pattern of disturbance is similar
in the different diagnostic groups, although it differs in degree.,
the most striking changes occurring in those patients with the
greatest abnormality of liver function tests. In patients with
severe impairment of hepatic parenchymal cell function the concentration
of many proteins including haemopexin may be low initially but increase
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as liver function improves. It is suggested that the "basic pattern
of change is due to the 'acute phase reaction1 "but this may "be modified
"by the limitation to synthesis imposed by the underlying liver
disease which evoked this non-specific response. A high concentration
of haptoglobin, normally a feature of the acute phase reaction, was
not found in any group of patients and this may be due to the
occurrence of mild haemolysis. Raised levels of ^-maoroglobulin,
which are not a feature of the acute phase reaction, strongly suggest
underlying hepatic fibrosis or cirrhosis.
Haemopexin levels are normal in patients with primary haemochromatosis
contrary to a previous report. Transferrin levels are reduced both
in patient© with primary haemoehromatosis and their first and second
degree relatives. This may be related to iron overload and in 3 of
the patients with primary haemochromatosis low levels rose with vene¬
section therapy.
A fall in ^-AC (third component of complement) following orthotopic
liver transplantation may indicate a rejection episode but the pattern
of chan e6 of the other proteins is of no help in the differential
diagnosis of abnormal liver function in the post-operative period.
Evidence from the literature suggests that the low plasma levels of
o(jantitrypsin found in subjects homozygous for the Pi allele are due
to a fault in the release of the protein from the liver. The present
work indicates that the problem does not eztend to other liver produced
plasma proteins.
There are changes in the concentration of several plasma proteins in
otherwise healthy epileptic patients being treated with long-term
anticonvulsant therapy. The pattern of disturbance is quite distinct
from the acute phase reaction. It may be related to hepatic microsomal
enzyme induction.
No individual plasma proteins have been found to be of particular
diagnostic value for the groups of patients with liver disease
studied. The error in reclassification of the cases using two
different discriminant functions was minimised by including the
values of all the plasma proteins measured. This was considerably
more accurate than the results of reclassification using only data
from cellulose acetate electrophoresis. However, the best diagnostic
accuracy is attained by combining both methods. The present work
supports the use of a battery of specific plasma protein estimations
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APPENDIX A
PBEPABATIQN OF BEAGBNTS ASP OTHER MATERIALS
1. Agarose (L'industrie Biologique Francaise S.A.) was added to "boiling
deionised water to make a 2$ solution and sodium aside was added (5/1000 W/W).
It was boiled for ijhrs filtered through gauze and stored till use in
20ml. aliquots in sterile screw cap containers.
2. Barbitone buffer (0.06M) was prepared in 10 1. batches1-
Sodium barbitone (Analar) 61.7g.
Calcium lactate (Analar) 3»84g.
Sodium azide (Analar) 50U®g»
Deionised water (51*)
Using a glass electrode and concentrated HC1 the pH of the buffer was
brought to 8.6 and it was then stored at +4°C. till use.
3. Antiserum to whole human serum was raised in goats (Dr. T. Freeman
and H.M. Clarke) by injecting antiwhole human serum in Freund's adjuvent.
4. Acetylated albumin was prepared by adding an excess of acetic anhydride
to pure human albumin in 6$ sodium bicarbonate at 0°C. After 10 minutes
an excess of lysine solution (pH 7*0) was added. After exhaustive dialysis
against physiological saline the concentration of protein was adjusted
to 6mg./ml. The solution was subdivided into 1ml. lots and freeze dried.
5. Amido Black stain. An 0.1$ solution was made up in alcohol-acetic
acid wash (Methyl alcoholf deionised water and glacial acetic acid in the
proportions 5*5*1 v/v).
6. Acetate buffer for the caeruloplasmin stain
yjml. 0.2M acetic acid + 463^1. 0.2M sodium acetate + 500®1* distilled
water makes up 1 1. of 0.1M acetate buffer pH 5*7•
* 2
7. Sudan black stain*
Ig. Sudan black/litre 60ethanol incubated for 24 hours at 37°C* and then
filtered and stored in a dark bottle* 0.1ml* 30% sodium hydroxide is
added to 160ml. dye before use and the plate is soaked for 24 hours and
then washed in 5Q$> ethanol*
Appendix B.
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APPEKDIX C
CLINICAL DETAILS OF PATIENTS WITH ACTIVE CHRONIC HEPATITIS
STUDIED SERIALLY DURING TREATMENT
Case 1. This 20 year old Jamaican joiner presented in July 1971 with a
4 month history of increasing jaundice. Apart from an isolated episode
of uveitis 4 years previously he had no past medical history and had had
no drugs or known exposure to hepatitis. His alcohol intake was moderate.
Physical examination showed deep jaundice and hepatosplenomegaly.
Investigations showed a normal "blood picture and the prothrombin
time was 8 seconds prolonged. Liver function tests weres- serum bilirubin,
19zag./l00ml., alkaline phosphatase, 260 I.U./l. (normal up to 80 I.U./l.)
and aspartate aminotransferase, 210 I.U./l. (normal up to 50 I.U./l.).
The total plasma protein concentration was 8g./lOQtal.j albumin 3*9g»/lOOml.;
gamma globulin 2.9g/lOQmlj and caeruloplasmin concentration 35mg./lOOml.
(normal 20-40mg./lOCtol). Australia antigen was demonstrated in the blood
by Immunoelectrophoresis. Serum autoantibodies to mitochrondria and
smooth muscle and antinuclear factor were absent. Liver biopsy showed
chronic aggressive hepatitis with marked piecemeal necrosis and established
cirrhosis.
Treatment was started with prednisone, 15mg./day and his further
treatment is shown in Fig. 19* Large doses of corticosteroids were
required to control the level of plasma bilirubin.
Summary A 20 year old man with Australia antigen positive active chronic
hepatitis and established cirrhosis responding poorly to corticosteroid
therapy.
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Case 2. This 50 year old English housewife was well till December 1971
when she had an episode of jaundice lasting about 2 months. In February
1972 the jaundice returned and she was referred for investigation and
treatment. There was no other past medical histoxy and no exposure to
drugs, injections or cases of hepatitis. Her alcohol intake was modest.
Physical examination showed jaundice, numerous spider naevi and hepatomegaly.
On investigation the blood picture was normal and the prothrombin
time prolonged by 3 seconds. The liver function tests showeds- serum
bilirubin, 8.5mg»/lOOml.j alkaline phosphatase, 269 I.U./l.5 aspartate
aminotransferase 935 I.U./l.j Total plasma protein was 7*9g«/lOOml.;
albumin 2.7g./lOQml. and gamma globulin 3»34g*AOQml. Antinuclear factor
(l/l60) and antibodies to smooth muscle (l/l60) were present in high titre
but mitochondrial antibodies were absent. Australia antigen was not
detected in the blood. Liver biopsy showed active chronic hepatitis with
prominent rosette formation and numerous necrotic cells. The architecture
was disturbed and nodular regeneration present.
Treatment with prednisone 30mg./day resulted in a rapid fall in serum
bilirubin and improvement in her condition (Fig.20).
Summary A 50 year old woman with active chronic hepatitis and cirrhosis
who responded well clinically and biochemically to corticosteroid therapy.
Case 3. This man became addicted to heroin in 1966 at the age of 19 and
was exposed to the risk of syringe transmitted hepatitis on numerous occasions.
He became jaundiced for the first time in December 1970 when a diagnosis
of Australia antigen positive hepatitis was made. His liver function
remained abnormal however, and a liver biopsy in May 1971 showed chronic
active hepatitis. He was referred to King's College Hospital in January 1972.
On physical examination he had numerous spider naevi and hepatomegaly.
Investigations showed normal hlood picture and prothrombin time. Liver
function tests were*- serum bilirubin 9.2mg,/lOQm.l. j alkaline phosphatase
198 I.U./l.f aspartate aminotransferase 385 I.U./l.f total serum proteins
7.0g. /lOOml.f albumin 3.5g./lQ&al. and gamma globulin 1.4g./lOCtal. Serum
autoantibodies were negative but Australia antigen was repeatedly detected
in the serum by Immunoelectrophoresis. Liver biopsy showed florid chronic
aggressive hepatitis with rosettes and septum formation.
Treatment with azathioprine produced slow improvement in liver
function tests (Fig. 21).
Summaryt A 25 year old drug addict with Australia antigen positive active
chronic hepatitis who responded slowly and incompletely to azathioprine.
Case 4. This 40 yaar old woman felt tired and unwell in June 1971 and
became jaundiced for the first time in September 1971* There was no
history of drug ingestion, injections or contact with cases of hepatitis.
She gave no family history of liver disease. Her father died of chronic
chest disease and her mother of rheumatoid arthritis and renal failure.
Her two children were well.
On admission to King's College Hospital in December 1971 she was in
hepatic pre-coma with fetor hepaticus and a flapping tremor. Jaundice was
marked but there were no skin stigmata of chronic liver disease. The liver
was enlarged but the spleen was not palpable.
Investigations showed normal blood picture with prolongation of the
prothrombin time by 10 seconds. The serum bilirubin was §iag./lOOml.j
alkaline phosphatase 220 I.U./l.f aspartate aminotransferase 335 I.U./l.f
Total serum protein 7«8g./lOOml.f albumin 29g./lOOml,5 gamma globulin
3.8g./lOQml,f antinuclear factor (l/S20) and antibodies to smooth muscle
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(1/320) were present in high titre but mitochondrial antibodies and
Australia antigen were not detected.
Azathioprine was started together with protein restriction and
neomycin for the encephalopathy and because of the development in hospital
of ascites sodium restriction and diuretics ware also added. She was
also given 225g. salt poor albumin over 2 days at one point during her
hospital stay (Fig.22). Bj* the time of her discharge from hospital her
serum bilirubin had fallen to 2mg./l0Qmi. and aspartate aminotransferase
to 133 I.U./l. Her general condition and liver function tests continued
to improve. At the time of her last visit in November 1972 she was
clinically well taking a 60g. protein diet with no added salt, neomycin
lg. b.d., prednisone, 10mg. per day, azathioprine 75®g'» per day, and
spironolactone 50mg. b.d. Liver function test3 on this occasion had
however deteriorated a little with the serum bilirubin 4«7®g./lOOml. and
serum aspartate aminotransferase greater than 250 I.U./l.
Summary A 40 year old woman with active chronic hepatitis with autoimmune
features who responded slowly clinically and biochemically to corticosteroids
but who showed recent slight deterioration in liver function.
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APPENDIX D
CLIHICAL DETAILS OF LIVES TRANSPLANT RECIPIENTS
Case 1 This 41 year old man presented with abdominal pain and swelling.
At laparotomy he was found to have a vascular primary hepatoma involving
both lobes of the liver. He was referred to King's College Hospital for
transplantation. Orthotopic transplantation was performed on 23rd
September 1968 the donor being a 13-year-old boy who had died from head
injuries. The immediate post-operative course was uncomplicated and he
was ambulant by the fourth post-operative day and was discharged home
on the seventeenth day. On the third post-operative day liver function
tests were normal apart from serum bilirubin 1.8mg./lOOml, but thereafter
they became increasingly disturbed, the serum bilirubin reaching a peak
of 13.4mg./lOOml. and aspartate aminotransferase 233 Units/lOQml. on the
21st day. Liver biopsy showed features consistent with rejection and his
immunosuppressive therapy with prednisone, azathioprine and antilymphocyte
globulin was temporarily increased (for details see Case 4 in Calne, et al,
1968). There was a progressive improvement in liver function the bilirubin
falling to 2.2mg./l00ml and he returned to work in the 6th week.
Prom the 9th week onwards there was a progressive rise in serum bili¬
rubin (Pig. 29) to levels of 30-40mg./100ml. and alkaline phosphatase to
170 K.A.j/nits/lOOml. and the serum transaminase fluctuated around 200 Units/
100ml. Despite massive immunosuppressive therapy his cholestatic jaundice
progressed and he developed a chest infeotion and fungal meningitis (for
details see Case 4, Williams et al, 1969)*
At necropsy (four and a half months after transplantation) the biliary
and vascular anastomoses were well healed and there was no extrahepatic
cause for obstructive jaundice. Liver histology showed dense cholestasis
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and periportal and centrilobular fibrosis with early septum formation but
no true cirrhosis. Branches of the hepatic artery had thickened walls
with lipid filled macrophages in the intima, appearances very similar to
those seen in chronic rejection of renal grafts. On the basis of these
findings and the demonstration of immunoglobulin in the vessel walls by
an immunofluorescent technique (Andres et al, 1972) the late phase of
progressive jaundice was thought to be due to chronic rejection.
Case 2. This 17-year-old boy was admitted to King's College Hospital
on December 12th 1968 with a diagnosis of subacute hepatic necrosis
proceeding to cirrhosis. In November 1968 he had had his first episode
of coma. He responded partially to protein restriction and neomycin but
further deterioration occurred on December 11th and at the time of
admission he was in deep coma with marked hepatic fetor. He was unresponsive
to noise or pain stimuli and his pupils were widely dilated and
unresponsive to light.
Orthotopic hepatic transplantation was done later that day and 12
hours following this the patient regained consciousness and he was talking
on the second day. The E.E.G. showed striking improvement (Parkes, Hurray-
Lyon and Williams, 1970). He was not given immunosuppressive therapy
because of the possible danger of reactivating the presumed viral hepatitis
infection. On the fifth post-operative day his temperature rose and he
became confused and the following day he deteriorated further and died
suddenly. Liver function which had improved initially deteriorated
markedly in the last few days (Pig. 30j see also ?/illiams et al, 1969*
Case 8). Necropsy showed centrilobular haemorrhage and cell necrosis.
Portal tracts were ©edematous and contained a dense infiltrate of
inflammatory cells including large lymphoid cells with pyroninophilic
cytoplasm. The appearances were thought to be consistent with acute
rejection.
Case 3, This 31 year old woman presented in May 1970 with abdominal
pain and dia$thoea and on investigation was found to have carcinoma of
the colon with hepatic metastases. In June the primary tumour was removed
and in August because there was no evidence of spread outside the livert
orthotopic liver transplantation was performed. The post-operative course
was uneventful except for an episode of early rejection accompanied by a
transient rise in bilirubin to 2.5mg*/lOOml. (Fig.3l). Liver biopsy on
the fifth day showed mononuclear cell infiltration and foci of liver cell
mecrosis typical of acute rejection. Temporary increase in immunosuppressive
therapy (prednisone 20Gmg./day and Actinomycin C, 3 doses of 200ug. and
azathioprine 150mg./day) resulted in gradual return of liver function tests
to normal.
The patient was discharged home on the 39th post-operative day taking
50mg. prednisone and 150 mg. azathioprine daily. Shortly after this she
started to complain of pain in the left shoulder and dorso-lumbar region
and began to lose weight. She died cachectic on January 10th 1971 and
necropsy confirmed carcinomatosis. Histological examination of the liver
showed no evidence of rejection.
Case 4. This 60 year old man presented in April 1971 with an eighteen
month history of ?/eight loss and more recent abdominal distension.
Investigation in King's College Hospital in November 1971 showed a porrly
differentiated adenocarcinoma in the liver, probably a cholangiocarcinoma.
There was no evidence of extrahepatic tumour.
He underwent laparotomy on 25th December 1971 and as the tumour was
found to involve both lobes of the liver orthotopic transplantation was
performed. The biliary anastomosis was bile duct to bile duct over a tube
(stent) which passed down 2cm. into the recipient's common bile duot and
brought out to the surface through the done of the liver.
His general condition was satisfactory in the immediate post-operative
period but the bilirubin remained around ^ng./lOCtol. On the 6th day the
bilirubin rose to 12mg./lQ0ffil. (Fig.32) and bile drainage stopped. Following
infection of contrast medium through the stent (no radiological evidence
of obstruction) the bilirubin gradually fell and reached 5mg./lOQml. on
day 13. It was felt that the episode of jaundice had been obstructive
in nature and no change was made in the immunosuppressive therapy (prednisone
60mg. and aaathioprine 75nig./day).
His general condition remained good and the stent was removed on the
18th day. Following this he experienced abdominal pain and there was a
progressive rise in serum bilirubin (Fig.32). On the 30th day laparotomy
was undertaken and a choleeyetenterostomy was performed. There was a
temporary fall in serum bilirubin but his condition again deteriorated
and the clinical course was marked by increasing jaundice, rigors thought
to be due to cholangitis and renal failure. He died 51 days after
transplantation.
At necropsy the biliary anastomosis was found to be infected and
partly obstructed by a small piece of tubing originating from the stent.
There were widespread infiltrates in most organs with Candida albicans
which was also grown from blood cultures.
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lness 4 30-34 date of 4 Less than-60 months
years 5 35-39 completing 5 Less than 72 months
6 40-44 form 6 Over 72 months (6 years
7 45-49 Y N.K.
8 50-54
9 55-59
X 60 yr and over
Y N.K.
.13 0 Full-time employment
-asent 1 Part-time employment
—3upa- 2 Not employed
)nal 3 Unemployed - economic
—itus 4 Unemployed - due to illness
Y N.K.
,14 0 Student No. 15 0
lial 1 Class 1 Menstrual 1
tss - 2 Class 2 status 2
;istrar 3 Class 3 3
leral 4 Class 4 4








Pregnant, first 6/l 2






























































Child under 14- yr
Single
Married now




























Viral hepatitis - acute viral











Up t' "1.0 units/week ~ v ... . ..
" " PC ^nits/week 1 unit = > pint of beer or
„ „ „ ' „ (1 double measure spirits
« n "
ft «t c-* « tt
51 or more units/week
Unrein able; ? under 30 units/week














None No. 22 0 None
-5 Past 1 Viral hepatitis - avh
-10 medical 2 Viral hepatitis - serum
-15 history - 3 Drug-induced





41 oi „nre 9 More than one of these









0 None No. 24 0 No children
1 1 Age of 1 1 year
2 2 youngest 2 2 w
3 3 child in 3 3 n
4 4 years 4 4 "
5 5 5 5 n
6 e 6 6 ■
7 7 7 7 "
8 8 or more 8 8 c -<
Y N.K. 9 5'or more
Y N.K.
0 None of these
1 Lethargy
(specify cause as2 Abdominal pain final clinical diagnosis)
3 Loss of libido
4 Lethargy and loss of libido
5 Pain and loss of !libido




0.26 0 None of these
ymptcms 1 G-um bleeding
n last 2 G-I bleeding
months 3 Weight loss
if Gum and G-I bleeding
5 Gum bleeding and weight less












4 Abdominal pain and swelling
5 Abdominal pain and ankle edema






























2 Poor nutrition (no wasting)
3 Poor nutrition (must include wasting)
Y N.K.



















(False) localising CNS signs
ir. * •-«
Exanuna- 1
- ,« • ••u
I •• t> spiders
tirn 2 6 or more spiders
e) Spider Y N.K.
nevi 2
Nfo.33 0 None of these
Examina¬ 1 1 ,s " Testicular hypotrophy
tion 2 2 " " Less of 2° sexual hair
f) 2° Sex 3 3 " " Smooth facial skin (includes reduced shaving)
characters 4 4 w n Gynecomastia
Y N.K.
-To.34 0 None of these
"ixamina- 1 1 " " Raised J.V.P.
;ion 2 2 " 51 Ankle edema in absence of ascites
-;) C.C.E. 3 3 " " Pulmonary edema
4 4 " " Abnormal rhythnv'sounds
Y N.K.
h.35 0 Impalpable No.36 0 No ascites
bcamina- 1 Loss than 2 cm, smooth Examination 1 Ascites doubtful
;ion 2 " M 4 " i) Ascites 2 Ascites present
t) liver 3 m « g r» n Y N.K.
dge belcw 4 iw v> Q n n
ostal r-.3 9 or more cm, smooth
iargin 6 Less than 2 cm, nodular
. C • L 0 7 ax «» " "
0 a* n g 11 it
9 re n g n it
X 9 or more cm, nodular
Y N.K.
O.37 0 Impalpable No.38 0 None
xamina- 1 Less than 2 cm Examination 1 Probable, legs
—ion 2 " " 4 k) Peri- 2 Certain, legs
) Spleen 3 " R 6 pheral neurc -3 Probable, arms
ip (cin 4 '' " 8 pathy 4 Certain, arms
slew xiphi--5 K 85 10 5 Probable arms, certain legs
ternum) 6 11 or more cm 6 Both probable
Y N.K. 7 Both certain
Y N.K.
3.39 0 None detected
—camina- 1 Rheumatoid polyarthritis
Lon 2 Spinal disease/S-iliitis
-) 3 Other moiaoar thritis
"thritis 4 Other polyarthritis
5 More than one of these
6 Hemochromatosis arthropathy only
7 n K and rhamatoid disease
8 " ** and other joint disease
Y N.K.
.40 0 Not confirmed
ray cr 1 Confirmed by biopsy
opsy 2 Confirmed by X-ray
nfirma- 3 Confirmed by biopsy and X-ray
on cf Y N.K.
thritis
.41 0 Skin normal No.42 0 Not present
amina- 1 Purpura Steat'*r- 1 Present
on 2 Xauthomata rhcea Y N.K.
Skin 3 Shovel skin disease (specify) (over 7 gm
—sions Nodular vasculitis fat/day)
5 Perianal lesicn(s)
6 Cther










































































None given No .2,4 0 None given
Still continuing Current 1 Less than 10 mg daily
Ceased in last 3 months therapy - 2 tt « 20
U IT* » g tt Steroids 3 « 11 30 «
fih ti tt C) n (in mg 4 W " 40 "
n in " 12 « equiv. 5 u « 50 n
tt n " 15 n Predniso¬ 6 n 60 "
*1 tt " 18 tt lone ) 7 w 70 n
H n « 21 n 8 71 mg daily or more








Aldosterone antagonists and thiazides
Aldosterone antagonists and other
All three
N.K.
None given Ne.47 0 Never
Still continuing Recent 1 In last 1 month
Ceased in last 3 months therapy - 2 tl « 2 n
M tt 6 " Venesec¬ 3 W tt ^ 51
« « 9 * tion 4 tt n
tt It 1 2 5 tt « ^ n
tt ti 15 " 6 W tt g H
tt «C 18 w 7 « tt y it
H tt 21 * 8 w M g n
Ceased over 21 months ago 9 tt M ^ tt
N.K. X Over 9 months ag®
Y N.K.
None No .49 0 Over 15
Less than 5 gm Current 1 34-13





31-35 7 2 gn$o and. below
36-40 Y N.K.
41 gm and more
N.K.
Up to 2.000 inclusive No. 51 0 0-4
K 4,000 tt Current 1 5-9
6,000 tt E.S.R. 2 10 - 14
K 8,000 tt mm/br 3 15 - 19
* 10,000 tt 4 20 - 24
" 12,000 tt 5 25- 29
»' 34,000 tt 6 30-34
14,001 and over 7 35 - 39
N.K. 8 40 - v+
9 45 - 49
X 50 and over
Y N.K.
Less than 50 No. 53 0 Normal " •































































0,1,2 No. 55 0 2 or less
3,4 Current 1 3-4
5,6 prothom- 2 5-6
7,8 bin time 3 7 - 8
9,10 (sec. pro¬ 4 9-10
11,12 longed over 5 11 or more




0-5 No. 57 0 132 - 46 mEq/l
6-15 . Current 1 90 - 103
16-25 Serum Na+ 2 104 - 117
26-33,. mEq/l 3 118- - 131
36-45 4 147 - 160
46-55 5 160 - 174
56-65 Y N.K.
2 4 2
66 and over .
N.K.



























No. 59 0 0-1
Current 1 1.1 - 2
serum bili¬ 2 2.1 - 3
rubin mg/t> 3 3-1 - 4
(I) 4 4.1 - 5
5 5.1 - 6
6 6.1 - 7
7 7.1 - 8
8 8.1 - 9
9 9.1 - 10
X Over 10.1 (See
Y N.K.
No. 61
SGOT i.u. 0 0-30
1 31 - 100
2 101 - 300
3 301 - 500
4 501 - 700
5 701 - 900
6 901 - 1100
7 1101 and over
Y N.K.
No.64 0 Not detected













10.0 mg$ and over
N.K.
I
0.661 0 No. 67 0
iver 1 Liver 1
iopsy - 2 biopsy 2
ode. 3 code. 3








3.69 0 0-50 mg^o
jrum Fe 1 51 - 100
$ 2 101 - 150
3 151 - 200
4 201 - 250
5 251 - 300
6 301 - 350
7 351 - 400
8 7-01 - 450





















0 None of these
1 1 H n
2 2 n it
3 3 n M
4 4 « W
Y N.K.
2^3
Varices on Ba. swallow
Hematemesis or melena


















1 Portal vein thrombosis
2 Collateral channels
3 Both
4 Shunt - Splenorenal
5 Shunt - Portocaval
6 Portal v thrombosis and surgical shunt
7 Collaterals and splenc-renal shunt




1 8 - 14
2 15 - 21
3 22-28
4 29 and over
Y N.K.
0 0-200
1 201 - 400
2 401 - 600
3 601 - 800
4 801 - 1000
5 1GC1 - 1200
6 1201 - 1400
7 1401 - 1600
8 1601 - 1800

















5 51 - 60 1
6 61-70
7 71 and over
Y N.K.
0 No antibodies
1 Smooth muscle (SM)
2 Mitochondrial (M)
3 ANN
4 SM and M
5 SM and ANF
6 M and ANF
7 SM and M and ANF
Y N.K.
8
Jo.77 0 No.78 0 244■Final 1 Final 1
diagnosis. 2 diagnosis. 2









0.79 0 Complete recovery
'."tcrne 1 Chronic course - alive
-S l-~7ear. 2 Dead in 6 months
3 Dead in 9 months
4 Dead in 12 months








Protein concentrations after liver transplantation are of
interest because most plasma proteins, other than the immuno¬
globulins, are made wholly or partly in the liver. The concentra¬
tions of eighteen immunologically distinct proteins have been
measured by a quantitative immunoelcctrophoresis technique1
in a single subject before and for 4.5 months after receiving an
orthotopic liver graft.
The recipient was a 41 year old man with a primary hepa¬
toma and the donor liver came from a 13 year old boy, who
died from head injuries. After the operation, carried out by
Professor R. Y. Calne, the patient made a good recovery and
was discharged on the seventeenth day. During the second
week he showed some evidence of rejection, but after a tempo¬
rary increase in immunosuppressive therapy he improved and
was able to return to work in the sixth week. Unfortunately, he
later developed progressive jaundice which was attributed to
chronic rejection and died at 4.5 months from fungal menin¬
gitis2.
The changes in serum protein concentrations observed led
to the definition of two principal groups of proteins. Group (A)
included those proteins which stayed at a normal or increased
concentration from the time of transplantation to death. These
proteins included haptoglobin, a, antitrypsin, caeruloplasmin,
group component, and a, acid glycoprotein (Fig. 1). The
concentrations of all these proteins were increased pre-opera-
tively, probably because of necrosis in the tumour, and the
concentrations remained high after the transplant. These
proteins are often called acute-phase proteins, and Werner and
Cohnen3 showed that their concentrations increased after
surgery, but returned to pre-operative levels within 18 days of
uncomplicated surgical trauma. The persistence of increased
concentrations in our patient beyond this time was probably
a reaction to the early rejection episode. At the fifty-sixth day,
the concentrations of these and the other sixteen plasma pro¬
teins measured were normal, but during the subsequent pro¬
longed phase of chronic rejection, the acute-phase protein
concentrations were again maintained above normal.
Days after transplantation
Fig. 1 Serial serum concentrations of haptoglobin (a), Cii
antitrypsin (6), albumin (c), transferrin (d) and A-C globulin
(e) expressed as a percentage of a standard serum. Serum
bilirubin concentrations are also shown.
Group (B) proteins included those that decreased gradually in
concentration after the transplant, particularly after the eightieth
day. They included albumin, transferrin and haemopexin.
The a, lipoprotein concentrations also decreased throughout
the study but at a greater rate than the other proteins mentioned.
Because there was no reason for increased catabolism, the
low concentrations of these proteins suggest either that there
was no stimulus for synthesis or that the liver was unable to
respond because of impaired parenchymal cell function. It
is interesting therefore that at the same time the liver was
able to maintain other proteins such as haptoglobin and
antitrypsin at concentrations above normal. These changes
may be a consistent feature of the acute-phase reaction3,4.
The changes in two other proteins not included in our two
groups are interesting. Thyroxine binding prealbumin behaved
differently from the other proteins in that its concentration
decreased initially, at the time of the marked increase in
acute phase proteins, and again during (he second increase
in acute phase proteins after the eightieth day. Similar changes
have been observed after simple surgery and virus infections4.
The concentration of Pi A-C globulin (the third component of
complement C'3), which is probably synthesized solely in the
liver5, decreased significantly in the first 17 days at the time of
the acute rejection episode (Fig. 1). At the beginning of the
period of chronic rejection, the concentration was also greatly
depressed but later, when infection may have been an important
stimulus to synthesis, it increased to normal. Hypercatabolism
of C'3, sometimes with a decline in serum concentration, has
been shown during episodes of renal graft rejection6 and this
seems a more likely explanation than poor hepatic synthesis
for the changes observed in our patient during rejection of the
liver graft, as increased concentrations were found later in the
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NTITATIVE IMMUNOELECTROPHORESIS OF SERUM PROTEINS IN
PTOGENIC CIRRHOSIS, ALCOHOLIC CIRRHOSIS AND ACTIVE
ONIC HEPATITIS
M. MURRAY-LYON, H. G. MINCHIN CLARKE, K. McPHERSON and ROGER
MAMS
:al Research Council Group on Metabolism and Haemodynamics of Liver Disease, King's
e Hospital, London, S.E.5., and Clinical Research Centre, Northwick Park Hospital, Harrow,
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ived February 2, 1972)
1ARY
Measurements of the concentrations of 10 serum proteins by quantitative im-
telectrophoresis, in 42 patients with inactive cryptogenic cirrhosis, alcoholic cir-
> and active chronic hepatitis, showed that a2-macroglobulin was increased in all
diagnostic groups and caeruloplasmin in two—alcoholic cirrhosis and active
ic hepatitis. In the latter condition transferrin and x1 easily precipitable glyco-
in were also elevated. Reduced concentrations of transferrin were found in al-
c cirrhosis and of haptoglobin in active chronic hepatitis.
These changes showed little correlation with clinical data including liver func-
2sts. The greatest disturbance in plasma protein concentration was observed in
chronic hepatitis and although the pattern was not typical, the mechanism may
t be an "acute phase reaction" to inflammatory changes in the liver. The fall in
jlobin is unexplained as is the mechanism of the rise in a2-macroglobulin.
The finding of normal haemopexin levels in all three groups, is of interest in
n to the marked increases previously reported in haemochromatosis, and further
of this apparently specific abnormality is indicated.
1UCTION
The majority of serum proteins are synthesized in the liver and certain patterns
rrbance have been described in different types of liver disease, although the
;tic value of conventional serum electrophoresis with separation into albumin
e globulin peaks has proved rather limited1. Each of these globulin peaks in-
may different proteins, and indeed by quantitative immunoelectrophoresis it
—ble to demonstrate the presence of at least 50 immunologically distinct serum
s, although only a few can be identified with certainty. We have already re-
the changes found in the sera of patients with haemochromatosis analysed by
Clin. Chim. Acta, 39 (1972) 215-220
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technique2. In this paper we describe an extension of that study to three other
js of chronic liver disease.
ERIMENTAL
ients
The 42 patients comprised 12 with inactive cryptogenic cirrhosis, 12 with
holic cirrhosis and 20 with active chronic hepatitis, of whom 13 had established
tiosis. In all but 2 cases liver biopsy was performed and separation between the
ips was made according to current clinical, biochemical, histological and immuno-
:al criteria3.
trophoresis
The concentrations of 10 serum proteins, namely oq-lipoprotein, ocl easily pre-
table glycoprotein, a2 group component, a2-macroglobulin, caeruloplasmin, pro-
No. 9 (ref. 4), haptoglobin, haemopexin, transferrin and /^-lipoprotein were
sured using a modification5 of Laurell's technique for quantitative immunoelec-
>horesis. Serum albumin was measured by standard paper electrophoresis.
istics
The protein levels for each patient were analysed statistically for correlations
ngst proteins and between protein changes and the clinical data. This was repeated
he 3 diagnostic groups so that relationships within the groups as well as in the
le series could be determined. The mean protein levels in the 3 diagnostic groups
: also compared with those previously found in 100 normal subjects5 and in those
haemochromatosis already reported2. Standard statistical techniques were used
ughout although adjustment of the distributions of all protein levels apart from
oglobin and haemopexin was necessary as these appeared to be log-normal6.
LTS
a2-Macroglobulin concentration was significantly increased in each of the 3 clini-
roups of patients (Table I). The patients with active chronic hepatitis also had
icantly higher levels of at easily precipitable glycoprotein, caeruloplasmin and
ferrin. Caeruloplasmin was raised in the patients with alcoholic cirrhosis. In con-
the only proteins to be significantly reduced were transferrin in alcoholic cir-
> and haptoglobin in active chronic hepatitis. The other five proteins namely
opexin, a2 group component, a.,- and /^-lipoprotein and protein No. 9 showed no
icant variation from normal.
In our previous study on 29 patients with haemochromatosis we found signifi-
ilevations of oc2 group component, a2-macroglobulin, caeruloplasmin and haem-
1. When the mean values for these proteins were compared with the correspond-
oires for the 3 groups of patients in the present study, the elevation of a2 group
inent and haemopexin in haemochromatosis was found to be significantly higher
• II). The mean level of haptoglobin in active chronic hepatitis was significantly
than in haemochromatosis (p < 0.001). The scatter of values for the other pro-
ivas wide and no other significant differences could be detected between the
rent conditions for which data is now available.
Clin. Chim. Acta, 39 (1972) 215-220
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TABLE II
COMPARISON BETWEEN THE MEAN PLASMA CONCENTRATIONS OF <X2 GROUP COMPONENT AND HAE]
PEXIN IN THE FOUR DIAGNOSTIC GROUPS
Values and symbols are as in Table I.
Groups a2 Group Haemopexin
compared component
Haemochromatosis with 138 156
cryptogenic cirrhosis 97*** 104* * *
Haemochromatosis with 138 *56
alcoholic cirrhosis 93*** 102***
Haemochromatosis with 138 *56
active chronic hepatitis 105*** 108***
Significant positive correlations were found between otx easily precipita'
glycoprotein and oo-lipoprotein, and between a2 group component and haemope:
in active chronic hepatitis, alcoholic cirrhosis, cryptogenic cirrhosis and in haen
chiomatosis. In these 4 groups and in the normal subjects positive correlations wi
also noted between xx easily precipitable glycoprotein and both a2-macroglobulin a
haemopexin, and between transferrin and haemopexin. Significant negative corre
tions (p < 0.01) were found between ocx easily precipitable glycoprotein and albun
in alcoholic cirrhosis and haemochromatosis.
An analysis of the protein levels with 15 indicants derived from the clinical d
(these included clinical signs, evidence of portal hypertension and liver function te<
showed significant correlations only in the patients with active chronic hepatitis,
this group the oc1 easily precipitable glycoprotein and transferrin were positively c
related with serum alkaline phosphatase (p < 0.001).
DISCUSSION
Tissue damage or an inflammatory reaction, however caused, are known tc
accompanied by changes in the concentrations in the serum of certain proteins—
so called "acute phase reaction". Levels of some proteins including haptoglobin, ara
trypsin, caeruloplasmin, xl easily precipitable glycoprotein and a2 group compon
rise, whereas the concentrations of others including transferrin, albumin and try]
phan a-ricb prealbumin fall7-8. Various studies to-date have shown little change in
macroglobulin and haemopexin following surgical trauma7-8, although Laurell (
sonal communication) found a slow rise in haemopexin following cholecystecto
Although the most striking changes in protein concentrations were found in the
tients with active chronic hepatitis and alcoholic cirrhosis, which of the 4 condit
now investigated show the most marked inflammatory changes in the liver, the ov<
pattern of these changes was unlike the acute phase reaction. However, some of—
changes may be explicable on this basis.
Increased caeruloplasmin concentration has been reported previously in 1
disease9 although in severe parenchymal impairment it may be reduced below noi
and this can cause diagnostic confusion with Wilson's disease10. The mechanis
probably impairment of hepatic synthesis and this may also account for the si
reduction in transferrin and the more marked decrease of serum albumin concei
tion in those with alcoholic cirrhosis. The poor nutritional state of these patients
Clin. Chim. Acta, 39 (1972) 215-220
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in important factor as similar depression of albumin and transferrin is a striking
ure of kwashiorkor11.
The significant reduction of haptoglobin observed only in active chronic hepatitis
its comment. In several patients the level was so low that there was no visible
:ipitation arc. A tendency towards low levels in cirrhosis has been attributed to
chronic haemolytic state so often associated with liver disease, although Williams
\12 could find no direct correlation with measurements of red cell survival.
Our previous finding of increased serum haemopexin concentration in haemo-
-matosis needs to be considered in the context of the normal levels found in the
r 3 types of chronic liver disease. Braun and Aly13 found normal or low levels in
icsis but no details of the type of disease are given. Haemopexin transports iron
ie form of haem and belongs to the group of what have been termed "suicidal pro-
for after combining with haem the complex is catabolised, probably by the
nchymal cells of the liver14. The high levels in haemochromatosis are unexplained
may be due to the disordered iron metabolism. This protein is not usually con¬
ed to be an acute phase reactant but raised levels have been found in rheumatoid
itis15, tuberculosis16 and inflammatory bowel disease17.
The marked and consistent elevation of a2-macroglobulin in all four types of
disease is of considerable interest although its cause and significance are un-
m, for the only certain functions of this protein are antiplasmin and antitrypsin
ity18. Raised levels have also been noted by other workers in chronic liver
se18-19 although Miiller and Muller-von Voigt20 found normal levels in cirrhosis,
diepatic sites of synthesis may be important in maintaining these high levels19.
A slight fall in ^-lipoprotein levels with a normal concentration of /3,-lipopro-
grees with previous findings in a group of patients with unclassified cirrhosis20.
iup component was at normal concentration in our patients but reduced levels
been reported in cirrhosis19-20.
Although there do appear to be distinct differences in the pattern of abnormality
, the relationship of changes in particular proteins to the underlying liver disease
:companying inflammatory response is far from clear. So far we have been un-
0 find much correlation between the changes in protein concentration and
1 or biochemical assessment of the severity of disease. To examine this further
■ currently examining serial samples of sera from patients with active chronic
tis both before and after treatment with corticosteroids or azathioprine.
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QUANTITATIVE IMMUNOELECTROPHORESIS ON
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SUMMARY
1. The concentrations of a number of plasma proteins in patients with haemo-
hromatosis were determined by quantitative immunoelectrophoresis, particular
ttention being paid to the three iron transporting proteins.
2. Transferrin and haptoglobin were within normal limits; haemopexin was sig-
ificantly greater than normal (P< 0-001).
3. Other changes observed were a significant (PcOOOl) increase of ix1 antitrypsin,
—f a2 macroglobulin and /f1A_c; these changes are discussed.
ist three serum proteins are involved in the ordinary physiological transport of iron,
are, first, transferrin, which carries free iron. In normal circumstances transferrin is
•artly saturated, whereas in haemochromatosis it may be 90-100% saturated. Second,
;lobin; this binds haemoglobin, and although it is known that the mass of haptoglobin
—->lized per day is not enough to play a large role in the daily haemoglobin breakdown, it
:eivable that an upset in this mechanism could, over the years, account for an increase
deposition of iron. And finally, haemopexin transports iron in the form of haem. Very
known about the metabolism of this protein. It is thought (MiillerEberhard etal., 1969)
lemopexin is a 'suicidal' protein like haptoglobin, in other words, after haem has com-
vith haemopexin the two are catabolized together. There is some evidence to support
■pothesis, in that a low haemopexin is sometimes found in haemolytic conditions;
;r, the concentration of haemopexin seldom drops as low as is found for haptoglobin,
these reasons it seemed of importance to study the concentrations of these proteins in
V idiopathic haemochromatosis, a condition associated with a slow accumulation of iron
tissues and eventual portal cirrhosis, and to compare the concentrations found with
r the normal population. At the same time the concentration of eight other proteins
udied.
—pondence: Dr T. Freeman, National Institute for Medical Research, Mill Hill, London, N.W.7.
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MATERIALS AND METHODS
Twenty-nine patients with primary idiopathic haemochromatosis were studied. The diagi
of haemochromatosis had been confirmed in all the patients by liver biopsy which sh<
portal cirrhosis and Grade IV iron deposition according to the criteria of Scheuer, Will
& Muir (1962). Many of them had been under observation for several years. All but one
being or had been treated by weekly venesection for periods up to 3 years prior to the st
Protein estimation
Eleven proteins (al lipoprotein (oqLp), a1 easily precipitable glycoprotein (oqPGp), oq
trypsin^jAT), a2 Group Component (a2GC), a2 macroglobulin (a2M), caeruloplasmin(C
haptoglobin (Hpt), haemopexin (Hpx), transferrin (Trf), [i lipoprotein (/ILp) and /i1A_ci
were measured according to the technique of quantitative immunoelectrophoresis as mod
from Laurell's initial description (1965) by Clarke & Freeman (1968). Using this techniqu
area contained under each individual protein curve is proportional to the concentration ol
protein in the serum. It is also inversely proportional to the concentration of antibody tc
particular protein; thus to make the technique quantitative it is necessary to use a single
of antiserum throughout the study, and to use some form of standard. In this study the star
used was that originally described (Clarke & Freeman, 1968) obtained from a pool of \
human serum. The areas under the curves were measured using an electronic planii
designed by J. Lewin of the National Institute for Medical Research, and manufactun
Chemical Electronics Co. (C.W.S. Hall, Durham Road, Birtley, Co. Durham, England)
values used throughout the study as normal were those obtained in the previous stud;
cribed by Clarke & Freeman (1968).
RESULTS
A photograph of a separation of normal serum is shown in Fig. 1 and that of a haemoch
totic serum is shown in Fig. 2. Table 1 gives the values for the twenty-nine patients with h
chromatosis and 100 normal subjects aged 16-65, giving means and SD. The sign
differences obtained between the normal group and patients are shown.
DISCUSSION
The present study has shown highly significant differences in protein concentration b
the patients with haemochromatosis and the normal subjects. It should be noted that
ferrin, the only protein transporting free iron, is within the normal range. In the light
concentrations obtained for other proteins, perhaps this is the most remarkable feature
study. There are no significant correlations between the protein concentrations measur
any of the clinical data, which included duration of venesection therapy and extent
overload at the time of measurement. The exact relationship between tissue damage ai
overload is difficult to determine, and recently Smith et al. (1969) were unable to corre)
clinical findings at the time of presentation with the total body iron store measured
differential ferroxamine technique.
A close relationship between haemopexin and the a2 Group Component was found (r
oroso
Fig.1.Aquantitativeimmunoelectrophoreticanalysisofn rmalseru , showingai-lipoprotein(a,Lp),,e silyprecipitableglycoprotein(jqP Gp),a,antitrypsin(a,AT),2Groupcomponent(a2GC),a2macrogIo- bulin(a2M),caeruloplasmin(Caer),haptoglobin(Hp ),haemopexin (Hpx).
(Facingp.614)
Fig.2.Aquantitativeimmunoelectrophoreticanalysisofserumfroma patientwithhaemochromatosisshowingthesamproteinsindicated inTable1.
Iron binding proteins in haemochromatosis 615
17, PcO-OOl). The reason for this is not clear. The function of the a2 Group component is
nown, but similar correlations between these two proteins have been noted in other con-
ins (Clarke, Freeman & Pryse-Phillips, 1970a). The interpretation of this finding must wait
I more is known about the metabolism and function of Group component, and indeed of
nopexin.
hilst it is appreciated that the measurement of concentration is not a valid way of assessing
tbolism of a protein, it would appear from this study that two of the three known iron
;porting molecules, transferrin and haptoglobin, are within normal limits, and that
Table 1. Protein concentrations (Mean Values and SD, expressed as
per cent reference serum) in twenty-ninepatientswith haemochromatosis
and 100 normal subjects
Haemochromatosis Normals Statistical
significance
Protein Mean (SD) (SD) Mean of difference
axLp 139 (46) 127 (20) —
ajPGp 142 (27) 115 (19) —
aiAT 152 (39) 114 (18) <0 001
a2GC 138 (41) 117 (15) <0-05
a2M 215 (68) 122 (25) <0 001
Caer 173 (59) 137 (25) <001
Hpt 113 (71) 103 (44) —
Hpx 156 (49) 107 (13) <0 001
Trf 119 (36) 110 (15) —
ySLp 146 (85) 177 (43) —
/?1A-C 155 (69) 107 (24) <0 001
n 29 100 —
>pexin is significantly above normal. From measurements of concentration alone it
t be said whether the increased concentration of haemopexin is due to an increase of
:sis or to a decrease in catabolism. Nor can it be said whether the increase is related to
tiology of haemochromatosis or merely the resultant of a high body iron load at some
uficantly high values for haemopexin have been found in other conditions: in active
ulosis (PcOOOl) but not in sarcoidosis (Clarke, et al., 1970a); in schizophrenia (P<
but not in epilepsy (Clarke, Freeman & Pryse-Phillips, 1970b); and to a lesser extent in
—atoid arthritis (P<0-05) (Clarke, Freeman & Pryse-Phillips, to be published). It could be
that all four conditions (tuberculosis, schizophrenia, rheumatoid arthritis and haemo-
—atosis) show protein changes consistent with the 'acute phase reaction'. This ill-defined
commonly used to describe that group of proteins which increase in concentration after
iamage. The concept is supported by an increase in ax antitrypsin in all four conditions
llosis, haemochromatosis and rheumatoid arthritis (P< 0-001), and schizophrenia
)5); however, the changes in concentration in other proteins are not similar, for example
iplasmin is increased in tuberculosis (P< 0-001) and in haemochromatosis (PcO-Ol)
t in rheumatoid arthritis or schizophrenia, and x1 easily precipitable glycoprotein is
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normal in haemochromatosis and rheumatoid arthritis but raised in active tubercu
(P=0-001) and to a lesser extent in schizophrenia (P<0'05). Finally haptoglobin, whii
often quoted as an example of an 'acute phase protein', is normal in haemochromatosis.
increased in tuberculosis (mean 378, n= 16, P<0-001) and rheumatoid arthritis (mean=
n= 18, PcO-OOl). It is however conceivable (though we think unlikely) that the normal
centration found for this protein in haemochromatosis is the resultant of increased syntl
('acute phase') and increased catabolism due to combination with haemoglobin. This f
can only be decided by metabolic studies using trace labelled haptoglobin.
The large increase in a2 macroglobulin seen in haemochromatosis is of some inte
Although a controlled study of other diseases with primary liver damage is not yet com;
it seems probable that similar high concentrations will be found. Again it is not clear wh
this is due to increased synthesis or to decreased catabolism, though high protein conce
tions are usually due to increase in synthesis. High concentrations of oe2 macroglobulin an
found in the new born (Abrams & Freeman, 1969), in children (Abrams, 1970) and in y
adults (Clarke & Freeman, 1968). The physiological reason for this is not known. Finalh
high significant increase (PcO-OOl) in concentration of /?lA_c (the third component of
plement: C'3) is unexplained. It would seem likely that this too is consequent to other p
logical processes, and is not necessarily related to its complement activity.
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